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Regulation by endogenous dopamine of the expression of the clock protein, 
PERIOD2, in the forebrain of the male Wistar rat. 
Suzanne Hood, Ph. D. 
Concordia University, 2010 
Daily exposure to light is the most powerful means of entraining circadian 
rhythms of clock gene expression in the suprachiasmatic nucleus (SCN), the 
body's master timekeeper, and in other brain regions and peripheral tissues; 
however, a variety of non-photic stimuli have also been found to entrain rhythmic 
clock gene expression in the brain, including motivationally significant events 
such as stressors and rewards. The present experiments investigated the role of 
the neurotransmitter, dopamine (DA), in entraining the daily rhythm of the clock 
protein, PERIOD2 (PER2), in the SCN of the male Wistar rat, as well as in 
several regions of the limbic forebrain that regulate motivational states: namely, 
the dorsal striatum, the oval nucleus of the bed nucleus of the stria terminalis 
(BNSTov), the central nucleus of the amygdala (CEA), the basolateral amygdala 
(BLA), and the dentate gyrus (DG). In the dorsal striatum, the normal daily peak 
of PER2 expression was blunted following selective destruction of midbrain DA 
neurons with 6-hydroxydopamine (6-OHDA) and after blockade of D2 DA 
receptors with the antagonist, raclopride, whereas daily injections of a D2 agonist 
but not a D1 agonist restored and entrained the PER2 rhythm in the 6-OHDA-
lesioned striatum. Disruption of catecholamine signaling in general using 
systemic injections of the tyrosine hydroxylase inhibitor, alpha-methyl-para-
iii 
tyrosine (AMPT), or daily morphine injections and withdrawal of morphine also 
blunted the normal PER2 peak in the dorsal striatum. Together, these results 
suggest that daily stimulation of D2 receptors is necessary for the striatal PER2 
rhythm. In the BNSTov and CEA, daily injections of a D2 agonist or morphine 
increased PER2 expression near the time of injection, but other manipulations of 
DA signaling or catecholamines in general had no effect on PER2. In the BLA 
and DG, disruption of catecholamine signaling using AMPT or morphine 
injections blunted the normal PER2 peak in these regions but DA-selective 
manipulations had no effect on PER2. None of these manipulations affected the 
normal PER2 rhythm in the SCN. Taken together, these findings indicate that 
daily stimulation of D2 receptors regulates the PER2 rhythm in the dorsal 
striatum, and that DA does not directly contribute to the normal PER2 rhythm in 
the SCN or in any other forebrain region examined. 
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Chapter 1 
Figure 1. 53 
PER2 immunoreactivity fluctuates in a 24-h rhythm in the dorsal striatum (top 
row) and the SCN (bottom row). Rats housed in a 12:12 LD cycle were killed at 
4-h intervals over 24 h beginning 1 h after lights were turned on (ZT1). In the 
dorsal striatum, PER2-immunoreactive (IR) nuclei are most abundant around 
ZT1, whereas in the SCN, PER2-IR nuclei are most abundant around ZT13. 
Scale bar= 100um. 
Figure 2. 54 
In rats housed in a 12:12 LD cycle, the 24-h rhythm of PER2 immunoreactivity in 
the dorsal striatum (a) is opposite in phase to the rhythm of PER2 expression in 
the SCN (b). The daily fluctuations in extracellular striatal dopamine (DA) levels 
(c) and wheel-running activity (d) peak at night, preceding the peak of PER2 in 
the striatum. In each panel, the grey block indicates the time of day when lights 
were off (between ZT12-24). (a) In the dorsal striatum, PER2 expression is 
greatest at ZT1, near the beginning of the light phase, and is lowest during the 
dark phase (expressed as mean number of PER2-IR nuclei ± SEM at each ZT; n 
= 4 per ZT). (b) In the SCN, PER2 expression is greatest at ZT13, near the 
beginning of the dark phase, and is lowest during the light phase, (c) In vivo 
microdialysis sampling in the dorsal striatum shows that extracellular DA levels 
are lowest during the middle of the light phase and highest in the middle of the 
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dark phase (expressed as mean pg DA/ul dialysate ± SEM, samples taken every 
30 min; n = 3). (d) Wheel-running activity is also greatest during the dark phase 
and is virtually absent during the light phase (expressed as mean wheel 
revolutions/10 min bin over 24 h ± SEM; n = 24). 
Figure 3. 56 
Photomicrographs showing the effect of unilateral injection of 6-OHDA into the 
MFB on dopamine transporter (DAT) immunoreactivity (shown in black) in the 
dorsal striatum ipsilateral to the injection. Lack of stain on the 6-OHDA side 
indicates a loss of DA input to the striatum in the lesioned hemisphere. Rats 
were killed 14 days after receiving a unilateral 6-OHDA injection (8 pg). 
Figure 4. 57 
A unilateral 6-OHDA injection into the MFB selectively reduces the normal 
morning peak of PER2 expression in the dorsal striatum ipsilateral to the lesion 
but does not affect the PER2 rhythm in the SON. (a,c) Photomicrographs 
showing PER2 expression in the intact and 6-OHDA-treated hemispheres in the 
dorsal striatum (a) and SCN (c) in rats killed at ZT1 or ZT13. (b, d) Means± SEM 
of PER2 immunoreactive (IR) nuclei on the intact and lesioned hemispheres in 
the dorsal striatum (b) and SCN (d) in rats killed at ZT1, 7, 13 and 19, two weeks 
after 6-OHDA treatment (n = 5-6 per ZT). (* indicates a significant difference 
between the intact and lesioned hemispheres, p < 0.05). 
Figure 5. 60 
Intra-MFB injection of 6-OHDA blunts the daytime increase in PER2 expression 
in the dorsal striatum (a) whereas a vehicle injection into the MFB has no effect 
(d) (expressed as mean PER2-IR nuclei at each ZT ± SEM; n = 3 per ZT). In the 
SCN, neither a unilateral 6-OHDA injection (b) nor a vehicle injection (e) into the 
MFB disrupts the daily fluctuation in PER2 expression. In contrast to the 
selective effect of 6-OHDA on PER2 in the dorsal striatum, nighttime wheel 
running activity (expressed as mean wheel revolutions/10 min bin over 24 h ± 
SEM) is decreased after a unilateral intra-MFB injection of either 6-OHDA (c) or 
vehicle (f). (* indicates a significant difference between the intact and lesioned 
hemispheres, p < 0.05). 
Figure 6. 61 
A unilateral 6-OHDA lesion selectively reduces the normal morning peak of 
PER1 expression in the dorsal striatum ipsilateral to the lesion but does not affect 
the PER1 rhythm in the SCN. Means ± SEM of PER1 immunoreactive (IR) 
nuclei in the intact and lesioned hemispheres in the dorsal striatum (a) and SCN 
(b) in rats killed at ZT1, 7, 13 and 19, two weeks after 6-OHDA treatment (n = 5-6 
per ZT). (* indicates a significant difference between the intact and lesioned 
hemispheres, p < 0.05). 
Figure 7. 64 
Inhibition of tyrosine hydroxylase activity suppresses DA levels and daytime 
PER2 expression in the dorsal striatum. Rats were given 3 injections of AMPT or 
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saline over 8 h and then killed at either ZT13 (5 h after the last injection) or ZT1 
(17 h after the last injection), (a) DA content in the dorsal striatum (expressed as 
pg DA/ug protein) in AMPT-injected rats (black bars) was significantly decreased 
at both ZT1 and ZT13 compared to saline-injected rats (white bars, n = 2 per 
treatment group per ZT; * p < 0.05). (b) In the dorsal striatum, AMPT treatment 
decreased daytime PER2 expression atZT1 and increased PER2 atZT13 
compared to saline controls (expressed as mean PER2-IR nuclei ± SEM at each 
ZT; n = 4 per treatment group per ZT; * p < 0.05). (c) In the SCN, AMPT 
treatment had no effect on PER2 expression at either time point. 
Figure 8. 66 
A unilateral 6-OHDA infusion into the MFB has no effect on PER2 in primary 
motor cortex (M1) or in the dentate gyrus (DG), whereas treatment with AMPT 
strongly suppresses the normal peak of PER2 expression in each of these 
regions. Mean PER2-IR nuclei ± SEM in the intact and 6-OHDA lesioned 
hemispheres of M1 (a) and DG (c) following a unilateral 6-OHDA lesion (n = 5 
per ZT). Mean PER2-IR nuclei ± SEM in primary motor cortex (b) and DG (d) 
following AMPT treatment (n = 4 per treatment group per ZT; * p < 0.05). 
Figure 9. 68 
(a) Continuous infusion of the D2 DA receptor antagonist, raclopride (2 mg/kg/24 
h), for 5 days via osmotic minipump reduces daytime expression of PER2 in the 
dorsal striatum, whereas infusion of the D1 DA antagonist, SCH 23390 (0.5 
mg/kg/24 h) has no effect (expressed as mean PER2-IR nuclei ± SEM at each 
xii 
ZT; n = 4 per treatment group per ZT). (b) Neither raclopride nor SCH 23390 
infusion affects PER2 in the SCN (* indicates a significant difference between 
raclopride and sham groups, p < 0.05). 
Figure 10. 71 
PER2 expression in the dorsal striatum and SCN and daily wheel running activity 
in 6-OHDA-lesioned rats injected daily at ZT1 with vehicle, the D2/3 agonist, 
quinpirole (0.5 mg/kg), or the D1 DA agonist, SKF 81297 (1 mg/kg). In the dorsal 
striatum (a, b, c), daytime PER2 expression was decreased on the 6-OHDA-
lesioned side in vehicle-injected rats (a) (expressed as mean PER2-IR ± SEM at 
each ZT; n = 7-8 per ZT). Daily injection of quinpirole (b) selectively increased 
PER2 expression at ZT13 in the dorsal striatum of the 6-OHDA lesioned 
hemisphere (n = 6 per ZT), whereas daily injection of SKF 81297 (c) had no 
effect on PER2 in either the lesioned or intact hemisphere (n = 3 per ZT). PER2 
expression in the SCN was not affected any of these treatments (d, e, f). The 
normal 24-h rhythm in wheel running during the 10-day injection period (g, h, i) 
was not disrupted by daily vehicle injection (g, expressed as mean wheel 
revolutions/10 min bin over 24 h ± SEM; n = 15). Quinpirole injection (h) 
suppressed nighttime wheel running (n = 12), whereas SKF 81297 injection (i) 
increased daytime wheel running (n = 6), particularly in the hour before the 
injection was given (ZT0-1). (* indicates a significant difference from the intact 
hemisphere; ** indicates significant difference from vehicle group lesioned 
hemisphere, p < 0.05; § indicates a significant difference from the vehicle group, 
p < 0.05). 
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Figure 11. 74 
Continuous infusion of the D2/3 agonist, quinpirole (0.5 mg/kg/24 h; n= 2-3 per 
ZT), or the D1 DA agonist, SKF 81297 (1 mg/kg/day; n=2-3 per ZT), for 10 days 
via osmotic minipump has no effect on mean (± SEM) PER2 expression in either 
the 6-OHDA lesioned or intact dorsal striatum (b, c) or SCN (e, f) compared to 
sham surgery group (Fig. 10a, d; n=3-5 perZT). Neither treatment affected daily 
wheel running activity (expressed as mean wheel revolutions/10 min bin over 24 
h ± SEM; Fig. 10g, h, i). (* indicates significant difference from intact 
hemisphere, p < 0.05). 
Figure 12. 76 
Central panel shows high magnification (X100) images depicting dorsal striatal 
neurons double stained for PER2 and GAD-67, D2 DA receptor, D1 DA receptor, 
enkephalin (ENK) or substance P (SP). Images in left and right panels are 
enlargements of framed cells in corresponding central panel, (a) Double 
immunostaining for GAD-67 (brown cytosolic stain) and PER2 (blue nuclear 
stain) reveals that many but not all GAD-immunopositive cells co-express PER2 
(shown with arrows, (b) Double-immunostaining for D2 DA receptor (brown 
cytosolic stain) and PER2 (black nuclear stain) revealed frequent co-expression 
of PER2 in D2 DA receptor-positive cells (marked with arrows), (c) Double 
immunostaining for D1 DA receptor (brown cytosolic stain) and PER2 (black 
nuclear stain) reveals segregation between PER2 and D1 DA receptor 
immunostaining. (d) Double immunostaining for enkephalin (brown cytosolic 
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stain) and PER2 (blue-gray nuclear stain) shows frequent co-expression (shown 
with arrows), (e) Double immunostaining for substance P (brown cytosolic stain) 
and PER2 (black nuclear stain) shows segregation between substance P and 
PER2. 
Chapter 2 
Figure 1. 95 
A unilateral 6-OHDA injection into the medial forebrain bundle decreases the 
normal peak of PER2 expression in the BNSTov (a) ipsilateral to the 6-OHDA 
injection, but has no effect on the normal daily fluctuation in PER2 expression in 
the CEA (b), the BLA (c), or the DG (d). For each brain region, data are shown 
as mean PER2-immunoreactive (IR) nuclei ± SEM perZT in the intact 
hemisphere (open circles) and lesioned hemisphere (black circles); n = 5-6 per 
ZT; * indicates p < 0.05 compared to intact hemisphere. 
Figure 2. 96 
Inhibition of catecholamine synthesis using the tyrosine hydroxylase inhibitor, 
AMPT, does not affect the normal daily pattern of PER2 in the BNSTov (a) or in 
the CEA (b), but strongly suppresses the daily peak in PER2 expression at ZT1 
in the BLA (c) and DG (d). For each brain region, data are shown as mean 
PER2-immunoreactive (IR) nuclei ± SEM per ZT in the vehicle-injected groups 
(open bars) and AMPT-injected groups (black bars); n = 4 per treatment group 
per ZT; * indicates p < 0.05 compared to vehicle. 
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Figure 3. 98 
In the BNSTov (a) and the CEA (b), chronic infusion of the D1 receptor-selective 
antagonist, SCH 23390 (0.5 mg/kg/24 h; black bars), or the D2 receptor-selective 
antagonist, raclopride (2 mg/kg/24 h; hatched bars), via osmotic minipump for 5 
days does not affect the normal daily fluctuation in PER2 expression. In the BLA 
(c), raclopride increases PER2 expression at ZT13 but does not affect the normal 
peak of PER2 at ZT1. In the DG (d), there is no effect of either raclopride or 
SCH 23390 infusion. For each brain region, data are shown as mean PER2-
immunoreactive (IR) nuclei ± SEM per ZT in each treatment group; n = 4 per 
treatment group per ZT; * indicates p < 0.05 compared to sham. 
Figure 4. 101 
(a) In the BNSTov, a 6-OHDA lesion significantly decreases the normal peak of 
PER2 at ZT13; (b) daily injection of quinpirole (0.5 mg/kg) at ZT1 increases 
PER2 at ZT1 in both the lesioned and intact hemispheres, and decreases PER2 
at ZT13; (c) daily injection of SKF 81297 (1 mg/kg) at ZT1 has no effect, (d) In 
the CEA, PER2 expression is unaffected by a unilateral 6-OHDA lesion; (e) daily 
injection of quinpirole at ZT1 significantly decreases PER2 at ZT13 in both the 
lesioned and intact hemispheres, whereas daily injections of SKF 81297 (f) have 
no effect, (g) In the BLA, PER2 expression is unaffected by a unilateral 6-OHDA 
lesion; (h) daily injection of quinpirole at ZT1 decreases PER2 at ZT1 in the intact 
hemisphere compared to saline control, whereas daily injections of SKF 81297 (i) 
increase PER2 at ZT13 in the 6-OHDA-lesioned hemisphere compared to saline 
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control. Q) In the DG, PER2 expression is unaffected by a unilateral 6-OHDA 
lesion, (k) by daily injections of quinpirole, (I) or by daily injections of SKF 81297. 
For each region and treatment group, data are shown as mean PER2-
immunoreactive (IR) nuclei ± SEM per ZT in the intact hemisphere (open bars) 
and lesioned hemisphere (black bars); saline n = 7-8 per ZT; quinpirole n = 6 per 
ZT; SKF n = 3 per ZT; * p < 0.05 compared to intact hemisphere; ** p < 0.05 
compared to 6-OHDA hemisphere in saline condition; § p < 0.05 compared to 
intact hemisphere in saline condition. 
Figure 5. 104 
In naive rats, the normal daily fluctuation in PER2 in the BNSTov (a) and CEA (b) 
is blunted by daily injections at ZT1 of quinpirole (0.5 mg/kg; hatched bars), but 
not by SKF 81297 (1 mg/kg; black bars) or saline (1 mL/kg; open bars): daily 
quinpirole injections significantly increased PER2 expression at ZT1, the normal 
trough of the PER2 fluctuation in the BNSTov and CEA. In the BLA (c) and DG 
(d), daily injections of quinpirole or SKF 81297 have no effect on the normal 
PER2 fluctuations. For each region, data are shown as mean PER2-
immunoreactive (IR) nuclei ± SEM per ZT; n = 3 per treatment group per ZT; * 
indicates p < 0.05 compared to saline. 
Figure 6. 105 
(a) In the BNSTov, a unilateral 6-OHDA lesion decreases the daily peak of PER2 
at ZT13; (b) chronic infusion via osmotic minipump of quinpirole (0.5 mg/kg/24 h) 
or (c) SKF 81297 (1 mg/kg/24 h) has no effect on the daily fluctuation in PER2 
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expression in the BNSTov. In the CEA (d, e, f), the BLA (g, h, i), and the DG (j, 
k, I), the daily fluctuation in PER2 expression is unaffected by a unilateral 6-
OHDA lesion or by chronic infusion of quinpirole or SKF 81297. For each 
treatment group, data are shown as mean PER2-immunoreactive (IR) nuclei ± 
SEM per ZT in the intact hemisphere (open bars) and lesioned hemisphere 
(black bars). Sham n = 3-5 per ZT; quinpirole pump n = 2-3 per ZT; SKF pump n 
= 2-3 per ZT; * indicates p < 0.05 compared to intact hemisphere. 
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Mean daily wheel-running activity in saline-treated (open circles) and morphine-
treated (filled circles) rats during each 6-day stage of Experiment 1. Rats were 
housed in a 12:12 light-dark (LD) cycle; the gray panel indicates the 12-h period 
when lights were off. Daily injections of morphine or saline were given between 
zeitgeber time 3-4. (a) Entrainment period, (b) Morphine injections, 5 mg/kg. (c) 
Morphine injections, 20 mg/kg. (d) Morphine injections, 40 mg/kg. (e) Withdrawal 
period (no injections given). *Significant difference in mean wheel running during 
the 12-h dark period between morphine and saline groups. Morphine group (n = 
6), saline group (n = 6). 
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Mean anticipatory wheel-running activity in saline (open bars) and morphine 
groups (filled bars) during the 3-h period before each daily injection, shown for 
each dose of morphine (5 mg/kg, 20 mg/kg, and 40 mg/kg) and for the 
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corresponding time period in withdrawal when no injections were given. Each 
bar represents the mean (± SEM) of 6 days' activity. *Significant main effect of 
drug treatment. Morphine group (n = 6), saline group (n = 6). 
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Mean number of PER2-immunoreactive (PER2-IR) cells (± SEM) at zeitgeber 
time (ZT) 1 (open bars) and ZT13 (filled bars) in the SCN and regions of the 
limbic forebrain and striatum in saline-treated rats and morphine-treated rats in 1 
(MWD-1), 2 (MWD-2), or 7 (MWD-7) days of withdrawal, (a) SCN. (b) BNSTov. 
(c)CEA. (d) Dorsolateral striatum, (e) BLA. (f) DG. *Significant difference from 
saline ZT13 group; fsignificant difference from saline ZT1 group. Saline group 
ZT1 (n = 4), ZT13 (n = 4); MWD-1 ZT1 (n = 4), ZT13 (n = 4); MWD-2 ZT1 (n = 4), 
ZT13 (n = 4); MWD-7 ZT1 (n = 4), ZT13 (n = 4). 
Figure 4. 134 
Mean number of PER2-immunoreactive (PER2-IR) cells (± SEM) at zeitgeber 
time (ZT) 1 (open bars) and ZT13 (filled bars) in the SCN and regions of the 
limbic forebrain and striatum in morphine-treated rats given an injection of 
quinpirole (MWD-2+Q; 0.5 mg/kg, IP) or vehicle (MWD-2+V) at ZT13 for 2 days 
beginning the evening after the last morphine injection, (a) SCN. (b) BNSTov. 
(c) CEA. (d) Dorsolateral striatum, (e) BLA. (f) DG. *Significant difference from 
MWD-2+V ZT13 group. MWD-2+Q ZT1 (n = 4), ZT13 (n = 4); MWD-2+V ZT1 (n 
= 3), ZT13(n = 2). 
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INTRODUCTION 
Circadian rhythms are 24-h fluctuations in cellular, physiological, and 
behavioral processes that are expressed by essentially all life forms on Earth. 
Familiar examples of these rhythms include the sleep-wake cycle, feeding, 
drinking, and locomotor activity. Circadian rhythms provide a mechanism for 
organisms to anticipate daily changes in the environment and to co-ordinate 
multiple, sometimes conflicting, physiological processes within the day. The 
ubiquitous expression of circadian rhythms and high degree of conservation of 
their genetic basis across species suggest the importance of these rhythms to 
the survival of organisms. The impact of circadian rhythms on normal 
physiological activity is also clearly demonstrated by the distressing symptoms 
experienced by individuals whose normal rhythms are disrupted, as in the case 
of jet lag or nighttime shift work. 
In mammals, circadian rhythms are regulated at a systems level by a 
master circadian pacemaker in the brain, the suprachiasmatic nucleus (SCN), 
and at a cellular level by several genes, referred to as clock genes, which are 
cyclically expressed in a series of feedback loops. The precise timing of these 
feedback loops is adjusted by daily exposure to light and darkness, which is 
conveyed from the eyes to the SCN via the retinohypothalamic tract (RHT)(for 
reviews see, Reppert and Weaver, 2001; Antle and Silver, 2005). Although the 
SCN is considered the master timekeeper, other brain structures and peripheral 
l 
tissues also rhythmically express clock genes (Abe et al., 2002; Balsalobre, 
2002; Shieh, 2003); however, signals from the SCN are thought to be required to 
entrain and co-ordinate the rhythms within other tissues and throughout the 
whole organism (Yoo et al., 2004). 
In addition to light, non-photic events can also entrain daily rhythms. 
Notably, these signals can shift rhythmic activity in the brain and periphery 
without significantly affecting the SCN clock. Among the events known to be 
effective non-photic time givers, or zeitgebers (ZTs), emotionally arousing stimuli, 
such as rewards, stressors, or stimuli paired with aversive events, can 
significantly influence normal rhythmic activity (Mrosovsky, 1996; Amir and 
Stewart, 2009). Interestingly, the impact of these stimuli on rhythms of clock 
gene expression outside of the SCN can be seen within brain regions that 
regulate motivated behaviors. Although the mechanisms by which emotional 
states affect circadian rhythms are not well understood, there is increasing 
interest in the role of the neurotransmitter dopamine (DA), long associated with 
the expression of motivated behaviors, in the regulation of circadian rhythms. 
The present thesis investigates the role of DA in the entrainment of circadian 
rhythms in the SCN and the limbic forebrain in the rat. 
The SCN is the master circadian clock in mammals 
The rat SCN comprises approximately 10 000 cells in each hemisphere 
and is located just above the optic chiasm in the hypothalamus and immediately 
adjacent to the third ventricle. It is roughly divided along a dorsolateral to 
2 
ventromedial axis into core and shell regions that differ in terms of innervation by 
the RHT, the kinds of peptides expressed in cells, and sites to which efferents 
project (Van den Pol, 1980; Moga and Moore, 1997; Leak et al., 1999). The core 
region, located in the ventrolateral portion of the nucleus, is heavily innervated by 
glutamatergic fibers of the RHT and is the primary region in the SCN to be 
affected by an organism's exposure to light (Tanaka et al., 1997; Morin and Allen, 
2006). Cells in the core contain the neurotransmitter GABA (gamma-amino-
butyric acid) that can be co-localized with various peptides that play a critical role 
in the regulation of rhythmic activity in the SCN, such as vasoactive intestinal 
polypeptide (VIP), gastrin-releasing peptide (GRP), and calbindin, as well as 
substance P (SP) and neurotensin (Moore et al., 2002). In contrast to the core, 
the shell region, which is located in the dorsomedial portion of the nucleus, is 
only sparsely innervated by the RHT. The cells of the shell region are also 
GABAergic, but these co-localize the peptides arginine vasopressin (AVP), 
calretinin, enkephalin (ENK), and somatostatin (Moore et al., 2002). Within the 
SCN, VIP- and GRP-positive cells in the core region project heavily into the shell 
and make synaptic contacts with AVP-positive cells; however, relatively few 
projections from the shell innervate the core (Daikoku et al., 1992; Drouyer et al., 
2010). Instead, efferents from the shell region project outside of the SCN, with 
the majority of fibers innervating other nuclei in the medial hypothalamus (Watts 
and Swanson, 1987; Leak and Moore, 2001). 
The SCN displays a 24-h rhythm in several activities, including the firing 
rate of individual cells (Welsh et al., 1995; although see Webb et al., 2009a) the 
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synthesis and release of peptides expressed in the core and shell (Yamase et al., 
1991; Hofman and Swaab, 1993; Shinohara et al., 1995), and expression of the 
immediate early gene, c-fos (Kornhauser et al., 1990; Colwell and Foster, 1992). 
Adjusting the timing of these activities in the SCN to changes in environmental 
light occurs by way of the RHT that projects from the retina to the core of the 
SCN. In the retina, light stimulates photoreceptors such as melanopsin, which is 
expressed in a widely distributed subset of retinal ganglion cells (Panda et al., 
2002; Provencio et al., 2002), the photopigment cryptochrome (Miyamoto and 
Sancar, 1998), and the opsin-based rod and cone receptors (reviewed in Lowrey 
and Takahashi, 2000). Stimulation of these receptors by light is conveyed to the 
SCN via fibers in the RHT and results in the release of glutamate, pituitary 
adenylate cyclase activating polypeptide (PACAP), and SP within the SCN core 
(Chen et al., 1999; Hamada et al., 1999; Hannibal et al., 2000). These signals 
can then adjust the phase of the SCN clock to a slightly earlier time (a phase 
advance) or to a later time (a phase delay), depending on when these signals 
occur in relation to the existing time in the cycle of the SCN clock. These 
adjustments in the phase of the SCN clock are evident in the timing of the daily 
locomotor activity rhythm in rodents housed in conditions of constant darkness. 
For example, exposure to a light pulse during the early subjective nighttime 
results in a phase delay in the SCN clock, such that the normal daily increase in 
activity occurs slightly later on the following day. In contrast, a light pulse in the 
late subjective nighttime produces a phase advance and results in a slightly 
earlier onset of activity on the following day. Synchronization of cellular activity 
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within and across the subregions of the SCN in response to this photic 
information is then achieved by communication from the core to the shell via 
electrical signals through gap junctions and activity-dependent release of GABA, 
VIP, and GRP in the shell (reviewed in Antle and Silver, 2005; Aton and Herzog, 
2005). 
Several lines of evidence demonstrate conclusively that the SCN serves 
as the master circadian clock in mammals. For example, the firing of individual 
SCN neurons continues to follow a circadian rhythm under conditions of constant 
darkness and persists when cells are cultured in isolation (Welsh et al., 1995; 
Herzog et al., 1998). The timing of activity within the SCN remains constant 
across a range of temperatures, a property that is referred to as temperature 
compensation and allows for maintenance of clock 'speed' irrespective of 
temperatures changes that would otherwise affect rates of cellular activity 
(Herzog and Huckfeldt, 2003). Furthermore, lesioning of the SCN in rodents 
abolishes circadian rhythms of behavior and hormone secretion, but can be 
restored in part by transplantation of SCN tissue from another animal (Lehman et 
al., 1987; Ralph et al., 1990). Remarkably, the temporal characteristics of the 
restored rhythm (e.g., its period) in the recipient of the transplanted tissue are not 
the same as the rhythm expressed before the loss of the SCN tissue, but rather 
match those of the donor animal. For example, following transplantation of SCN 
tissue from a tau mutant hamster, which displays a locomotor activity rhythm with 
a period shorter than 24 h (Ralph and Menaker, 1988), into an SCN-lesioned 
wild-type hamster, the wild-type hamster develops a locomotor activity rhythm 
5 
with a shortened period that matches that of the mutant donor, instead of the 24-
h rhythm it expressed before the SCN lesion (Ralph et al., 1990). This result 
indicates that the properties of the SCN tissue itself determine the circadian 
rhythm of locomotor activity. 
To transmit time-of-day information to other tissues in the body, the SCN 
uses both synaptic transmission and diffusible signals. For example, severing 
axonal projections from the SCN using knife cuts disrupts some rhythmic 
functions, but not others (Inouye and Kawamura, 1979; Honma et al., 1984). 
Conversely, transplantation of SCN tissue that is encapsulated in plastic, which 
thereby prevents the growth of new projections from the transplanted cells, 
restores some rhythms in SCN-lesioned rats, but not all rhythms (e.g., Lehman et 
al., 1987; Silver et al., 1996). GABAergic axons from the shell region of the SCN 
project primarily to the subparaventricular zone and nuclei within the medial 
hypothalamus, such as the paraventricular nucleus, dorsomedial and 
ventromedial nuclei of the hypothalamus, and medial preoptic area, and 
stimulation of these regions by the SCN regulates several rhythmic functions 
(Morin and Allen, 2006). For example, activity-dependent release of AVP from 
SCN terminals in the paraventricular nucleus regulates the rhythm of activity of 
the hypothalamic-pituitary-adrenal axis (Kalsbeek et al., 2010). Several 
humoural factors from the SCN have also been identified, such as transforming 
growth factor alpha (TGF-alpha), and prokineticin-2 (PK-2), and evidence 
suggests that secretion of these signals from the SCN regulate the locomotor 
activity rhythm in rodents (Kramer et al., 2001; Cheng et al., 2002). 
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Clock genes as the basis of circadian rhythms 
The molecular mechanisms underlying the expression of circadian 
rhythms consist of a group of genes, referred to as clock genes, which regulate 
their own transcription in a series of feedback loops that takes approximately 24 
h to complete. A core set of clock genes was initially characterized in the fruit fly, 
drosophila melanogaster, and homologues for most of these genes have been 
identified in many other species (for reviews, see Lowrey and Takahashi, 2000; 
Reppert and Weaver, 2001; Ko and Takahashi, 2006). Although ongoing 
research is likely to uncover new and critical components to this system, in 
mammals the core group of genes known at this time includes the following: the 
PER-ARNT-SIM (PAS)-domain containing basic helix-loop-helix transcription 
factors, circadian locomotor cycles kaput (clock) and brain and muscle ARNT-like 
protein 1 (bmall); the Cryptochrome {Cry1 and Cry2) and Period (Perl, Per2, 
and Per3) genes; and the orphan nuclear receptors, Rev-erb-a and Ror-a. The 
importance of each of these genes in the maintenance of normal circadian 
rhythmicity is clearly illustrated by the consequences of mutating individual clock 
genes. For example, mice having a single mutation of clock, bmall, Perl, or 
Per2, or a double mutation of Cry1 and Cry2, display arrhythmic locomotor 
activity when housed in the absence of light cues (i.e., constant darkness) (Kume 
etal., 1999; van der Horst et al., 1999; Vitaterna etal., 1999; Bungeretal., 2000; 
Albrecht et al., 2001). In humans, a mutation of the Per2 gene is associated with 
a condition known as familial advanced sleep phase syndrome, in which 
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individuals fall asleep and awaken much earlier than is usual in the general 
population (Toh et al., 2001). 
The following is a simplified overview of the operation of the transcription-
translation feedback loops of these genes within the mammalian SCN: the 
protein product of the transcription factor clock (CLOCK), which is constitutively 
expressed, and the protein product of bmall (BMAL1, also known as MOP3) 
form heterodimers in the cytoplasm through interaction at their PAS sites 
(Hogenesch et al., 1998). Transcription of the bmall gene is rhythmic and is 
regulated in part by the nuclear receptors, REV-ERB-a (which inhibits bmall 
transcription) and ROR-a (which enhances its transcription) (Guillaumond et al., 
2005), as well as by the protein products of the Cry (CRY) and Per2 (PER2) 
genes (Shearman et al., 2000; Yu et al., 2002). The CLOCK:BMAL1 
heterodimers translocate to the nucleus and initiate transcription of Rev-erb a, 
Ror-ct, and the Cry and Per genes by binding to E-box sites on the promoter 
regions of these genes. In turn, the proteins CRY1, CRY2, PER1, PER2, and 
PER3 form multimeric complexes with each other in the cytoplasm, which then 
translocate into the nucleus and inhibit their own transcription by interfering with 
the binding of CLOCK:BMAL1 to their promoter regions (Griffin et al., 1999; 
Kume et al., 1999). Although previous research has indicated that this inhibitory 
feedback by the CRY:PER multimer is mediated primarily through an interaction 
of CRY1 with CLOCK, recent evidence suggests that it is PER2 that serves as 
this interface (Chen et al., 2009). In addition to inhibiting their own transcription, 
the CRY1, CRY2, and PER2 proteins initiate transcription of bmall. Thus, the 
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molecular clockwork contains both positive (CLOCK:BMAL1-mediated 
transcription of Rev-erb-a, Ror-a, Cry, and Per genes; CRY- and PER2-mediated 
upregulation of bmall expression; ROR-a upregulation of bmall expression) and 
negative (downregulation of Cry and Per transcription by their proteins; REV-
ERB-a inhibition of bmall transcription) loops that maintain cyclic expression of 
these genes over 24 h in individual SCN neurons. 
The interaction of these feedback loops produces distinct and predictable 
peaks and troughs in the expression of most of the clock genes and their proteins 
over 24 h (Reppert and Weaver, 2001). In the early morning (circadian time, or 
CT, 0), CLOCK: BMAL1 dimers accumulate in the nucleus of SCN neurons and 
initiate transcription of the Cry and Per genes, as well as the Rev-erb-a and Ror-
a genes. Among these genes, the expression of Perl and Rev-erb-a mRNA 
peaks first, near midday (CT4-6), followed by Per3 (CT4-8), Ror-a (CT6-10), 
Per2 (CT8-10), and Cry1 (CT8-10). The expression of clock is constitutive, as 
previously noted, and the expression of Cry2 mRNA is weak and does not have a 
clearly defined rhythm (Lowrey and Takahashi, 2000). Although the time of peak 
mRNA expression of each of these genes is different, their time of peak protein 
expression coincides around dusk (CT12-14). The accumulation of REV-ERB-a 
protein during the daytime decreases BMAL1 levels through inhibition of bmall 
transcription. As CRY and PER complexes translocate to the nucleus, they 
inhibit the transcriptional activity of CLOCK:BMAL1 dimers and result in 
decreasing levels of CRY and PER throughout the night. In addition to inhibiting 
their own transcription, CRY1, CRY2, and PER2 proteins provide a positive drive 
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on the expression of bmall. Along with ROR-a, these proteins enhance the 
transcription of bmall, such that its mRNA increases mid-nighttime (CT15-18) 
and its protein levels peak near the end of the night (CT22-24). The 
accumulation of BMAL1 protein and its subsequent dimerization with CLOCK 
marks the completion of the feedback loops and the beginning of another day. 
In addition to these genes, enzymes that regulate post-translational 
modifications of clock proteins are also considered critical components of the 
core clock loop because they adjust the precise timing of gene expression, in 
part by regulating the localization and rate of degradation of clock proteins. For 
example, casein kinase I epsilon (CKIe) phosphorylates PER1 and PER2, which 
modulates the ability of these proteins to dimerize with CRY1 and CRY2, to move 
between cellular compartments (i.e., into the nucleus), and their rate of 
ubiquitylation (Lowrey et al., 2000; Vielhaber et al., 2000). One illustration of the 
significant role that CKIs has in the clock is found in tau mutant hamster, which 
results from a mutation of the gene encoding CKIe (tau). This mutation results in 
a reduced ability of CKIs to phosphorylate PER and results in a more rapid 
translocation of the CRY:PER multimers into the nucleus to repress their own 
transcription (Lowrey et al). As described above, the tau mutant hamster exhibits 
a shortened circadian period in which locomotor activity rhythms are less than 24 
h and PER protein expression in the SCN peaks earlier than in wild-type 
hamsters. Hamsters heterozygous for the tau mutation show a shortening of the 
rhythm by approximately 2 h, whereas homozygous mutants have rhythms that 
are approximately 4 h shorter than wild-type. Another enzyme, glycogen 
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synthase kinase 3 beta (GSK3U), has also been implicated in the post-
translational modification of multiple clock proteins, including PER2 and BMAL1 
(Martinek et al., 2001; litaka et al., 2005; Sahar et al., 2010). Disruption of the 
activity of this enzyme results in a lengthened circadian period of locomotor 
activity and rhythm of expression of the clock proteins PER2 and BMAL1 that is 
believed to be due to a disruption of the normal rate of their nuclear translocation 
and ubiquitylation. 
In addition to their roles in maintaining the circadian clockwork, several 
clock genes have been found to regulate functions other than those involved in 
rhythmicity. In particular, the Per genes have been found to contribute to several 
different processes, such as regulation of tumour growth, metabolism of 
catecholamines in the brain, and extracellular glutamate uptake (for a review, see 
Albrecht et al., 2007). Of particular relevance to this thesis, Per2 is reported to 
modulate the expression of the gene for monoamine oxidase A (maoa) synthesis 
and the expression of the excitatory amino acid transporter (eaat), in astrocytes, 
which contributes to the re-uptake of glutamate from the extracellular space 
(Spanagel et al., 2005; Hampp et al., 2008). Changes in these proteins following 
mutation of the Per2 gene are believed to underlie the enhanced extracellular 
levels of DA and glutamate in the ventral striatum of Per2 knock-out mice and the 
increased responsiveness of these mutants to drugs of abuse, such as cocaine 
and alcohol (Abarca et al., 2002; Hampp and Albrecht, 2008). 
l i 
How does light entrain clock gene expression? 
Photic entrainment of the SCN is manifested at the level of clock genes 
and involves a glutamatergic-mediated induction of Per expression. In the early 
nighttime, when exposure to light results in a phase delay of the locomotor 
activity rhythm, activation of NMDA receptors by glutamate release in the SCN 
core leads to the rapid upregulation of Perl mRNA levels within approximately 60 
min via CREB-mediated transcription (Shigeyoshi et al., 1997; Gau et al., 2002; 
Travnickova-Bendova et al., 2002). Per2 mRNA is also increased in response to 
a light pulse at this time of day, although its expression increases more slowly 
than does Perl (peaking after approximately 2 h) (Zylka et al., 1998; Yan and 
Silver, 2002). Interestingly, previous reports indicate that there are no changes 
in PER2 protein expression in the SCN following a light pulse (Beaule et al., 
2003). In the late nighttime, when a light pulse induces a phase advance, Perl 
mRNA is also induced in response to light via a CREB-dependent mechanism, 
but not Per2 (although see Zylka et al.; Yan and Silver). Given the differential 
pattern of Perl and Per2 induction following a light pulse, it has been suggested 
that the increase in Per2 mRNA during the early nighttime mediates phase 
delays, whereas Perl expression in the late nighttime mediates phase advances 
(Albrechtetal.,2001). 
Rhythmic clock gene expression outside of the SCN 
Although the SCN is considered the dominant or master pacemaker in 
mammals, many other brain regions and peripheral tissues exhibit rhythmic 
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activity and clock gene expression. One of the earliest demonstrations of 
rhythmic activity in mammalian tissues outside of the SCN was in the retina of 
the mouse, in which it was observed that melatonin synthesis followed a 
circadian rhythm that persisted even in conditions of constant darkness (Tosini 
and Menaker, 1996). More recently, several studies using luminescent reporter 
genes linked to either the Perl (Per1::Luc) or Perl (PER2::Luc) gene in mice 
have demonstrated that these components of the clock are rhythmically 
expressed in brain regions including (but not limited to) the olfactory bulbs, 
cortex, limbic forebrain, hypothalamic nuclei, pineal gland, pituitary, cerebellum, 
as well as in peripheral tissues such as bone, skeletal muscle, liver, lung, kidney, 
cornea, and testes (Yamazaki et al., 2000; Abe et al., 2002; Shieh, 2003; Yoo et 
al., 2004). 
Consistent with the role of the SCN as the primary timekeeper for the 
body, the peak or phase of clock gene expression in extra-SCN tissues typically 
lags behind that of the SCN (Zylka et al., 1998; Yoo et al., 2004; Davidson et al., 
2009). However, each tissue exhibits its own characteristic period of activity that 
is evident in PER2::Luc samples cultured in isolation (Yoo et al., 2004) and 
capacity to re-entrain to shifts in the LD cycle (Yamazaki et al., 2000; Davidson et 
al., 2009). These tissue-specific characteristics suggest that these extra-SCN 
regions have intrinsic oscillating properties in and of themselves and their 
rhythms are not driven exclusively by the SCN (Yoo et al., 2004; Guilding and 
Piggins, 2007). 
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Signals from the SCN are required, however, to synchronize clock gene 
expression within a given tissue, as well as to re-entrain the phase of rhythmic 
gene expression in these tissues after a change in the light schedule. In support 
of this, clock gene expression in the SCN shifts rapidly in response to an altered 
light schedule, whereas the adjustment of clock gene rhythms in extra-SCN 
tissues occurs more slowly, in some cases on the order of several days (e.g., 
Yamazaki et al., 2000; Davidson et al., 2009). Extra-SCN tissues explanted from 
Perl::Luc or PER2::Luc mice to in vitro conditions will show rhythmic expression 
of the fluorescent reporter for several days, but the strength of this signal 
gradually diminishes over cycles, whereas in vitro cultures of the SCN continue 
to exhibit robust rhythms in luminescence for weeks (Yamazaki et al., 2000; Abe 
et al., 2002; Yoo et al., 2004). Importantly, the reduction in reporter expression 
within extra-SCN tissues over time does not appear to be attributable to a 
shutting down of the molecular clockwork, but rather reflects a loss of coherence 
in the phase of the rhythm across individual cells in the absence of a 
synchronizing input. Indeed, changing of the in vitro medium, or the addition of 
dexamethasone orforskolin to the medium after several days in culture can 
reinstate a rhythm in PER2 fluorescence in extra-SCN tissues (Yamazaki et al., 
2000). Furthermore, tissues harvested from SCN-lesioned animals killed several 
weeks after the lesion was made appear arrhythmic in the expression of the 
reporter (Sakamoto et al., 1998), although rhythmic activity is still evident in 
individual cells (Yoo et al., 2004). These results suggest that the SCN is 
necessary to synchronize the phase of activity within each tissue. 
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Among these extra-SCN regions, the retina and the olfactory bulbs are 
unique in that the rhythms of cellular activity and clock gene expression in these 
tissues are independent of entraining signals from the SCN. In fact, studies of 
the retina and olfactory bulbs indicate that the oscillatory mechanisms in these 
regions meet the defining criteria for independent or master clocks (for a review, 
see Guilding and Piggins, 2007): their rhythms free-run in constant conditions, 
they exhibit temperature compensation, they can be entrained to daily cues other 
than light, and they can entrain rhythms of activity and clock gene expression in 
other tissues (Tosini and Menaker, 1996; Granados-Fuentes et al., 2004; Tosini 
et al., 2008). In the retina of rodents and non-mammalian vertebrates, functions 
such as melatonin synthesis, as noted above, outer disc segment shedding, and 
synthesis and release of neurotransmitters including DA follow a circadian 
rhythm that persists following the removal of potential entraining signals from the 
SCN (for a review, see Tosini et al., 2008). In most vertebrates studied, including 
the rat, clock genes in the retina are rhythmically expressed within cells of the 
inner nuclear and inner plexiform layers (Ruan et al., 2006). Clock gene 
expression can be directly modulated by light itself, as well as by non-photic 
cues, such as injections of the D2/3 DA receptor agonist quinpirole (e.g., 
Steenhard and Besharse, 2000; Besharse et al., 2004; Ruan et al., 2008). 
In the olfactory bulbs, clock genes are rhythmically expressed by 
GABAergic mitral cells and rhythmic activity in this region is thought to regulate 
day-night differences in olfactory sensitivity (Funk and Amir, 2000; Abe et al., 
2002; Granados-Fuentes et al., 2006). Rhythmic gene expression in the 
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olfactory bulbs persists in rodents housed in conditions of constant light (which 
disrupt rhythmic activity in the SCN and other tissues), following lesions of the 
SCN, and when the olfactory bulbs themselves are isolated in vitro (Granados-
Fuentes et al., 2004). The olfactory bulbs and SCN do not project directly to one 
another, but receive indirect projections via brainstem nuclei (Krout et al., 2002). 
Interestingly, evidence suggests that the olfactory bulbs modulate rhythmic 
functions controlled by the SCN, as well as rhythmic activity within the SCN itself. 
For example, olfactory stimulation can modulate light pulse-induced phase shifts 
in locomotor activity and FOS protein expression in the SCN, whereas olfactory 
bulbectomy speeds re-entrainment to a 6-h phase advance in the LD cycle (Amir 
et al., 1999; Granados-Fuentes et al., 2006). 
Non-photic entrainment 
Although light is the most powerful zeitgeber to entrain daily rhythms, a 
number of non-photic entraining stimuli have also been identified. These include 
restricted feeding (Stephan, 2002; Waddington Lamont et al., 2007), metabolic 
signals (Diaz-Munoz et al., 2000), steroid hormones (Amir and Robinson, 2006; 
Perrin et al., 2006; Segall et al., 2006), physical activity (Salgado-Delgado et al., 
2008), and motivationally relevant cues, such as fear-associated stimuli, 
stressors, and rewards (Mrosovsky, 1996; Amir et al., 1999; Amir and Stewart, 
1999b; Takahashi et al., 2001; Angeles-Castellanos et al., 2008). Interestingly, 
the effect of non-photic stimuli in entraining the circadian clock is not limited to 
the SCN; rather, non-photic cues can entrain rhythms in extra-SCN tissues 
independently of the activity of the SCN clock. Indeed, the presentation of non-
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photic stimuli to animals housed in a regular LD schedule can shift rhythmic 
activity in the brain and periphery such that these rhythms diverge entirely from 
the rhythm in the SCN, which remains entrained to the LD cycle (e.g., Masubuchi 
et al., 2000; Waddington Lamont et al., 2007). 
The most prominent example of a non-photic entraining stimulus in 
rodents is the restriction of food availability to a time of day when eating does not 
normally occur (i.e., the light phase). Under regular LD conditions, restricted 
feeding schedules can entrain rhythms of locomotor activity, secretion of 
hormones including corticosterone, insulin, leptin, and expression of clock genes 
in both the brain and peripheral tissues, without affecting the rhythm of the SCN 
(Honma et al., 1983; Diaz-Munoz et al., 2000; Wakamatsu et al., 2001; Stephan, 
2002; Angeles-Castellanos et al., 2007; Waddington Lamont et al., 2007). 
Interestingly, clock gene expression in the SCN can be entrained by a restricted 
feeding schedule, but in conditions of constant light, in which the activity of the 
SCN is otherwise arrhythmic (Lamont et al., 2005b). One of the remarkable 
features of entrainment by restricted feeding schedules is the resulting 
synchronization of clock gene expression in several different tissues to a 
common phase that is timed to the presentation of food. For example, in rats 
given ad libitum food access, the rhythm of expression of the PER2 protein in the 
oval nucleus of the bed nucleus of the stria terminalis (BNSTov) and central 
nucleus of the amygdala (CEA) peaks near the transition from the light phase to 
the dark phase (Amir et al., 2004; Lamont et al., 2005a), whereas this rhythm in 
the basolateral amygdala (BLA) and dentate gyrus of the hippocampus (DG) 
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peaks at the beginning of the light phase, approximately 12 h later than the 
BNSTov and CEA (Lamont et al., 2005a). When food presentation is limited to 2 
h in the middle of the light phase, the peak of PER2 expression in all of these 
regions shifts to the middle of the dark phase, occurring approximately 12 h after 
food is presented, whereas the rhythm in the SCN is unaffected (Waddington 
Lamont etal., 2007). 
The specific mechanisms by which restricted feeding schedules entrain 
rhythms in the brain and periphery remain unknown, although evidence suggests 
that this effect is not solely attributable to metabolic deficits resulting from 
reduced food intake or to the reward value of food presentation (Waddington 
Lamont et al., 2007). Several studies have implicated the dorsomedial nucleus 
of the hypothalamus (DMH) as a critical site mediating entrainment by restricted 
feeding (Gooley et al., 2006; Fuller et al., 2008). Although controversial, some 
evidence indicates that lesions of the DMH prevent the entrainment of the 
locomotor activity rhythm by a restricted feeding schedule (Gooley et al., 2006). 
Clock genes are not rhythmically expressed in the DMH under ad libitum feeding 
conditions, but rhythms in PER1 expression have been found to develop in this 
region in rats fed on a restricted schedule (Verwey et al., 2009). 
Although not as potent as restricted feeding schedules, motivationally 
significant or arousing stimuli have also been demonstrated to entrain circadian 
rhythms of behavior, physiology, and clock gene expression (for reviews, see 
Mrosovsky, 1996; Amir and Stewart, 2009). Evidence for an association 
between motivational state and circadian rhythms arises in part from the 
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circadian disturbances observed in a number of psychiatric conditions involving 
mood, such as bipolar disorder and seasonal affective disorder (for reviews, see 
McClung, 2007; Harvey, 2008; Falcon and McClung, 2009; Mendlewicz, 2009). 
Powerful demonstrations of the effect of motivational state on the circadian 
system have also been previously reported by Amir and Stewart, who showed in 
rats that presenting a light pulse in an environment previously paired with shock, 
or a light that has itself been paired with shock, suppresses the induction of FOS 
protein in the SCN and reduces the phase shift in wheel-running activity that 
normally results from light exposure (Amir and Stewart, 1998, 1999b). 
Importantly, the presentation of a shock-associated light pulse enhances FOS 
protein expression in primary visual cortex, indicating a differential impact of the 
light on the visual and circadian systems of light perception (Amir and Stewart, 
1999a, 2009). 
Additional studies have demonstrated an effect of arousing stimuli on the 
entrainment of rhythmic clock gene expression in brain regions outside of the 
SCN that are involved in the regulation of motivated behaviors. In rodents, 
exposure to stressors such as intermittent restraint or injection of 
lipopolysaccharide can shift the expression of Perl mRNA within the 
paraventricular nucleus of the hypothalamus (Takahashi et al., 2001) and 
repeated restraint stress shifts the expression of PER2 in regions of the extended 
amygdala, specifically in the BNSTov and CEA (Robinson et al., 2005). 
Importantly, research from the Amir laboratory and others has shown that 
corticosterone, the primary stress hormone in rodents, can modulate the 
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expression of clock genes in several tissues including the BNSTov and CEA 
without affecting the SCN (Balsalobre et al., 2000; Amir et al., 2004; Segall et al., 
2006; Segall and Amir, 2010). Changes in circulating corticosterone levels could 
be a mechanism by which stressful events affect normal rhythmic activity and 
disrupt clock gene expression in tissues ordinarily entrained by SCN signals. 
Related to the link between motivational states and circadian rhythms are 
findings demonstrating an effect of drugs of abuse on rhythms of behavior and 
clock gene expression. Treatment with drugs such as methamphetamine, 
cocaine, nicotine, and opiates, can entrain rhythms of locomotor activity and 
clock gene expression in several brain regions and peripheral tissues in rodents 
(Honma etal., 1986; Shibata etal., 1994; Kosobud eta!., 1998; Masubuchi etal., 
2000; Nikaido et al., 2001; lijima et al., 2002; Uz et al., 2005; Vansteensel et al., 
2005; Wang et al., 2006; Kosobud et al., 2007). Importantly, these effects on 
locomotor activity have not been observed when drugs without abuse potential 
are used, such as haloperidol (Kosobud et al., 2007; Gillman et al., 2009), 
suggesting that the mechanisms underlying this entrainment involve the 
activation of reward or positive motivational, and perhaps withdrawal, states. 
The profound effect of drugs of abuse, particularly chronic administration of 
methamphetamine, on locomotor activity rhythms has led to the suggestion that 
there is a specialized oscillatory mechanism in the brain that provides an 
interface between drugs of abuse and the circadian system (for a review, see 
Honma and Honma, 2009). This putative oscillator, referred to as the 
methamphetamine-sensitive oscillator (MASCO), was posited in view of findings 
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that long-term delivery of methamphetamine through the drinking water to rats 
and mice can entrain the locomotor activity rhythm to a period greater than 24 h, 
even in the presence of a functional SCN (which ordinarily regulates the 
locomotor rhythm) and regular light cues (a potent zeitgeber and suppressor of 
locomotor activity) (Honma et al., 1986; Masubuchi et al., 2000; Tataroglu et al., 
2006). The location of such an oscillator and the specific signals to which it 
responds remain a matter of speculation. Previous evidence showing that pre-
treatment with the non-selective DA receptor antagonist, haloperidol, blocks the 
induction of Perl in the dorsal striatum by an acute injection of 
methamphetamine (Nikaido et al., 2001) and that injections of haloperidol can 
shift the locomotor rhythm entrained by chronic methamphetamine (Honma and 
Honma, 1995) suggests that DA might be involved. However, additional studies 
have questioned whether the expression of MASCO involves traditional genetic 
clock mechanisms, inasmuch as mutations of individual clock genes do not 
prevent the entrainment of the locomotor activity rhythm in mice by chronic 
methamphetamine (Honma et al., 2008; Mohawk et al., 2009). 
Taken together, there is converging evidence supporting a role for 
motivational or emotional states in the entrainment of circadian rhythms. 
Importantly, many of the brain regions affected by these stimuli are those that 
mediate behavioral and physiological responses to motivationally significant 
events, which might suggest that rhythmic clock gene expression in these 
regions plays an important role in the organization of these responses. 
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DA as a non-photic zeitgeber 
The evidence reviewed so far suggests that the entrainment of circadian 
rhythms by motivational states involves mechanisms not only upstream of the 
SCN, as shown by the modulation of the SCN response to light input (Amir and 
Stewart, 1999), but also those signals downstream of the SCN control, such as 
corticosterone secretion (Balsalobre et al., 2000; Amir et al., 2004; Segall et al., 
2006). Another candidate signal downstream from SCN control of increasing 
interest in the entrainment of circadian rhythms is the neurotransmitter DA. The 
activity of neurons in the ventral tegmental area (VTA), site of the 
mesocorticolimbic DA cells, follows a circadian rhythm that is controlled by 
indirect inputs from the SCN and extracellular levels of DA the dorsal striatum, a 
terminal region of the nigrostriatal DA system, fluctuate in a 24 h rhythm (Paulson 
and Robinson, 1994; Castaneda et al., 2004; Luo and Aston-Jones, 2009). As 
reviewed in the sections below, previous research has already established a role 
for DA release in the entrainment of circadian rhythms, such as the entrainment 
of foetal rhythms in utero, as well as in the activity of the retinal clock in 
adulthood. More recent findings show that stimulation of DA receptors can 
directly modulate clock gene expression in other brain regions, suggesting a 
mechanism by which alterations of mood and ingestion of abused drugs might 
affect circadian oscillators outside the SCN. 
As mentioned, some of the first evidence demonstrating a role for DA in 
the entrainment of circadian rhythms arose from developmental studies of 
circadian rhythms in foetal rats. Rhythmic c-fos mRNA expression in the SCN 
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and locomotor activity patterns in neonates are initially entrained in utero to the 
circadian rhythm of the mother (Reppert and Schwartz, 1986; Weaver and 
Reppert, 1995). A series of studies by Reppert and colleagues demonstrated 
that this entrainment in early life requires stimulation of D1 DA receptors in the 
SCN during a restricted window of time (Weaver et al., 1992). Although D1 
receptors are still expressed at low levels within the SCN of the adult rat, this role 
for DA in the entrainment of the SCN clock is unique to early life. Indeed, 
injections of the D1 receptor agonist, SKF 38393, given to SCN-lesioned dams 
near the end of the gestation period will entrain the subsequent activity rhythm of 
the neonate but have no effect on the activity of the dam (Viswanathan et al., 
1994). 
DA also plays a critical role in the rhythmic activity of the retina. In the 
majority of vertebrate species studied, DA is found in amacrine cells within the 
inner nuclear and inner plexiform layers, where clock genes are also rhythmically 
expressed (Ruan et al., 2006). One of its primary functions is in mediating light 
adaptation and cone-based vision, in part through stimulation of D2 receptors 
that are expressed by both rod and cone photoreceptors (for a review, see 
Witkovsky, 2004). Consistent with this role, DA synthesis and release in the 
retina follows a rhythm that peaks in the daytime, and these rhythms are 
regulated by both light and melatonin (Tosini and Menaker, 1996; Green and 
Besharse, 2004). DA release is also believed to mediate the effects of light on 
the circadian system in the retina. Studies in the African clawed frog (xenopus 
laevi) and in mice demonstrate that both light and stimulation of DA receptors 
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can induce Per expression in the retina, and stimulation of DA receptors can 
mimic the effect of light in suppressing nighttime melatonin release (Cahill and 
Besharse, 1991; Steenhard and Besharse, 2000; Doi et at., 2006). The specific 
mechanisms by which DA exerts this effect on rhythmic activity in the retina is not 
yet clear, as there is evidence for both D1 receptor- and D2 receptor-mediated 
effects on clock gene expression. For example, Ruan et al (2008) showed that 
the application of D1 agonists, but not D2 agonists, to explants of retina from 
PER2::Luc mice shifts the PER2 rhythm and that antagonism of D1 receptors 
attenuates the phase shift in PER2 induced by light pulsing the tissue. In 
contrast, in vitro evidence shows a direct mechanism by which stimulation of D2 
receptors enhances the transcriptional activity of CLOCK:BMAL1 through a 
CREB-dependent mechanism (Yujnovsky et al., 2006). Furthermore, D2 
receptor knock-out mice show impaired light masking of locomotor activity, a 
blunted rhythm of Perl expression in the retina, and reduced induction of Perl in 
the retina following a light pulse (Doi et al., 2006; Yujnovsky et al., 2006). 
Additional evidence supporting an association between dopaminergic 
activity and circadian rhythms derives from the disrupted rhythms of physiological 
functions and clock gene expression observed in pathologies involving midbrain 
DA systems, such as Parkinson's disease (PD) and drug addiction. Several 
symptoms of PD involve disturbances in normal physiological rhythms, including 
the sleep-wake cycle, body temperature, heart rate, Cortisol secretion, and blood 
pressure (Bruguerolle and Simon, 2002; Willis, 2008). Furthermore, a diurnal 
fluctuation in the motor symptoms of PD in humans - specifically, a worsening in 
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the afternoon - is frequently reported. Notably, some evidence suggests that the 
rhythmic expression of BMAL1 protein is blunted in red blood cells of individuals 
with PD, which suggests that a loss of normal dopaminergic activity affects clock 
gene expression in peripheral cell types (Cai et al., 2010). Another association 
between dopaminergic signaling and modulation of circadian rhythms has also 
been suggested from studies of addictive drugs (Falcon and McClung, 2009). 
Most abused drugs have the common property of increasing extracellular DA 
levels in terminal regions of the mesolimbic DA system, such as the dorsal and 
ventral striatum, BNSTov, and amygdala (Di Chiara and Imperato, 1988; Harmer 
et al., 1997; Carboni et al., 2000). Conversely, withdrawal from prolonged 
exposure to drugs such as morphine, ethanol, and cocaine is associated with a 
reduction in extracellular DA content (Acquas et al., 1991; Rossetti et al., 1992; 
Tran-Nguyen et al., 1998; Diana et al., 1999). Abnormal rhythms of sleep, 
hormone secretion, and clock gene expression are observed in animals and in 
humans following drug exposure (Howe et al., 1980; Yuferov et al., 2003; Uz et 
al., 2005; Lynch et al., 2008) and during withdrawal from long-term drug use 
(Stinus et al., 1998; Ammon et al., 2003; Li et al., 2009a; Li et al., 2009b). 
Finally, recent evidence suggests a role for DA in modulating rhythmic 
clock gene expression directly within extra-SCN tissues. In vitro studies indicate 
that DA receptor signaling at both D1 and D2 receptors can regulate clock gene 
expression in the mouse striatum (Imbesi et al., 2009). In vivo studies have 
similarly demonstrated an effect of DA receptor stimulation on clock gene 
expression in the rodent striatum (Masubuchi et al., 2000; Nikaido et al., 2001; 
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lijima et al., 2002; Imbesi et al., 2009; Sahar et al., 2010). For example, the 
rhythmic expression of Pert, the clock-controlled gene dbp, and BMAL1 protein 
is blunted in the striatum of D2 receptor knock-out mice (Sahar et al., 2010). 
These findings parallel the loss of rhythmic Perl expression in the retina of D2 
knock-out mice (Yujnovsky et al., 2006) and suggest that DA contributes to the 
maintenance of rhythmic clock gene expression in multiple tissues. 
It is important to note that only a limited number of studies have examined 
the effect of DA receptor manipulations on clock gene expression in regions 
outside of the SCN and dorsal striatum (Masubuchi et al., 2000; Uz et al., 2005), 
in spite of diverse projections of midbrain DA neurons. Furthermore, none to my 
knowledge has studied the effects of direct manipulations of endogenous DA in 
vivo. The BNSTov and CEA are heavily innervated by DA fibers from the ventral 
tegmental area and administration of drugs of abuse alters extracellular DA 
levels in these regions (Freedman and Cassell, 1994; Harmer et al., 1997; 
Carboni et al., 2000). As noted above, clock gene expression in these regions 
has been found to be highly sensitive to changes in hormones, restricted feeding 
schedules, as well as to stressors. The BLA and DG are also innervated by DA 
fibers from the midbrain and activity within these regions is implicated in 
responses to drugs of abuse (Fallon et al., 1978; Scatton et al., 1980; Fuchs et 
al., 2005; Fuchs et al., 2007). Although restricted feeding schedules shift clock 
gene expression in these regions, other non-photic stimuli do not affect clock 
gene expression in the same manner observed in the BNSTov and CEA. It 
would be of interest to determine whether DA modulates the expression of clock 
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genes in multiple regions outside of the SCN and if so, whether the mechanisms 
by which it acts are region-specific. 
Present thesis 
The experiments presented in this thesis were intended to address the 
role of DA in the rhythmic expression of clock genes in several regions of the rat 
limbic forebrain. Two experimental approaches were used to this end. In the 
first, endogenous DA levels in the forebrain were manipulated directly using DA-
selective lesions and pharmacological disruption of DA signaling. The rhythmic 
expression of the clock protein, PER2, was examined in the SCN and several 
terminal regions of the mesolimbic DA system in which clock genes are 
expressed rhythmically; namely, the dorsal striatum, BNSTov, CEA, BLA, and 
DG. Agonists selective for D1 or D2 DA receptors were also used to address the 
specific mechanisms by which DA modulates PER2 expression in these regions. 
In the second approach, the expression of PER2 in these regions was 
investigated following a course of daily, timed injections of morphine. Although it 
is well known that morphine affects the release of a number of neurotransmitters 
and hormones capable of affecting clock gene expression, acute injections of 
morphine increase extracellular levels of DA in the striatum and BNST (Di Chiara 
and Imperato, 1988; Carboni et al., 2000). Furthermore, as mentioned earlier, 
termination of chronic morphine injections, so-called morphine withdrawal, is 
associated with a severe reduction in DA levels in the striatum. Thus in these 
experiments, the expression of PER2 was examined following the withdrawal of 
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daily morphine injections, a period associated with disruptions in several rhythmic 
functions (Howe et al., 1980; Stinus et al., 1998; Li et al., 2009b). 
The activity of the circadian transcription-translation feedback loops was 
monitored using the PER2 protein as a marker of clock activity within cells of the 
SCN and in regions of the limbic forebrain. As previously described, PER2 plays 
a pivotal role in the circadian clock in part by regulating the transcriptional activity 
of CLOCK:BMAL1 and the transcription of the bmal1 gene. The Per2 gene has 
also been implicated in several functions outside of the core clock feedback 
loops that pertain to the activity of DA systems and responses to drugs of abuse. 
As such, changes in PER2 expression not only reflect the state of the molecular 
clockwork, but might also speak to the functional implications of altered clock 
gene expression in regions of the limbic forebrain. 
The regions of the limbic forebrain studied here, namely the dorsal 
striatum, the BLA, the DG, the BNSTov, and the CEA, were selected on the basis 
of previous research showing a unique role of these regions in responding to 
selected non-photic entraining cues having motivational salience. The dorsal 
striatum forms a critical component of the basal ganglia and plays a central role 
in the regulation of movement, as well as learning, reward, and other functions. 
The activity of the primary outputs of the dorsal striatum, GABAergic medium 
spiny neurons, are regulated by glutamatergic innervation from cortex and 
thalamic nuclei and by dopaminergic inputs arising from the substantia nigra pars 
compacta (for a review, see Gerfen, 2004). As noted above, Pert expression in 
this region has been found to regulate the tone of both of these neurotransmitters 
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within the striatum by modulating their clearance from the extracellular space. 
The output projections of the dorsal striatum are segregated into two different 
paths that are distinguishable on the basis of the sites to which they project and 
the receptors and peptides they each express. In general, neurons in the 
striatonigral projection, or direct pathway, innervate the substantia nigra pars 
reticulata, and express D1 DA receptors and the peptides dynorphin and 
substance P, whereas neurons of the striatopallidal projection, or indirect 
pathway, innervate the external compartment of the globus pallidus and the 
subthalamic nucleus, and express D2 DA receptors and the peptide enkephalin. 
In view of the anatomical and functional compartmentalization of circuits within 
the dorsal striatum, it would be of interest to determine whether the expression of 
clock genes in this region is widespread or confined to a particular class of 
striatal cells. These findings could provide further insight into the functional role 
of the clock. Previous experiments have demonstrated that PER rhythms in this 
region, which peak in the early morning approximately 12 h after the peak in the 
SCN, are sensitive to particular non-photic signals, such as restricted feeding 
schedules (Amir, unpublished observations) and drugs of abuse (Masubuchi et 
al., 2000; lijima et al., 2002; Uz et al., 2005), but not to others, such as changes 
in thyroid hormone levels (Amir and Robinson, 2006) or melatonin (Amir et al., 
2006). 
Cells within the BLA and DG also express PER2 rhythms that are in phase 
with the dorsal striatum (that is, peaking in the early morning) and that are 
sensitive to restricted feeding schedules (Wakamatsu et al., 2001; Lamont et al., 
29 
2005a). The BLA receives some innervation by midbrain DA neurons originating 
in the ventral tegmental area and both D1 and D2 receptors are expressed in this 
region (for a review, see de la Mora et al., 2010). DA release within the BLA has 
been implicated in the organization of motivated behavior, including the formation 
of associations between conditioned stimuli and rewards (Meil and See, 1997; 
Weiss et al., 2000; Berglind et al., 2006). Similarly, the DG receives some 
dopaminergic input arising from the midbrain DA cell groups (Scatton et al., 
1980) and activity in the hippocampus is associated with motivational states, 
including responses to environments previously paired with drugs of abuse 
(Fuchs et al., 2005). Interestingly, evidence suggests that clock gene expression 
in the hippocampus is implicated in the action of antidepressants (Uz et al., 
2005). The hippocampus and portions of the amygdala are closely 
interconnected and send reciprocal projections to each other (Petrovich et al., 
2001). Notably, rhythms of PER2 expression in the DG and BLA are similarly 
affected by a restricted feeding schedule (whereby the phase of PER2 in each 
region shifts to 12 h after the presentation of food) yet are insensitive to other 
non-photic events, such as stressors. This insensitivity of clock gene expression 
in the DG to stressors and to changes in corticosterone levels is surprising, given 
the pivotal role of the hippocampus in regulating activity of the hypothalamic-
pituitary-adrenal (HPA) axis (for a review, see Schmidt and Duman, 2007). 
The PER2 rhythms in the BNSTov and CEA are unusual in comparison to 
the rhythms of clock gene expression in the majority of other brain regions and 
peripheral tissues, in that their phase is synchronized to that in the SCN (Amir et 
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al., 2004; Lamont et al., 2005a). The anatomical composition and functional 
roles of the BNSTov and CEA are closely related and these regions are often 
described as components of the central extended amygdala (Alheid and Heimer, 
1988; Dong etal.,2001a; Dongetal., 2001b; Alheid, 2003). Furthermore, it has 
been noted that the morphological and neurochemical composition of the 
BNSTov and the CEA resembles that of the dorsal striatum (Cassell et al., 1986; 
Swanson and Petrovich, 1998; Swanson, 2000). DA innervation of the BNSTov 
and CEA arises from the ventral tegmental area (Hasue and Shammah-Lagnado, 
2002) and changes in DA release in these regions are associated with responses 
to a variety of motivationally relevant stimuli, including drugs of abuse (Tran-
Nguyen et al., 1998; Carboni et al., 2000) and stressors (Inglis and Moghaddam, 
1999; Kozicz, 2002). It is notable that in spite of the associations of these 
regions with the striatum, their PER2 rhythms are 180 degrees out of phase. In 
addition to restricted feeding schedules, PER2 expression in the BNSTov and 
CEA is modulated by other non-photic cues including stressors (Robinson et al., 
2005), corticosterone (Segall and Amir, 2010), and estrogen levels (Perrin et al., 
2006). 
Experiments 
The first study was designed to examine the relation between diurnal 
changes in DA levels in the dorsal striatum and the rhythmic expression of PER2 
in this region. Using immunohistochemistry and in vivo microdialysis, the pattern 
of PER2 expression and extracellular DA levels in the dorsal striatum over 24 h 
was characterized. DA levels within the dorsal striatum were then directly 
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modulated to examine the impact of changes in DA content on the daily 
fluctuation of PER2 expression in this region and in the SCN in rats housed 
under 12:12 LD conditions. Using DA-selective lesions by injecting 6-
hydroxydopamine (6-OHDA) into the medial forebrain bundle or systemic 
injections of the tyrosine hydroxylase inhibitor, alpha methyl para tyrosine 
(AMPT), to inhibit catecholamine synthesis, it is shown that the amplitude of 
rhythmic PER2 expression within the dorsal striatum is regulated by daily 
fluctuation in DA levels, whereas PER2 expression in the SCN does not respond 
to changes in DA activity. Pharmacological experiments using D1 and D2 
receptor selective agonists were subsequently conducted to determine the 
specific mechanisms by which DA affects the pattern of PER2 expression in the 
dorsal striatum. Additional immunohistochemical staining studies were also 
undertaken to investigate the particular cell types in the dorsal striatum within 
which PER2 is expressed. Together, the results of the first chapter indicate that 
daily fluctuation in DA activity at D2 receptors contributes to the normal pattern of 
PER2 expression in the dorsal striatum, but does not affect PER2 expression in 
the SCN. 
In the second chapter, the relation of DA activity to PER2 expression in 
the BNSTov, the CEA, the BLA, and the DG was examined using additional brain 
sections from the same rats used in the experiments of study 1. It is 
demonstrated that, compared to the dorsal striatum, depletion of DA using 6-
OHDA lesions or AMPT injections produce different effects on the daily 
fluctuation in PER2 expression in these regions, suggesting that DA might only 
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indirectly regulate PER2 expression within these regions and that the role of DA 
in modulating PER2 expression in the dorsal striatum is perhaps specific to that 
tissue. 
In the third chapter, changes in PER2 expression in each of the 
aforementioned regions was examined in response to daily injections of 
morphine and following withdrawal of morphine injections. The use of daily 
morphine injections in this experiment provided an additional means of 
manipulating extracellular DA levels and disrupting the normal daily rhythm of DA 
release in terminal regions of the mesolimbic DA pathway, such as the dorsal 
striatum. Although the effects of morphine are not limited to actions on DA 
systems, the results of this experiment corroborate the results of the preceding 
studies by demonstrating that daily morphine injections, limited to the early light 
phase in rats housed under 12:12 LD conditions, disrupt rhythms of PER2 
expression in the dorsal striatum, BNSTov, CEA, BLA, and DG, without affecting 
the SCN. In addition, daily morphine injections disturbed rhythms of wheel-
running activity, such that running during the nighttime (the normal active period 
of rats) was dramatically suppressed. PER2 rhythms were also disturbed during 
the initial period of withdrawal from daily morphine injection in each region 
examined, except for the SCN; however, these rhythms reverted to their normal 
pattern following 7 days of withdrawal from morphine. 
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SECTION 1: Endogenous dopamine signaling is necessary for the rhythmic 
expression of the clock protein, PERIOD2, in the dorsal striatum, but not in 
other regions of the limbic forebrain or in the suprachiasmatic nucleus. 
The experiments in Chapter 1 were carried out to investigate the role of 
dopamine (DA) in regulating the daily pattern of expression of the clock protein, 
PERIOD2 (PER2), in the dorsal striatum and suprachiasmatic nucleus (SCN) in 
the male Wistar rat. First, endogenous DA levels in the forebrain were reduced 
by making unilateral lesions of midbrain DA projections with the toxin 6-
hydroxydopamine; by inhibiting synthesis of DA and other catecholamines with 
systemic injections of the tyrosine hydroxylase inhibitor, alpha methyl para 
tyrosine; and by chronically infusing DA receptor antagonists via osmotic 
minipumps. Second, D1 or D2 DA receptors were stimulated with either timed, 
daily injections or continuous infusion of D1 or D2 receptor agonists in rats with 
unilateral 6-OHDA lesions to determine the consequences of this stimulation on 
the PER2 rhythms in the dorsal striatum and SCN. 
Chapter 2 examines the effects of the manipulations of endogenous DA 
activity described in Chapter 1 on the daily pattern of PER2 expression in four 
other areas of the limbic forebrain; the bed nucleus of the stria terminalis 
(BNSTov), the central nucleus of the amygdala (CEA), the basolateral amygdala 
(BLA), and the dentate gyrus of the hippocampus (DG). The results described in 
this chapter were obtained using additional brain sections from the rats used in 
the experiments presented in Chapter 1. 
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CHAPTER 1 
Endogenous dopamine signaling regulates the rhythm of expression of the clock 
protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine 
receptors. 
Suzanne Hood, Pamela Cassidy, Marie-Pierre Cossette, Michael Verwey, Barry 
Robinson, Jane Stewart, and Shimon Amir 
Accepted by The Journal of Neuroscience, August 2010. 
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ABSTRACT 
A role for dopamine (DA) in the regulation of clock genes in the 
mammalian brain is suggested by evidence that manipulations of DA receptors 
can alter the expression of some clock genes outside the suprachiasmatic 
nucleus (SCN), the master circadian clock. The role of endogenous DA in the 
regulation of clock gene expression is unknown. Here we demonstrate a direct 
relation between extracellular DA levels and the rhythm of expression of the 
clock protein PERIOD2 (PER2) in the dorsal striatum of the male Wistar rat. 
Specifically, we show that the peak of the daily rhythm of extracellular DA in the 
dorsal striatum precedes the peak of PER2 by about 6 h and that depletion of 
striatal DA by 6-hydroxydopamine or alpha-methyl-para-tyrosine or blockade of 
D2 DA receptors by raclopride blunts the rhythm of striatal PER2. Furthermore, 
timed daily activation of D2 DA receptors, but not D1 DA receptors, restores and 
entrains the PER2 rhythm in the DA-depleted striatum. None of these 
manipulations had any effect on PER2 rhythms in the SCN. Finally, we present 
evidence that PER2 is co-expressed with D2 DA receptors in the striatum. Our 
findings are consistent with the idea that PER2 is expressed in striatopallidal 
projection neurons and that the rhythm of expression of PER2 in these neurons 
depends on daily dopaminergic activation of D2 DA receptors. These 




Circadian rhythms of physiology and behavior are generated by a core set 
of clock genes, which regulate their own expression in a 24-h transcriptional-
translational feedback cycle (for reviews, see Reppert and Weaver, 2001; Ko and 
Takahashi, 2006). Among these genes, Period2 (Pert) plays a critical role in the 
regulation of this 24-h rhythm by serving as the interface between the negative 
and positive limbs of the cycle (Chen et al., 2009). 
In mammals, the master circadian clock resides in the suprachiasmatic 
nucleus (SCN), and the phase of rhythmic clock gene expression in this region is 
entrained primarily by environmental light (Lowrey and Takahashi, 2000). 
Rhythmic clock gene expression is not limited to the SCN, however, and has 
been characterized in several other regions of the brain and in peripheral tissues 
(Abe et al., 2002; Shieh, 2003; Amir et al., 2004; Lamont et al., 2005a; Guilding 
and Piggins, 2007). It is believed that these rhythms in clock gene expression 
serve to control, in a tissue specific manner, daily variations in cellular and 
metabolic activity and functional output. Although signals from the SCN are 
required to maintain and coordinate rhythmic gene expression in the brain and 
periphery, these extra-SCN rhythms can also be influenced independently by a 
variety of other signals, including steroid hormones, stressors, and restricted 
feeding schedules (Takahashi et al., 2001; Wakamatsu et al., 2001; Perrin et al., 
2006; Segall et al., 2006; Angeles-Castellanos et al., 2007; Amir and Stewart, 
2009; Verwey and Amir, 2009). 
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Increasing evidence suggests that the neurotransmitter dopamine (DA) 
may be involved in the regulation of extra-SCN clock gene expression. In 
particular, activation of D2 receptors has been demonstrated to modulate the 
circadian effects of light on locomotor activity in mice (Doi et al., 2006) and to 
regulate expression of clock genes in the retina (Besharse et al., 2004; 
Yujnovsky et al., 2006) and striatum (Imbesi et al., 2009; Sahar et al., 2010), a 
region important for motor control, learning, cognition and reward. There is no 
direct evidence, however, that endogenous DA regulates rhythmic expression of 
clock genes. To study this, we characterized the rhythm and the cellular 
expression of the clock protein PERIOD2 (PER2) in the dorsal striatum, a region 
richly innervated by dopaminergic projections from the substantia nigra. 
Furthermore, we examined the relationship between the circadian rhythms of 
locomotor activity, extracellular DA level, and PER2 expression in this region. To 
determine the role of endogenous DA in the regulation of PER2 expression in the 
dorsal striatum, we depleted DA or blocked activity at DA receptors by making 
unilateral central injections of 6-hydroxydopamine (6-OHDA) into the medial 
forebrain bundle (MFB), systemic injections of the tyrosine hydroxylase inhibitor 
alpha-methyl-para-tyrosine (AMPT), or continuous infusions of selective D1 or D2 
DA receptors antagonists. Finally, we studied the effect of D1 and D2/3 DA 
receptor agonists, delivered either by timed daily injection or continuously, on the 
rhythmic expression of PER2 in the dorsal striatum of 6-OHDA-lesioned or intact 
rats. Our results establish endogenous DA, acting via D2 DA receptors, as a 
regulator of PER2 rhythms in the dorsal striatum. 
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MATERIALS AND METHODS 
Subjects. A total of 168 male Wistar rats (Charles River, St. Constant, 
QC), weighing approximately 300 g at the start of each experiment, were used. 
Rats were housed singly in shoebox cages equipped with running wheels and 
kept in individual lightproof and sound-attenuated cabinets. Within each cabinet, 
an overhead fluorescent tube provided light on a 12:12 light-dark (LD) cycle (light 
intensity within the cage was approximately 300 lux) and wheel-running activity 
was monitored continuously by computer using VitalView software (Minimitter, 
Sunview, OR, USA). Rats used in the AMPT experiment were housed singly in 
plastic shoebox cages, but without running wheels, and were kept in a private 
room with a 12:12 LD cycle (lights on at 08:00 h). Throughout all experiments, 
rats had ad libitum access to laboratory chow (Purina Foods) and tap water. 
Rats were left in their home cages for at least 10 days to entrain to the LD cycle 
before the start of each experiment, and were randomly assigned to an 
experimental condition. All experimental procedures followed the guidelines of 
the Canadian Council on Animal Care and were approved by the Animal Care 
Committee of Concordia University. 
Drugs. 6-OHDA (Sigma, Oakville, Ont.) was prepared in a concentration of 
2 ug/ul in physiological saline containing 0.5% ascorbic acid. Desipramine 
hydrochloride, quinpirole hydrochloride, SKF 81297, AMPT, SCH 23390, and 
raclopride tartrate were purchased from Sigma and were dissolved in distilled 
water. 
41 
Intra-cranial cannulation for in vivo microdialysis. Rats were anaesthetized 
using a mix of ketamine (Ketaset, 90 mg/kg, intraperitoneal injection (i.p.); Ayerst, 
Guelph, ON) and xylazine (Rompun, 10 mg/kg, i.p.; Bayer, USA). Bilateral 
cannulae (21 gauge, 8.1 mm below pedestal; Plastics One, Roanoke, VA, USA) 
were implanted in the dorsal striatum using the following stereotaxic coordinates: 
posterior (from bregma) - 0.1 mm, medial/lateral 3.4 mm, ventral (from skull 
surface) - 3.0 mm. Cannulae were secured to the skull surface using dental 
acrylic. As a post-operative treatment, rats were given 2 ml of saline with 2 
mg/kg ketoprofen (Anafen, Merial, CAN) subcutaneously (s.c.) and 0.15 ml 
Procillin (Penicillin G 150 000 I.U.; Bayer) intramuscularly. 
Unilateral 6-OHDA lesion. One hour before surgery, rats were injected i.p. 
with desipramine (2.5 mg/kg) to protect noradrenergic fibers from the 6-OHDA 
toxin. Rats were then anaesthetized using a mix of ketamine and xylazine, and a 
unilateral injection of 8 ug 6-OHDA was made over 8 min into either the right or 
left MFB (counterbalanced across rats) using the following stereotaxic 
coordinates: posterior (from bregma) - 3.0 mm, medial/lateral +/-1.4 mm, ventral 
(from skull surface) - 8.2 mm. Following the infusion of the toxin, the injector 
was left in place for 1 min and then was slowly raised over 3 min. Ketoprofen 
(2mg/kg) and 0.15 ml Procillin were given post-operatively. The extent of the 
lesion was confirmed post-mortem with immunohistochemical staining for 
expression of the dopamine transporter (DAT). 
Osmotic minipump surgery. Osmotic minipumps (Alzet model 2ML2, 
Durect Corp., Cupertino, CA) were implanted to deliver a constant 24-h infusion 
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of SCH 23390, raclopride, quinpirole, or SKF 81297. The pumps were filled 
according to the manufacturer's instructions and were left in 0.09% saline for 24 
h before implantation. Rats were anaesthetized using isoflurane (Vetoquinol NA 
Inc., Lavaltrie, PQ) and a small incision was made between the scapulae. Using 
a hemostat, a small pocket was created under the skin into which a pump was 
inserted with the flow moderator pointing away from the incision site. The 
incision was then closed with wound clips. For rats in the sham surgery group, 
the same surgical procedure was followed but no pump was inserted. 
Immunohistochemistry. At the end of each experiment, rats were given an 
overdose of sodium pentobarbital (Somnotol, 100 mg/kg) at their assigned 
zeitgeber time (ZT, where ZT1 indicates 1 h after lights on and ZT13 1 h after 
lights off) and perfused intracardially with 300 ml of cold 0.09% saline, followed 
by 300 ml of cold 4% paraformaldehyde in 0.1 M phosphate buffer. Brains were 
extracted and kept in 4% paraformaldehyde solution overnight at 4° C, then 
sliced with a vibratome into 50 urn coronal sections. Sections were stored in 
Watson's cryoprotectant (Watson et al., 1986) at -20° C until 
immunohistochemistry was performed. 
Immunohistochemical staining for PER2 and PERIOD1 (PER1) 
immunoreactive (IR) nuclei was carried out according to protocols described 
previously (Amir et al., 2004; Verwey et al., 2009). Briefly, PER2 staining was 
carried out using a polyclonal rabbit primary antibody (concentration 1:1000, ADI, 
San Antonio, TX, USA) in a Triton Trizma-buffered saline solution (Triton TBS: 
0.3% Triton, 50 mM Trizma buffer, 0.9% saline) containing 2% normal goat 
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serum (NGS, Vector Laboratories, Burlington, ON, CAN) or using a polyclonal 
goat primary antibody (concentration 1:4000; Santa Cruz Biotechnology, USA) in 
Triton TBS containing 2% normal horse serum (NHS, Vector Laboratories, 
Burlington, ON, Canada) for 40 h at 4° C. We found no differences between 
these primary antibodies in the pattern or amount of staining for PER2 in a 
number of different brain regions. Sections stained for PER1 were incubated in a 
polyclonal primary antibody raised in rabbit (concentration 1: 24 000; generous 
gift of Dr. S. M. Reppert, University of Massachusetts Medical School, Worcester, 
MA, USA) in Triton TBS containing 2% NGS and 5% milk buffer for 40 h at 4° C. 
Staining for DAT was carried out with a monoclonal antibody raised in rat 
(1:1500, Millipore, USA) in Triton TBS containing 2% NGS for 40 h at 4° C. After 
incubation in the primary antibody, sections were incubated for 1 h at 4° C in 
biotinylated secondary antibody (for PER2, anti-rabbit 1:200 or anti-goat 1:400 
(both from Vector Laboratories); for PER1, anti-rabbit 1:200; for DAT, anti-rat 
1:500 (Millipore)) and then incubated for 2 h at 4° C in an avidin-biotin-
peroxidase solution (Vectastain Elite ABC kit; Vector Laboratories). Sections 
were then rinsed in a 0.5% 3,3-diaminobenzidine (DAB) solution, and 
immunoreactive (IR) nuclei were visualized with a solution containing 0.5% DAB, 
0.1% H202, and 8% NiCI2. The specificity of the PER2 and PER1 primary 
antibodies was previously confirmed with blocking experiments, in which addition 
of the PER2 peptide or the PER1 peptide (1 ug/ml in phosphate-buffered saline) 
to the primary incubation solution prevented staining of PER2 or PER1 
expression, respectively, in the tissue (Hastings et al., 1999; Field et al., 2000). 
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Sections stained for co-expression of PER2 with glutamic acid 
decarboxylase (GAD-67) were first incubated in a monoclonal primary antibody 
against GAD-67 raised in mouse (concentration 1:20,000, Millipore) in TBS 
containing 2% NHS for 45 h at 4° C. Sections were then transferred to a TBS 
solution containing 2% NHS and a biotinylated anti-mouse secondary antibody 
(concentration 1:100; Vector Laboratories) for 1 h at 4° C. After incubation in the 
secondary antibody, sections were incubated for 2 h at 4° C in an avidin-biotin-
peroxidase solution, rinsed in 0.5% DAB, then visualized with a second DAB 
rinse containing 0.1% H2O2. Sections were transferred to a blocking solution of 
TBS containing 5% NHS for 1 h at 4° C, and then stained for PER2 expression 
according to the protocol described above. Double-labeling for expression of 
PER2 and the D1 DA receptor, the D2 DA receptor, enkephalin, or substance P 
was carried out using 30 urn sections. Sections were first incubated in a Triton-
TBS solution containing primary antibody against the first antigen of interest (D1 
DA receptor, goat polyclonal 1:200 in 1% NHS; D2 receptor, mouse monoclonal, 
1:600 in 1% NHS; enkephalin, rabbit polyclonal, 1:500 in 2% NGS; substance P, 
mouse monoclonal, 1:800 in 1% NHS; all primary antibodies from Santa Cruz 
Biotechnology) for 45 h at 4° C, and then transferred to a Triton-TBS solution 
containing a biotinylated secondary antibody (for D1 DA, anti-goat 1:200 in 1% 
NHS; for D2, anti-mouse 1:33 in 1% NHS; for enkephalin, anti-rabbit 1:200 in 2% 
NGS; for substance P, anti-mouse 1:66 in 1% NHS; all secondary antibodies 
from Vector Laboratories) for 1 h at 4° C. Sections were then incubated in an 
avidin-biotin-peroxidase solution for 2 h at 4° C, rinsed in a 0.5% DAB solution, 
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and visualized with a second DAB rinse containing 0.1% H202. Sections were 
then incubated in a blocking solution of Triton-TBS containing 5% NHS and were 
subsequently stained for PER2 expression according to the protocol described 
above. All sections were mounted on gelatin-coated slides, dehydrated in a 
series of alcohols, and cleared in Citrisolv. Glass coverslips were secured with 
Permount. 
Microscopy. Striatal sections double-stained for PER2 and GAD-67, PER2 
and D1 DA receptors, PER2 and D2 DA receptors, PER2 and enkephalin, or 
PER2 and substance P were examined under a light microscope at a 100x 
objective and images were taken using a Leica DFC 480 camera and Leica 
Firecam 3.1 software. For all other experiments, stained brain sections 
containing the dorsal striatum and SCN were examined under a light microscope 
using a 20x objective and 400 x 400 urn images of each region were captured 
using a Sony XC-77 video camera, a Scion LG-3 frame grabber, and Image SXM 
software (v1.8, S. D. Barrett, http://www.lmageSXM.orq.uk). Images of the right 
and left dorsal striatum were taken in the upper lateral quadrant from 5-6 
sections between approximately +a/p 0.4 mm (from bregma) and the junction of 
the anterior commissure (approximately -a/p 0.2 mm from bregma). Images of 
the right and left SCN were taken from 5-6 representative sections. The number 
of PER2- or PER1-IR nuclei was then counted in each image. The mean number 
of IR nuclei in the right and left SCN and dorsal striatum was calculated for each 
subject from the four images having the highest number of labeled nuclei out of 
all the images taken of that structure in a given hemisphere. 
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We also examined the pattern of PER2 expression in images taken from 
the medial part of the striatum in the same sections, as well as the lateral and 
medial regions of sections that were posterior to the junction of the anterior 
commissure. We found that the rhythms of PER2 expression were consistent 
across these regions and that the effects of each experimental manipulation on 
their expression did not vary within the striatum. As such, we report here only 
the data from the dorsolateral region of anterior striatal sections. 
In vivo microdialysis for extracellular DA levels in the dorsal striatum. In 
vivo microdialysis sampling was carried out in custom-made Plexiglas chambers 
(42 x 39 x 33.5 cm3) with stainless steel rod floors. Each chamber was housed 
individually in a plywood cabinet. An overhead fluorescent tube in each cabinet 
provided light on a 12:12 LD schedule that was the same as that maintained in 
the rats' home cages. Food and water were available ad libitum. 
Microdialysis probes. Probes were made from a 4.0 mm length of 
semipermeable dialysis membrane (Spectra/Por, 240 urn OD, 13 000 MW cutoff, 
Spectrum Laboratories, Rancho Dominguez, CA) and a 21 mm long section of 25 
g stainless steel tubing. A 40-50 cm section of polyethylene tubing (PE), flared at 
one end, was connected to the stainless steel tubing. Three cm from the join 
between the PE tubing and the stainless steel tubing, an incision was made in 
the PE tubing to allow the insertion of small diameter fused silica tubing 
(Polymicro Technologies, Phoenix, AZ). The fused silica tubing extended 
internally through the PE tubing and into the probe with one end positioned 0.5 
mm from the tip of the probe. The incision site was glued with epoxy to prevent 
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leakage. The opposite end of the silica tubing was attached to the other end of 
the PE tubing with masking tape and 0.4 ml microcentrifuge tubes (Fisher 
Scientific Canada, Ottawa, ON) were fastened to the masking tape to collect 
dialysate samples from the silica tubing. The probe assembly was connected to 
a liquid swivel, positioned directly above the testing chamber, by the PE tubing. 
The swivel itself was connected to a variable speed syringe infusion pump 
(Harvard Apparatus Canada, Montreal, QC) located outside of the sampling 
chamber. During dialysis testing, the full lengths of the PE tubing and fused 
silica tubing were covered by a steel spring to protect against chewing by the rat. 
Dialysis probes were secured to each rat's head by screwing a stainless steel 
collar at the end of the steel spring onto the guide cannula (HRS Scientific, 
Montreal, QC). 
Sampling procedure. Following stereotaxic surgery, rats remained in their 
home cages for a one-week recovery period during which they were handled 
daily. One day before in vivo microdialysis sampling began, rats were moved 
from their home cages to the sampling chambers to habituate them to the 
sampling environment. The dialysis probes were inserted into the rats' heads 
approximately 6 h before dialysate sampling began. Artificial cerebrospinal fluid 
(145 mM Na+, 2.7 mM K+, 1.2 mM Ca2+, 1.0 mM Mg2++, 150 mM CI", 0.2mM 
ascorbic acid, 2mM Na2HP04, pH 7.4+0.1) was perfused during this period at a 
rate of 0.5 ul/min to prevent the probes from blocking. Beginning 8 h after the 
lights turned off, or ZT20, the flow rate was increased to 1 ul/min and dialysate 
samples were collected from both the right and left hemispheres of each rat 
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every 30 min for a full 24-h period. Samples were frozen on dry ice and kept at -
80° C until analysis using high-performance liquid chromatography (HPLC). 
Analysis of DA content in tissue samples from the dorsal striatum. To 
quantify the depletion of DA in the dorsal striatum following AMPT treatment, rats 
were decapitated and brains were flash-frozen using cooled 2-methylbutane. 
Brains were later sectioned on a cryostat at 300 urn, and 1 mm punches of the 
right and left anterior dorsal striatum were taken from a single section for each rat 
(approximately + a/p 0.4 from bregma). Punches were then treated with buffer 
containing 30 mM citric acid, 60 mM sodium phosphate monobasic, 0.10 mM 
EDTA, and 0.08 mM sodium dodecyl sulphate (pH 3.35) and were frozen at -80° 
C for 20 min. Samples were then thawed, centrifuged (10 min at 10 000 rpm, 4° 
C), and the supernatant was extracted and filtered. Supernatant samples were 
stored at -80° C until assayed using HPLC. The insoluble material in each pellet 
was suspended in 0.1 N NaOH overnight, then treated with Bradford reagent and 
quantified using a spectrophotometer. 
HPLC. To assay for DA, samples (10 pi in the case of dialysate, or 5 pi in 
the case of tissue punch supernatant) were injected into a reverse-phase column 
(15 cm x 0.46 cm Spherisorb ODS2, 5 pm, Higgins analytical, Mountain View, 
CA). The mobile phase consisted of 30 mM citric acid, 60 mM sodium phosphate 
monobasic, 0.10 mM EDTA, 17% acetonitrile, and 0.08 mM sodium dodecyl 
sulphate (pH 3.35). The mobile phase was pumped through the system at 1.2 
ml/min using a Waters 515 HPLC pump. Compounds were detected and 
quantified with an ESA Coulochem detector (model 5100A) equipped with an 
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analytical cell (model 5011; E1 = +0.35 V, E2 = -0.3 V, ESA, Inc.). 
Concentrations of DA were estimated from peak heights by comparison with 
injections of known amounts of pure DA standard (Sigma) using EZChrom 
Chromatography Data System (Scientific Software Inc., San Ramon, CA). 
Extracellular levels of DA measured from in vivo microdialysis samples are 
expressed as pg of DA per pi of dialysate. The amount of DA content measured 
in striatal tissue punches is expressed as pg of DA per pg of insoluble material. 
Statistical analysis ofPER2- and PER1-IR nuclei counts. In the 
experiments involving unilateral injections of 6-OHDA toxin into the MFB, data 
were analyzed only from those rats with complete unilateral lesions, as confirmed 
by an absence of DAT staining in the dorsal striatum ipsilateral to the 6-OHDA 
injection. Differences in PER2- or PER1-IR nuclei were analyzed using mixed-
model analyses of variance (ANOVA) with ZT and drug treatment group as 
between-subjects factors and hemisphere as a within-subjects factor. 
Differences in PER2 expression in experiments using AMPT, the chronic DA 
receptor antagonists, and injections of DA receptor agonists in naive rats were 
analyzed using two-way ANOVA with ZT and treatment group as between-
subjects factors. Alpha level was set at 0.05 for all tests. Significant interactions 
were analyzed further using one-way ANOVA and Bonferroni-corrected post-hoc 
comparisons, or t-tests where appropriate. 
Analysis of wheel-running activity rhythms. Mean wheel-running activity 
during the 12-h light and 12-h dark phases was calculated for the last week of the 
entrainment period, the second week after the 6-OHDA lesion surgery, and the 
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10-day period of treatment with SKF 81297 or quinpirole (daily injections or 
chronic treatment via minipump). The effect of the 6-OHDA lesion surgery on the 
rhythm and amplitude of wheel-running activity was analyzed using separate 
repeated measures ANOVA with stage of experiment (entrainment and post-
lesion surgery) or phase (light and dark) as within-subjects factors. The effects 
of SKF 81297 and quinpirole treatment on the amount of wheel running in the 
light and dark phases were analyzed using separate one-way ANOVA, and a 
repeated measures ANOVA was used to evaluate the rhythm of activity across 
the light and dark phases. The alpha level was set at 0.05 for all analyses. 
Significant group differences were followed-up with Bonferroni-corrected post-
hoc comparisons. 
RESULTS 
Phase relation between locomotor activity, PER2 expression and 
extracellular DA levels in the dorsal striatum 
To study the relation between PER2 expression in the dorsal striatum and 
changes in extracellular DA levels in this region, we first examined the rhythm of 
PER2 in naTve rats housed in a normal 12:12 LD cycle. Following a 10-day 
entrainment period, rats were killed at 4-h intervals over 24 h beginning 1 h after 
lights on, or ZT1, and brain sections containing the dorsal striatum and SCN 
were stained for PER2 expression using immunohistochemistry. The daily 
rhythm of PER2 expression in the dorsal striatum and SCN is illustrated in 
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representative images in Fig. 1, and the mean number of PER2-IR nuclei at each 
sampling time is shown in Fig. 2a and 2b. As can be seen from Figs. 1 and 2a, 
the rhythm of PER2 expression in the dorsal striatum peaks in the morning, at 
the beginning of the light phase (ZT1) and reaches its trough in the evening, at 
the beginning of the dark phase (ZT13). In the SCN the rhythm of PER2 
expression peaks in the evening, in anti-phase to that in the dorsal striatum 
(Figs.1 and 2b). 
Using in vivo microdialysis, we then measured extracellular DA levels in 
the dorsal striatum of three rats over 24 h. As shown in Fig. 2c, extracellular DA 
levels in the dorsal striatum (expressed as pg DA/ul of dialysate) fluctuate in a 
circadian rhythm falling during the light phase and peaking in the middle of the 
dark phase. Thus, this rhythm of extracellular DA levels in the dorsal striatum, 
while resembling the PER2 rhythm in the SCN, is significantly out of phase with 
the PER2 rhythm in the dorsal striatum. 
To illustrate the temporal relation between the rhythms of PER2 
expression, extracellular DA levels in the dorsal striatum, and wheel-running 
activity, Fig. 2d shows the 24-h pattern of wheel running in those rats killed for 
PER2 immunohistochemistry. As in the case of striatal levels of DA, wheel-
running activity occurs primarily in the dark phase and is absent during the light 
phase. Thus, the rhythms of PER2 expression in the SCN, extracellular DA levels 
in the dorsal striatum, and wheel running are in phase with one another, but are 
in anti-phase to the rhythm of PER2 expression in the dorsal striatum. 
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Figure 1. 
PER2 immunoreactivity fluctuates in a 24-h rhythm in the dorsal striatum (top 
row) and the SCN (bottom row). Rats housed in a 12:12 LD cycle were killed at 
4-h intervals over 24 h beginning 1 h after lights were turned on (ZT1). In the 
dorsal striatum, PER2-immunoreactive (IR) nuclei are most abundant around 
ZT1, whereas in the SCN, PER2-IR nuclei are most abundant around ZT13. 
Scale bar = 100um. 
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Figure 2. 
In rats housed in a 12:12 LD cycle, the 24-h rhythm of PER2 immunoreactivity in 
the dorsal striatum (a) is opposite in phase to the rhythm of PER2 expression in 
the SCN (b). The daily fluctuations in extracellular striatal dopamine (DA) levels 
(c) and wheel-running activity (d) peak at night, preceding the peak of PER2 in 
the striatum. In each panel, the grey block indicates the time of day when lights 
were off (between ZT12-24). (a) In the dorsal striatum, PER2 expression is 
greatest at ZT1, near the beginning of the light phase, and is lowest during the 
dark phase (expressed as mean number of PER2-IR nuclei ± SEM at each ZT; n 
= 4 per ZT). (b) In the SCN, PER2 expression is greatest at ZT13, near the 
beginning of the dark phase, and is lowest during the light phase, (c) In vivo 
microdialysis sampling in the dorsal striatum shows that extracellular DA levels 
are lowest during the middle of the light phase and highest in the middle of the 
dark phase (expressed as mean pg DA/ul dialysate ± SEM, samples taken every 
30 min; n = 3). (d) Wheel-running activity is also greatest during the dark phase 
and is virtually absent during the light phase (expressed as mean wheel 
revolutions/10 min bin over 24 h ± SEM; n = 24). 
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PER2 expression after unilateral 6-OHDA lesion 
To determine whether changes in endogenous levels of DA would affect 
the normal rhythm of PER2 in the dorsal striatum, we made unilateral injections 
of 6-OHDA in the right or left MFB to destroy dopaminergic inputs to the dorsal 
striatum and examined PER2 expression in both the lesioned and intact 
hemispheres. Immunohistochemical staining of DAT expression confirmed that 
the unilateral 6-OHDA injection caused a dramatic loss of dopaminergic fibers in 
the dorsal striatum ipsilateral to the toxin injection (see Fig. 3). Fig. 4 shows 
examples of PER2 expression and the mean number of PER2-IR nuclei in the 
dorsal striatum (Fig. 4a, b) and SCN (Fig. 4c, d), on the intact side and lesioned 
side in rats killed 14 days after 6-OHDA injection. In the dorsal striatum (Fig. 4b), 
the 6-OHDA injection severely blunted the rhythm of PER2 expression in the 
lesioned hemisphere, but did not affect the normal PER2 rhythm on the intact 
side (main effect of ZT, F (3, 17) = 32.36, p < 0.01; main effect of lesion, F (1 , 17) 
= 80.33, p < 0.01; ZT x lesion interaction, F (3, 17) = 92.23, p < 0.01). 
Specifically, PER2 expression in the 6-OHDA-lesioned striatum was significantly 
reduced at ZT1 (t (5) = 13.60, p < 0.01) and ZT19 (t (3) = 7.41, p < 0.01). In the 
SCN (Fig. 4d), the 6-OHDA injection had no effect on the normal rhythm of 
PER2-IR in either the lesioned or the intact hemispheres (main effect of ZT, F (3, 
18) = 44.28, p < 0.01; ZT13 significantly greater than ZT1 and ZT7, p < 0.05, 
post-hoc comparisons with Bonferroni correction; main effect of lesion, F (1 , 18) 




Photomicrographs showing the effect of unilateral injection of 6-OHDA into the 
MFB on dopamine transporter (DAT) immunoreactivity (shown in black) in the 
dorsal striatum ipsilateral to the injection. Lack of stain on the 6-OHDA side 
indicates a loss of DA input to the striatum in the lesioned hemisphere. Rats 
were killed 14 days after receiving a unilateral 6-OHDA injection (8 ug). 
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Figure 4. 
A unilateral 6-OHDA injection into the MFB selectively reduces the normal 
morning peak of PER2 expression in the dorsal striatum ipsilateral to the lesion 
but does not affect the PER2 rhythm in the SCN. (a,c) Photomicrographs 
showing PER2 expression in the intact and 6-OHDA-treated hemispheres in the 
dorsal striatum (a) and SCN (c) in rats killed at ZT1 or ZT13. (b, d) Means± SEM 
of PER2 immunoreactive (IR) nuclei on the intact and lesioned hemispheres in 
the dorsal striatum (b) and SCN (d) in rats killed at ZT1, 7, 13 and 19, two weeks 
after 6-OHDA treatment (n = 5-6 per ZT). (* indicates a significant difference 
between the intact and lesioned hemispheres, p < 0.05). 
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Previous reports have indicated that 6-OHDA-lesioned dopaminergic 
systems can undergo some degree of recovery over time, particularly when rats 
engage in exercise after the lesion (Tillerson et al., 2003; Moroz et al., 2004; 
Anstrom et al., 2007). To determine whether any recovery of PER2 expression 
would develop in the lesioned striatum with time after the 6-OHDA injection, a 
group of rats was killed 28 days after receiving a unilateral 6-OHDA injection into 
the MFB. In the dorsal striatum, PER2 expression atZT1 was significantly 
reduced in the lesioned hemisphere compared to the intact hemisphere 28 days 
after the 6-OHDA injection (data not shown; main effect of ZT, F (1, 3) = 56.85, p 
< 0.01; main effect of lesion, F (1, 3) = 171.94, p < 0.01; ZT x lesion interaction, F 
(1 , 3) = 194.00, p < 0.01; ZT1 paired samples t-test, t (1) = 18.42, p = 0.04, ZT13 
paired samples t-test, t (2) = -0.63, n.s.). In the SCN, there was no effect of the 
lesion on the daily variation of PER2 expression (data not shown; main effect of 
ZT, F (1, 3) = 273.84, p < 0.01; main effect of lesion, F (1, 3) = 0.62, n.s.; ZT x 
lesion interaction, F (1, 3) = 1.08, n.s.). This finding indicates that the blunting of 
peak PER2 expression in the dorsal striatum after a unilateral 6-OHDA lesion 
does not recover with time, even when rats have access to running wheels in the 
intervening period. 
To confirm that the effect of the 6-OHDA lesion on the PER2 rhythm in the 
dorsal striatum was attributable to the elimination of DA inputs to this region and 
not merely to a mechanical lesion of MFB fibers, two additional groups of rats 
received a unilateral injection of either 6-OHDA or vehicle (0.5% ascorbic acid in 
saline) into the MFB and were killed 14 days later at either ZT1 or ZT13. As 
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shown in Fig. 5a, in 6-OHDA-treated rats, PER2 expression in the dorsal striatum 
was significantly reduced at ZT1 on the lesioned side, whereas there was no 
effect on PER2 in vehicle-injected rats in either hemisphere (Fig. 5d), indicating 
that the changes in PER2 in the striatum can be unambiguously attributed to the 
elimination of the DA innervation. As expected, PER2 expression in the SCN was 
not affected in either treatment group (Figs. 5b,e). 
An additional finding from the 6-OHDA-lesion group in this latter 
experiment is that although wheel-running activity across the 24-h period remains 
rhythmic, the amount of nighttime activity in the 6-OHDA lesioned rats is 
significantly reduced (Fig 5c). This might raise the possibility that the unilateral 
change in PER2 expression seen after unilateral DA depletion could in some way 
be related to changes in levels of nighttime activity. Contrary to this idea, 
however, a similar reduction in activity levels was observed in vehicle-treated rats 
(Fig. 5f). Thus changes in PER2 expression appear to be related specifically to 
DA and not to a reduction in locomotor activity. 
PER1 expression after unilateral 6-OHDA lesion 
In view of evidence that DA receptor agonists modulate the expression of 
the clock gene Perl in the dorsal striatum (Nikaido et al., 2001), we also 
examined the effect of a unilateral 6-OHDA injection into the MFB on the rhythm 
of expression of the PER1 protein in the dorsal striatum and SCN using alternate 
brain sections from rats in our first 6-OHDA lesion experiment. These data are 
shown in Figure 6. In the dorsal striatum (Fig. 6a), the normal rhythm of PER1 
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Figure 5. 
!ntra-MFB injection of 6-OHDA blunts the daytime increase in PER2 expression 
in the dorsal striatum (a) whereas a vehicle injection into the MFB has no effect 
(d) (expressed as mean PER2-IR nuclei at each ZT ± SEM; n = 3 per ZT). In the 
SCN, neither a unilateral 6-OHDA injection (b) nor a vehicle injection (e) into the 
MFB disrupts the daily fluctuation in PER2 expression. In contrast to the 
selective effect of 6-OHDA on PER2 in the dorsal striatum, nighttime wheel 
running activity (expressed as mean wheel revolutions/10 min bin over 24 h ± 
SEM) is decreased after a unilateral intra-MFB injection of either 6-OHDA (c) or 
vehicle (f). (* indicates a significant difference between the intact and lesioned 
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Figure 6. 
A unilateral 6-OHDA lesion selectively reduces the normal morning peak of 
PER1 expression in the dorsal striatum ipsilateral to the lesion but does not affect 
the PER1 rhythm in the SCN. Means ± SEM of PER1 immunoreactive (IR) 
nuclei in the intact and lesioned hemispheres in the dorsal striatum (a) and SCN 
(b) in rats killed at ZT1, 7, 13 and 19, two weeks after 6-OHDA treatment (n = 5-6 
per ZT). (* indicates a significant difference between the intact and lesioned 
hemispheres, p < 0.05). 
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expression approximates the rhythm of PER2 in this region and peaks near ZT1. 
Following the 6-OHDA lesion, the amplitude of this rhythm in the lesioned 
hemisphere was significantly blunted compared to the intact hemisphere (main 
effect of ZT, F (3, 12) = 10.53, p < 0.01; main effect of lesion, F(1, 12) = 21.60, 
n.s.; ZT x lesion, F (3,12) = 11.24, p < 0.05) and PER1 was significantly reduced 
in the lesioned hemisphere at ZT1 (p < 0.05) and ZT19 (p < 0.05). In the SCN, 
the normal rhythm of PER1 expression is similar to the rhythm of PER2 and 
peaks near ZT13. As shown in Fig. 6b, the 6-OHDA lesion did not affect PER1 in 
the SCN (main effect of ZT, F (3, 12) = 11.37, p < 0.01; main effect of lesion, F 
(1, 12) = 1.09, n.s.; ZTx lesion interaction, F (3, 12) = 0.09, n.s.). 
PER2 expression after inhibition of tyrosine hydroxylase 
The results of our 6-OHDA experiments indicate that a unilateral lesion of 
dopaminergic projections and subsequent depletion of DA in the dorsal striatum 
significantly blunts the normal rhythm of PER2 expression in this region without 
affecting the rhythm in the SCN. To determine whether pharmacological 
depletion of DA without destruction of DA cells would produce the same result, 
we gave 3 injections of the tyrosine hydroxylase inhibitor, AMPT, over 8 h. The 
first injection was given at ZT 0 (AMPT 300 mg/kg or vehicle 1 ml/kg), the second 
injection at ZT4 (AMPT 200 mg/kg or vehicle), and the third injection at ZT8 
(AMPT 200 mg/kg or vehicle). Rats were then perfused for 
immunohistochemistry or decapitated for HPLC quantification of DA at ZT13, 5 h 
after the last injection, or at ZT1, 17 h after the last injection. 
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Analysis of striatal tissue punches from both hemispheres using HPLC 
revealed a 95% reduction in DA content in AMPT-treated rats killed at ZT13 and 
an 88% reduction in DA content in AMPT-treated rats killed at ZT1 (Fig. 7a), 
indicating a profound depletion of DA in the dorsal striatum as a result of this 
treatment (ZT1 independent samples t-test, t (2) = 13.05, p < 0.01; ZT13 
independent samples t-test, t (2) = 29.02, p < 0.01). Figures 7b and c show the 
daily fluctuation in PER2 expression in the dorsal striatum and SCN of rats 
injected with AMPT or vehicle. In the dorsal striatum (Fig. 7b), AMPT significantly 
reduced PER2 expression at ZT1 (main effect of ZT, F (1, 11) = 31.45, p < 0.01; 
main effect of treatment, F (1, 11) = 10.28, p < 0.01; ZT x treatment interaction, F 
(1,11) = 25.56, p < 0.01; independent samples t test at ZT1, t (6) = 4.66, p < 
0.01) and slightly increased it at ZT13 compared to the vehicle group 
(independent samples t-test, t (5) = -3.22, p < 0.05). AMPT treatment had no 
effect on PER2 expression in the SCN (Fig. 7c; main effect of ZT, F (1, 12) = 
1208.25, p < 0.01; main effect of treatment, F (1, 12) = 0.17, n.s.; ZTx treatment 
interaction, F (1, 12) = 1.66, n.s.). These findings corroborate the results of our 
unilateral 6-OHDA lesion experiments and indicate that depletion of normal DA 
levels in the dorsal striatum by lesioning or pharmacological means blunts the 
normal daily peak in PER2 expression in this region. Interestingly, the magnitude 
of the AMPT effect on striatal PER2 appears larger than the effect of a 6-OHDA 
lesion. Because inhibition of tyrosine hydroxylase prevents the synthesis of 
noradrenaline (NA) as well as dopamine, it is possible that the additional 
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Inhibition of tyrosine hydroxylase activity suppresses DA levels and daytime 
PER2 expression in the dorsal striatum. Rats were given 3 injections of AMPT or 
saline over 8 h and then killed at either ZT13 (5 h after the last injection) or ZT1 
(17 h after the last injection), (a) DA content in the dorsal striatum (expressed as 
pg DA/ug protein) in AMPT-injected rats (black bars) was significantly decreased 
at both ZT1 and ZT13 compared to saline-injected rats (white bars, n = 2 per 
treatment group per ZT; * p < 0.05). (b) In the dorsal striatum, AMPT treatment 
decreased daytime PER2 expression at ZT1 and increased PER2 at ZT13 
compared to saline controls (expressed as mean PER2-IR nuclei ± SEM at each 
ZT; n = 4 per treatment group per ZT; * p < 0.05). (c) In the SCN, AMPT 
treatment had no effect on PER2 expression at either time point. 
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decrease in PER2 following AMPT reflects a role for NA in the regulation of 
PER2 expression in the dorsal striatum. 
PER2 expression in primary motor cortex and hippocampus following 6-
OHDA lesion and inhibition of tyrosine hydroxylase 
To confirm that the effect of the 6-OHDA lesion on PER2 in the dorsal 
striatum was attributable to a loss of DA innervation and not to a non-specific 
lesion of catecholamines fibers in general, we examined the effects of a 6-OHDA 
lesion and AMPT treatment on PER2 expression in two other regions innervated 
by NA fibers, namely primary motor cortex (M1) and the dentate gyrus of the 
hippocampus (DG) (Swanson and Hartman, 1975; Fallon and Moore, 1978; 
Asan, 1998). In both M1 and DG, the normal daily fluctuation in PER2 
expression peaks at ZT1 and falls at ZT13, consistent with the PER2 phase in 
the dorsal striatum. As shown in Fig. 8, a unilateral 6-OHDA lesion had no effect 
on PER2 expression in M1 (Fig. 8a) or DG (Fig. 8c) in either hemisphere. In 
contrast, systemic AMPT treatment dramatically decreased PER2 expression at 
ZT1 in both M1 (Fig. 8b) and DG (Fig. 8d). Together, these results indicate that 
catecholamines regulate the daily fluctuation in PER2 expression in M1 and DG. 
The dissociation between the effects of 6-OHDA and AMPT, however, suggests 
that the catecholaminergic regulation of PER2 in these regions is primarily 
attributable to NA. Importantly, the lack of effect of the 6-OHDA lesion on PER2 
in these regions indicates that the lesion did not damage NA fibers in addition to 
DA fibers. 
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Figure 8. 
A unilateral 6-OHDA infusion into the MFB has no effect on PER2 in primary 
motor cortex (M1) or in the dentate gyrus (DG), whereas treatment with AMPT 
strongly suppresses the normal peak of PER2 expression in each of these 
regions. Mean PER2-IR nuclei ± SEM in the intact and 6-OHDA lesioned 
hemispheres of M1 (a) and DG (c) following a unilateral 6-OHDA lesion (n = 5 
per ZT). Mean PER2-IR nuclei ± SEM in primary motor cortex (b) and DG (d) 
following AMPT treatment (n = 4 per treatment group per ZT; * p < 0.05). 
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PER2 expression during chronic treatment with DA receptor antagonists 
Having found that a depletion of DA in the dorsal striatum disrupts the 
normal rhythm of PER2 expression in this region, we investigated whether 
blocking either D1 or D2 DA receptors using chronic, 24-h infusion of DA 
receptor antagonists would affect the normal rhythm of PER2 expression in the 
dorsal striatum and SCN. Following a 10-day entrainment period, naive rats 
underwent surgery to receive osmotic minipumps containing the D1 DA receptor 
antagonist, SCH 23390 (0.5 mg/kg/24 h), or the D2 DA receptor antagonist, 
raclopride (2 mg/kg/24 h), or underwent sham surgery (no pump inserted). Rats 
remained in their home cages for 5 days after pump insertion and were then 
perfused at either ZT1 or ZT13. The doses of SCH 23390 and raclopride were 
chosen on the basis of previous studies indicating dose ranges that were 
effective in occupying approximately 80% of striatal D1 or D2 DA receptors and 
that did not impede motor function (Creese and Chen, 1985; Neisewander et al., 
1998; Wadenberg et al., 2001; Kapur et al., 2003). The duration of drug 
treatment was limited to 5 days in this experiment because of evidence indicating 
that longer delivery of DA antagonists is less effective than shorter-term 
treatment in blocking DA receptors due to increasing sensitivity of DA receptors 
over time (Samaha et al., 2008). 
The results of this experiment are shown in Fig. 9. In the dorsal striatum 
(Fig. 9a), PER2 expression was unaffected by five days of chronic treatment with 
the D1 DA antagonist, SCH 23390, but was significantly reduced at ZT1 by 
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Figure 9. 
(a) Continuous infusion of the D2 DA receptor antagonist, raclopride (2 mg/kg/24 
h), for 5 days via osmotic minipump reduces daytime expression of PER2 in the 
dorsal striatum, whereas infusion of the D1 DA antagonist, SCH 23390 (0.5 
mg/kg/24 h) has no effect (expressed as mean PER2-IR nuclei ± SEM at each 
ZT; n = 4 per treatment group per ZT). (b) Neither raclopride nor SCH 23390 
infusion affects PER2 in the SCN (* indicates a significant difference between 
raclopride and sham groups, p < 0.05). 
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chronic infusion of the D2 DA antagonist, raclopride (ZT x treatment interaction, F 
(2, 18) = 8.24, p < 0.01; one-way ANOVA at ZT1, F (2, 9) = 5.53, p < 0.05, 
raclopride group less than vehicle and SCH 23390 groups, p < 0.05, post-hoc 
comparison with Bonferroni correction). No differences in PER2 expression 
between groups were found at ZT13 in the dorsal striatum (one-way ANOVA at 
ZT13, F (2, 9) = 2.93, n.s.). In the SCN (Fig. 9b), neither SCH 23390 nor 
raclopride changed the normal daily variation in PER2 (main effect of ZT, F (1 , 
18) = 727.79, p < 0.01; main effect of treatment, F (2, 18) = 1.07, n.s.; ZT x 
treatment interaction, F (2, 18) = 0.69, n.s.). These results suggest that the 
normal PER2 rhythm in the dorsal striatum depends on the availability of D2, but 
not D1 DA receptors. 
Effect of D1 or D2/3DA receptor agonist injections on PER2 expression and 
wheel running in 6-OHDA-lesioned rats 
Previous research indicates that changes in the expression of peptides 
and receptors in striatal medium spiny neurons that develop following a unilateral 
6-OHDA lesion can be reversed with intermittent or chronic DA receptor agonist 
treatment (Gerfen et al., 1990). To investigate whether such treatments could 
also restore the normal rhythm of PER2 expression in the 6-OHDA-lesioned 
dorsal striatum, we gave systemic injections of the D1 DA agonist, SKF 81297 (1 
mg/kg), the D2/3 DA agonist, quinpirole (0.5 mg/kg), or vehicle (1 ml/kg) at ZT1 
for 10 days, beginning 15 days after surgery. Drug doses were in the range 
shown previously to enhance expression of immediate early genes, striatal 
peptides, and electrophysiological responses of striatal neurons in 60HDA-
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lesioned rats (Gerfen et al., 1990; Hu et al., 1992; Gerfen et al., 1995; Zhang et 
al., 2007; Ballion et al., 2009). We chose to give the daily agonist injection at 
ZT1, a time at which extracellular DA levels in the striatum are normally low, to 
determine whether exogenous stimulation of DA receptors would not only restore 
PER2 expression in the lesioned striatum, but also establish a new rhythm of 
PER2 expression whose phase was determined by the time of the agonist 
injection. Rats were then killed on the day after the last injection at either ZT1 or 
ZT13. 
The results of this experiment are shown in Fig. 10. As shown previously, 
a unilateral 6-OHDA lesion blunted the daily variation of PER2 expression in the 
dorsal striatum on the lesioned side by strongly reducing the normal peak seen at 
ZT1 (ZT x lesion interaction, F (1, 27) = 85.64, p < 0.01) (vehicle-treated rats, 
Fig. 10a). Daily systemic injection of quinpirole at ZT1 restored and reversed the 
daily fluctuation of PER2 expression on the lesioned side. Specifically, quinpirole 
had no effect on PER2 expression at ZT1 (Fig. 10b, one-way ANOVA at ZT1, F 
(2, 14) = 0.16, n.s.), but dramatically increased expression PER2 at ZT13, a time 
when the normal rhythm of PER2 expression in the striatum would otherwise be 
at its trough (one-way ANOVA at ZT13, F (2, 13) = 64.02, p < 0.01). It can also 
be seen in Fig. 10b that quinpirole injections had no effect on the normal daily 
variation in PER2 expression in the intact dorsal striatum (main effect of ZT, F (1, 
27) = 174.99, p < 0.01; main effect of treatment, F (2, 27) = 0.04, n.s.; ZT x 
treatment interaction, F (2, 27) = 2.00, n.s.). Daily injection of SKF 81297 at ZT1 
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Figure 10. 
PER2 expression in the dorsal striatum and SCN and daily wheel running activity 
in 6-OHDA-lesioned rats injected daily at ZT1 with vehicle, the D2/3 agonist, 
quinpirole (0.5 mg/kg), or the D1 DA agonist, SKF 81297 (1 mg/kg). In the dorsal 
striatum (a, b, c), daytime PER2 expression was decreased on the 6-OHDA-
lesioned side in vehicle-injected rats (a) (expressed as mean PER2-IR ± SEM at 
each ZT; n = 7-8 per ZT). Daily injection of quinpirole (b) selectively increased 
PER2 expression at ZT13 in the dorsal striatum of the 6-OHDA lesioned 
hemisphere (n = 6 per ZT), whereas daily injection of SKF 81297 (c) had no 
effect on PER2 in either the lesioned or intact hemisphere (n = 3 per ZT). PER2 
expression in the SCN was not affected any of these treatments (d, e, f). The 
normal 24-h rhythm in wheel running during the 10-day injection period (g, h, i) 
was not disrupted by daily vehicle injection (g, expressed as mean wheel 
revolutions/10 min bin over 24 h ± SEM; n = 15). Quinpirole injection (h) 
suppressed nighttime wheel running (n = 12), whereas SKF 81297 injection (i) 
increased daytime wheel running (n = 6), particularly in the hour before the 
injection was given (ZT0-1). (* indicates a significant difference from the intact 
hemisphere; ** indicates significant difference from vehicle group lesioned 
hemisphere, p < 0.05; § indicates a significant difference from the vehicle group, 
p < 0.05). 
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(Fig. 10c) had no effect on PER2 expression at ZT1 or ZT13 in either the 
lesioned or intact dorsal striatum. 
Consistent with our earlier results, unilateral injection of 6-OHDA had no 
effect on the normal daily variation of PER2 expression in the SCN (Fig. 10d). 
Furthermore, as shown in Figs. 10e, f the daily variation of PER2 expression in 
the SCN was unaffected by quinpirole or SKF 81297 injection. In contrast, it can 
be seen from Figs. 10g-i that daily injections of the DA agonists had differential 
effects on wheel-running activity rhythms. Quinpirole strongly suppressed 
nocturnal activity (Fig. 10h), whereas SKF 81297 increased activity during the 
day especially just after the injections (Fig. 10i). 
Having found that a daily injection of quinpirole, but not SKF 81297, at 
ZT1 establishes a new pattern of PER2 expression in the 6-OHDA-lesioned 
dorsal striatum, though not in the intact striatum, we asked whether similar 
treatments with quinpirole or SKF 81297 would have any effect on PER2 
expression in the dorsal striatum or SCN of naive, intact rats. No effects of these 
drug treatments were found in either the dorsal striatum or SCN (data not 
shown). 
Finally, having found that scheduled daily injections of quinpirole restored 
a rhythm of PER2 expression in the 6-OHDA-lesioned dorsal striatum, whereas 
SKF 81297 injections did not, we asked whether the induction of a new PER2 
rhythm in the lesioned dorsal striatum requires a timed, bolus delivery of a DA 
receptor agonist or only a general level of DA receptor stimulation that is time-
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insensitive. To address this, we prepared rats with unilateral 6-OHDA lesions of 
the MFB and inserted osmotic minipumps 15 days after the 6-OHDA lesion 
surgery to deliver a constant 24-h infusion of quinpirole (0.5 mg/kg/24 h) or SKF 
81297 (1 mg/kg/24 h). Rats were perfused 10 days later at either ZT1 or ZT13. 
As shown in Fig. 11a, 6-OHDA had the expected effect on PER2 expression in 
the dorsal striatum at ZT1. Furthermore it can also be seen that chronic delivery 
of quinpirole (Fig. 11 b) or SKF 81297 (Fig. 11 c) at the doses used did not alter 
the effect of lesions on PER2 expression in the dorsal striatum nor did they alter 
PER2 expression in the intact hemisphere. No effects were seen in the SCN 
(Fig. 11d, e, f). Finally, during the 10-day period of chronic infusion of quinpirole 
or SKF 81297, wheel-running activity remained rhythmic in all groups (Fig. 11g, 
h,i). 
Cell types expressing PER2 in the dorsal striatum 
The vast majority of cells in the dorsal striatum are GABAergic medium 
spiny neurons that project to the output nuclei of the basal ganglia. These 
medium spiny neurons are subdivided into two populations that are 
distinguishable on the basis of the regions to which they project and the 
receptors and peptides expressed by each. Striatonigral neurons, belonging to 
the 'direct' pathway, project primarily to the substantia nigra pars reticulata and 
express D1 DA receptors and the peptides, substance P and dynorphin. 
Striatopallidal neurons, belonging to the 'indirect' pathway, project to the globus 
pallidus and express D2 DA receptors and enkephalin (for a review, see Gerfen, 
2004). On the basis of these known histological characteristics, we used double 
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Figure 11. 
Continuous infusion of the D2/3 agonist, quinpirole (0.5 mg/kg/24 h; n= 2-3 per 
ZT), or the D1 DA agonist, SKF 81297 (1 mg/kg/day; n=2-3 per ZT), for 10 days 
via osmotic minipump has no effect on mean (± SEM) PER2 expression in either 
the 6-OHDA lesioned or intact dorsal striatum (b, c) or SCN (e, f) compared to 
sham surgery group (Fig. 10a, d; n=3-5 per ZT). Neither treatment affected daily 
wheel running activity (expressed as mean wheel revolutions/10 min bin over 24 
h ± SEM; Fig. 10g, h, i). (* indicates significant difference from intact 
hemisphere, p < 0.05). 
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immunohistochemical staining to determine which types of striatal cells express 
PER2. Representative images of cells in the dorsal striatum double-labeled for 
PER2 and GAD-67 (the rate-limiting enzyme for the synthesis of GABA), the D2 
DA receptor, the D1 DA receptor, enkephalin, or substance P from rats killed at 
ZT1 are presented in Fig. 12. Double-labeling for GAD-67 and PER2 (Fig. 12a) 
revealed that many, though not all, GAD-67-IR cells express PER2, 
demonstrating that PER2 is expressed in medium spiny neurons. Double-
labeling for D2 DA receptor and PER2 (Fig. 12b), however, revealed that most 
D2-IR cells also express PER2. In contrast, only a few D1 DA receptor-IR cells 
expressed PER2 (Fig. 12c). Double-labeling for PER2 and the peptides 
enkephalin or substance P revealed that PER2 is frequently co-localized with 
enkephalin (Fig. 12d), and much less often with substance P (Fig. 12e). These 
observations demonstrate that PER2 in the dorsal striatum is expressed more 
frequently in D2 DA receptor- and enkephalin-containing medium spiny neurons 
belonging to the striatopallidal projection. 
DISCUSSION 
Daily, timed stimulation ofD2 receptors regulates PER2 in the dorsal striatum. 
There is evidence that molecular components of the circadian clock, including 
Per2, participate in the regulation of striatal dopaminergic activity in rodents 
(McClung et al., 2005; Roybal et al., 2007; Hampp et al., 2008). In turn, it has 
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Figure 12 
Central panel shows high magnification (X100) images depicting dorsal striatal 
neurons double stained for PER2 and GAD-67, D2 DA receptor, D1 DA receptor, 
enkephalin (ENK) or substance P (SP). Images in left and right panels are 
enlargements of framed cells in corresponding central panel, (a) Double 
immunostaining for GAD-67 (brown cytosolic stain) and PER2 (blue nuclear 
stain) reveals that many but not all GAD-immunopositive cells co-express PER2 
(shown with arrows, (b) Double-immunostaining for D2 DA receptor (brown 
cytosolic stain) and PER2 (black nuclear stain) revealed frequent co-expression 
of PER2 in D2 DA receptor-positive cells (marked with arrows), (c) Double 
immunostaining for D1 DA receptor (brown cytosolic stain) and PER2 (black 
nuclear stain) reveals segregation between PER2 and D1 DA receptor 
immunostaining. (d) Double immunostaining for enkephalin (brown cytosolic 
stain) and PER2 (blue-gray nuclear stain) shows frequent co-expression (shown 
with arrows), (e) Double immunostaining for substance P (brown cytosolic stain) 
and PER2 (black nuclear stain) shows segregation between substance P and 
PER2. 
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expression of Per genes in the striatum (Nikaido et al., 2001; lijima et al., 2002; 
Uz et al., 2005; Lynch et al., 2008; Imbesi et al., 2009). Here, we examined the 
role of endogenous DA in the regulation of the expression of the clock protein, 
PER2, in the dorsal striatum in order to better characterize the relation between 
DA and the circadian oscillations seen in clock gene expression in this region of 
the brain. We found that treatments that deplete striatal DA strongly blunt the 
rhythm of PER2 and, furthermore, that daily stimulation of D2, but not D1 DA 
receptors, restores and entrains the PER2 rhythm in the DA-depleted striatum. 
Furthermore, we showed that the peak of the daily rhythm of extracellular DA in 
the dorsal striatum precedes the peak of PER2. In addition, we observed that 
PER2 is expressed in striatal cells that co-express D2 DA receptors. Our 
findings are consistent with the idea that the expression of PER2 within the 
dorsal striatum is expressed in neurons of the striatopallidal projection and that 
the rhythm of expression of PER2 in these neurons depends on daily 
dopaminergic activation of D2 DA receptors. 
The daily peak of extracellular DA in the dorsal striatum preceded that of 
PER2 by approximately 6 h. Specifically, extracellular DA levels peak in the 
middle of the dark (active) phase and fall during the light (inactive) phase of the 
daily cycle (see also Paulson and Robinson, 1994; Castaneda et al., 2004), 
whereas PER2 expression peaks at the beginning of the light phase and reaches 
its trough near the beginning of the dark phase (see also Amir and Robinson, 
2006). When striatal DA was depleted unilaterally using 6-OHDA, the peak 
expression of PER2 on the lesioned side was strongly suppressed and the daily 
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rhythm of PER2 in this region was blunted both at 2 and 4 weeks post-surgery. 
Furthermore, we found that treatment with AMPT, which blocks the synthesis of 
DA and other catecholamines acutely, suppressed PER2 expression within 24 h. 
These findings indicate that normal rhythmic expression of PER2 in the dorsal 
striatum relies on DA availability. We next showed that the rhythm of PER2 in 
the dorsal striatum relies on phasic activation of D2 DA receptors. Daily 
injections of a D2 DA receptor agonist, given to induce a peak of activation of DA 
receptors at a time of day when DA levels are normally low, not only restored, but 
also shifted the daily peak of PER2 in the lesioned dorsal striatum. Continuous 
infusion of the D2 DA agonist had no effect, underscoring the role of phasic 
activation. Importantly, neither daily injections nor continuous infusion of a D1 
DA agonist was effective. Together these findings point to a link between the 
daily rise of endogenous DA, D2 DA receptor activation and the subsequent peak 
in PER2 expression in the dorsal striatum. 
The requirement of D2 DA receptor activation for the maintenance of 
PER2 rhythm in the dorsal striatum is further demonstrated by our finding that 
chronic infusion of a selective D2, but not D1, DA receptor antagonist attenuates 
the daily fluctuation in PER2 expression in the dorsal striatum. Furthermore it is 
also consistent with our observation that PER2 is found frequently in striatal 
GABA-containing neurons that express D2 DA receptors and enkephalin, and 
rarely in those expressing D1 DA and substance P. This apparent anatomical 
selectivity of PER2 expression within the dorsal striatum, and its modulation by 
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D2 DA activation may provide a clue to the functional significance of rhythmic 
PER2 expression in this system. 
Mechanisms ofPER2 modulation by DA in the dorsal striatum. 
The mechanisms whereby DA depletion and D2 DA receptor activation 
suppress and restore, respectively, PER2 expression in the dorsal striatum 
remain to be resolved. It is clear that changes in locomotor activity brought about 
by DA depletion or, indeed, by D2 DA receptor stimulation cannot explain the 
changes in PER2 expression. For example, unilateral depletion of striatal DA, 
which strongly blunted the rhythm of PER2 expression on the lesioned side, did 
not disrupt the daily activity rhythm even though the level of nighttime activity was 
reduced. Furthermore, comparable changes in level of nighttime activity, but not 
PER2 expression, were seen after unilateral injection of vehicle into the MFB. A 
similar lack of relation between PER2 expression in the dorsal striatum and 
activity emerges from the experiments with the daily morning injections of the D2 
DA receptor agonist, quinpirole. Thus, injection of quinpirole given when striatal 
levels of DA would be low restored the daily variation of PER2 expression in the 
lesioned striatum while suppressing nighttime activity, but had no effect on PER2 
expression in the intact hemisphere; neither did it affect PER2 expression in 
naive rats. 
The absence of an effect of quinpirole injections on the PER2 rhythm in 
the intact dorsal striatum and in the striatum of naive rats is likely due to the time 
of day when injections were given. The dose of quinpirole used in the present 
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experiments has been shown to reliably inhibit the activity of DA neurons in na'fve 
rats through activation of D2 DA autoreceptors on DA cell bodies (Lacey et al., 
1987; Jeziorski and White, 1989). Indeed, we have found that injecting the same 
dose of quinpirole in naive rats at the start of the dark phase, when extracellular 
DA levels in the dorsal striatum are beginning to rise, strongly reduced the 
normal peak of PER2 expression in the striatum at ZT1 (unpublished 
observations). Because quinpirole injections were given at ZT1 in the present 
experiments, during the trough of the rhythm of extracellular DA in the striatum, a 
further reduction in dopaminergic cell activity at this time of day would have little 
impact on the normal PER2 rhythm. Following a 6-OHDA lesion, however, the 
expression of D2 DA receptors on cell bodies is lost through destruction of DA 
fibers, whereas post-synaptic expression of D2 DA receptors in medium spiny 
neurons is upregulated (e.g., Gerfen et al., 1990). As a result, the 6-OHDA-
lesioned hemisphere would be highly sensitive to D2 DA receptor stimulation. 
The question then remains, how might activation of D2 DA receptors 
regulate the rhythm of PER2 expression in the dorsal striatum? In addition to the 
immunohistochemical data we report here, we have preliminary results from an 
ongoing study using real time PCR (Weigl, 2010) showing a 40-50% reduction in 
the amplitude of the Per2 mRNA rhythm in the dorsal striatum ipsilateral to a 6-
OHDA injection (unpublished observations). These findings corroborate those of 
Sahar et al.(2010) who reported a decrease in the amplitude of the Pert 
transcription rhythm in the striatum of D2 knock-out mice, and suggest that D2 
signaling modulates PER2 expression in this region at the level of transcription. 
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This modulation could occur through changes in the cAMP-CREB signaling 
pathway, which is regulated by DA signaling (Montmayeur and Borrelli, 1991). 
The Pert promoter region contains a CRE-responsive site (Travnickova-Bendova 
et al., 2002) and previous studies in vitro have demonstrated that D2 receptor 
stimulation upregulates Per expression in the retina through a CREB-dependent 
mechanism (Besharse et al., 2004; Yujnovsky et al., 2006). It is possible, 
however, that DA also regulates PER2 expression directly through changes in 
post-translational phosphorylation mechanisms (litaka et al., 2005) or indirectly 
by modulating other components of the clock, for example through D2 receptor-
mediated changes in BMAL1 phosphorylation by GSK3P (Beaulieu et al., 2004; 
Saharetal.,2010). 
A different possibility is that DA acts through presynaptic D2 DA receptors 
to affect PER2 expression by modulating the activity of corticostriatal 
glutamatergic neurons (Bamford et al., 2004) or by modulating the effect of 
glutamate on D2 DA receptor-expressing striatopallidal neurons (for review, see 
Surmeier et al., 2007). Indeed, it is well known that glutamate plays a key role in 
the regulation of clock gene expression in the SCN (Reppert and Weaver, 2001). 
Importantly, it has been shown that following 6-OHDA-induced lesions of DA 
inputs to the dorsal striatum there are changes in both glutamate release as well 
as in responsiveness of D2 DA receptor-bearing striatopallidal neurons to 
glutamate (see Day et al., 2006). These changes in glutamate transmission 
within the striatum could potentially be linked in as yet unknown ways to changes 
in expression of PER2 in these striatal neurons. 
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Our results also leave open a possible role for NA in the modulation of 
PER2 expression in the dorsal striatum. AMPT depletion of catecholamines 
strongly reduced PER2 expression in this region, as well as in M1 and DG, which 
receive NA inputs. There is mixed evidence supporting NA signaling in the 
regulation of circadian rhythms, with some findings indicating an important role of 
forebrain NA for rhythms of sleep-wake, melatonin synthesis, and clock gene 
expression (Warnecke et al., 2005; Gonzalez and Aston-Jones, 2006, 2008; 
Wongchitrat et al., 2009) whereas others demonstrate no effect of NA (e.g., 
Fukuhara et al., 2002; Reilly et al., 2008). Taken together, it would seem that an 
involvement of NA in clock gene expression is probably region-specific, similar to 
the role proposed for DA here. 
DA does not regulate PER2 in the SCN. 
It should be noted that in all our experiments we assessed PER2 
expression in the SCN. Without exception, however, no changes in PER2 
expression were found either after DA depletion or activation/blockade of DA 
receptors. This insensitivity of the SCN is consistent with previous reports that 
the adult SCN, unlike the fetal SCN (Weaver et al., 1992; Schurov et al., 2002), is 
impervious to dopaminergic manipulations (Duffield et al., 1998; Masubuchi et 
al., 2000) and is also consistent with our finding that dopaminergic manipulations 
did not affect the daily rhythm of locomotor activity. 
83 
Functional significance of PER2 regulation by DA. 
Finally, it is interesting to speculate about the role of clock genes in 
functions mediated by the striatum. One idea is that clock genes, including Pert, 
play a role in the modulation of reward processes known to involve dopaminergic 
activity in the striatum (Abarca et al., 2002; McClung et al., 2005; Roybal et al., 
2007). This is supported by the evidence that Pert mutant mice exhibit greater 
responsivity to cocaine (Abarca et al., 2002), drink more alcohol and, 
interestingly, have higher levels extracellular glutamate in the brain secondary to 
a reduction in glutamate uptake (Spanagel et al., 2005). Another idea, more 
directly related to the present findings, is that the loss of circadian rhythms in 
clock gene expression in the striatum after DA depletion could be linked to 
disruptions of daily behavioral and physiological rhythms frequently reported in 
Parkinson's disease (Bruguerolle and Simon, 2002; Cai et al., 2010). Current 
models posit that the symptoms of Parkinson's disease result from changes in 
excitability of striatopallidal neurons secondary to depletion of striatal DA (Day et 
al., 2006). Our findings showing that loss of striatal DA can disrupt the rhythm of 
PER2, an essential component of the circadian clock, and that PER2 is 
expressed in D2 DA receptor-containing striatal neurons may provide a clue to 
understanding the origins of the circadian symptoms of the disease. 
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CHAPTER 2 
The effects of modulating endogenous dopamine levels on the daily fluctuation of 
PER2 expression in the limbic forebrain. 




The rhythms of expression of the clock protein, PER2, in several regions 
of the rat limbic forebrain are normally entrained by signals from the master clock 
in the SCN; however, they are also sensitive to a number of non-photic 
zeitgebers, which can uncouple the timing of these rhythms from the SCN. We 
have shown in the dorsal striatum that daily stimulation of D2 dopamine (DA) 
receptors is required for the normal daily fluctuation in PER2 expression in this 
region, but not in the SCN. Here, we examined the effect of manipulating 
endogenous levels of DA on the daily fluctuation in PER2 expression in several 
forebrain regions - specifically, the oval nucleus of the bed nucleus of the stria 
terminalis (BNSTov), the central nucleus of the amygdala (CEA), the basolateral 
amygdala (BLA), and dentate gyrus (DG) - using additional brain sections 
collected in the experiments described in chapter 1. Depletion of DA using a 
unilateral 6-OHDA lesion blunted the normal daily peak in PER2 expression 
selectively in the BNSTov, but had no effect in the other regions examined. In 
contrast, inhibition of catecholamine synthesis in general using AMPT had no 
effect on the BNSTov or on the CEA, yet strongly suppressed the daily peak in 
PER2 expression in the BLA and DG. Daily stimulation of D2 receptors, but not 
D1 receptors, inverted the normal PER2 pattern in the BNSTov and CEA, but 
had no effect on the BLA or DG. Taken together, these findings indicate that DA 
signaling at D2 receptors modulates PER2 expression in the BNSTov and CEA, 
but likely via mechanisms that are different from those involved in the dorsal 
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striatum. In contrast, endogenous DA signaling does not play a role in rhythmic 
PER2 expression in the BLA or DG. 
INTRODUCTION 
In the preceding experiments, it was found that DA acting at D2 receptors 
is necessary for rhythmic PER2 expression in the dorsal striatum, but has no 
effect on the PER2 rhythm in the SCN of rats housed in a 12:12 LD cycle. In 
addition to the dorsal striatum, PER2 is expressed rhythmically in several other 
regions of the limbic forebrain that also receive DA projections from the midbrain. 
These regions include the oval nucleus of the bed nucleus of the stria terminalis 
(BNSTov), the central amygdala (CEA), the basolateral amygdala (BLA), and the 
dentate gyrus (DG) (Fallon et al., 1978; Fallon and Moore, 1978; Freedman and 
Cassell, 1994; Shieh, 2003; Amir et al., 2004; Lamont et al., 2005a). As in the 
dorsal striatum, PER2 rhythms in these limbic forebrain regions are entrained by 
the SCN, but are also influenced by non-photic factors that do not otherwise 
affect the rhythm of the master clock. Notably, the PER2 rhythms in these 
regions do not respond uniformly to all non-photic factors. For example, the 
PER2 rhythms in the BNSTov and CEA, which are in phase with each other and 
with the rhythm in the SCN, are modulated by fluctuations in steroid hormone 
levels, such as corticosterone (Amir et al., 2004; Lamont et al., 2005a; Segall et 
al., 2006). Removal of the corticosterone rhythm in rats through adrenalectomy 
significantly blunts PER2 expression in the BNSTov and CEA, but has no effect 
on PER2 in the BLA, DG, dorsal striatum, or in the SCN. 
Using indirect DA agonists such as cocaine or methamphetamine, a 
limited number of studies has implicated DA receptor activation in the modulation 
of clock gene expression in areas outside of the dorsal striatum, such as the 
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hippocampus and parietal cortex (e.g., Masubuchi et al., 2000; Uz et al., 2005). 
To determine whether changes in levels of endogenous DA in vivo contribute to 
rhythmic clock gene expression in the BNSTov, CEA, BLA, or DG and to follow-
up on some preliminary work from this laboratory (Verwey et al., 2006), we 
studied brain sections from animals in each of the experiments described in the 
previous chapter. A portion of these results, specifically those demonstrating the 
effects of a unilateral 6-OHDA lesion and AMPT treatment on PER2 expression 
in the DG, were already presented in chapter 1, but are reviewed here. 
METHODS 
All of the methods and experimental procedures used were described in 
full in the previous chapter. 
Microscopy. The BNSTov, CEA, BLA, and DG were visualized with a light 
microscope using a 20x objective and images were taken using a Sony XC-77 
video camera, a Scion LG-3 frame grabber, and Image SXM software. 400 \im x 
400 urn images were taken of each region on the right and left hemispheres of 5-
6 representative sections. PER2-IR nuclei were counted in each image of a 
given structure. The mean number of IR nuclei in the right and left hemisphere 
was then calculated for each subject from the four images having the highest 
number of labeled nuclei out of all the images taken of that structure in a given 
hemisphere. 
Statistical analysis ofPER2-IR nuclei counts. In the experiments involving 
unilateral injections of 6-OHDA toxin into the MFB, data were analyzed only from 
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those rats with complete unilateral lesions, as confirmed by an absence of DAT 
staining in the dorsal striatum ipsilateral to the 6-OHDA injection (for an example 
of DAT staining following a unilateral injection of 6-OHDA toxin into the MFB, see 
Fig. 3 in chapter 1). Differences in PER2-IR nuclei counts were analyzed using 
mixed-model ANOVA with ZT and drug treatment group as between-subjects 
factors and hemisphere as a within-subjects factor. Differences in PER2 
expression in the experiments involving injections of AMPT, chronic infusion of 
DA receptor antagonists, and injections of DA receptor agonists in naive rats 
were analyzed using two-way ANOVA with ZT and treatment group as between-
subjects factors. Alpha level was set at 0.05 for all tests. Significant interactions 
were analyzed further using one-way ANOVA and Bonferroni-corrected post-hoc 
comparisons, or t-tests where appropriate. 
RESULTS 
Table 1 summarizes the effects of each experimental manipulation on 
PER2 expression at ZT1 and ZT13 in the BNSTov, CEA, BLA, and DG. For 
comparison purposes, the effects of these manipulations on PER2 in the dorsal 
striatum that were described in chapter 1 are also reported in Table 1. The 
results of each experiment are described in brief below. 
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Table 1. Summary of the effects of each experimental manipulation described in 
Chapters 1 and 2 on the daily fluctuation of PER2 expression in the limbic 
forebrain and SCN. § indicates a statistically significant (p < 0.05) effect. 
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PER2 expression after a unilateral 6-OHDA lesion 
As mentioned above, in the BNSTov and CEA, PER2 rhythms are 
synchronized and in phase with the rhythm of PER2 in the SCN, which peaks at 
the beginning of the dark phase (Amir et al., 2004; Lamont et al., 2005a). PER2 
rhythms in the BLA and DG are synchronized with each other and with the 
rhythm in the dorsal striatum, and peak at the beginning of the light phase 
(approximately 12 h out-of-phase with the peak of the SCN PER2 rhythm) 
(Lamont etal.,2005a). 
Figure 1 shows the mean number of PER2-IR nuclei in the BNSTov, CEA, 
BLA, and DG at four time points in rats killed 14 days after a unilateral 6-OHDA 
injection into the MFB. The effect of the lesion on PER2 expression in each of 
these regions is summarized in row 1 of Table 1. In the BNSTov (Fig. 1a; column 
1 of Table 1), a unilateral 6-OHDA lesion significantly blunted the peak of the 
PER2 rhythm in the hemisphere ipsilateral to the lesion but did not affect the 
rhythm in the BNSTov of the intact hemisphere (ZT x lesion interaction, F (3, 18) 
= 8.62, p < 0.01); specifically, PER2 expression in the lesioned hemisphere was 
significantly decreased at ZT7 (t (4) = 4.26, p < 0.01) and ZT13 (t (5) = 4.10, p < 
0.01). 
In the CEA (Fig. 1b; column 2 of Table 1), PER2 expression was slightly 
reduced in the lesioned hemisphere compared to the intact hemisphere. 
Although statistical analysis indicated a significant main effect of lesion (F (3, 18) 
= 11.01, p < 0.01), there was no interaction of the lesion effect with ZT (ZT x 
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lesion, F (3, 18) = 0.52, n.s.), and this reduction in PER2 expression on the 
lesioned side was not significant when comparisons were made at individual time 
points. In the BLA(Fig. 1c; Table 1, column 3) and in the DG (Fig. 1d; Table 1, 
column 4), no effect of a unilateral 6-OHDA lesion on PER2 was observed in 
either hemisphere. 
Effect of tyrosine hydroxylase inhibition on PER2 
Having found that a unilateral 6-OHDA injection into the MFB blunts PER2 
expression in the BNSTov and CEA, but not in the BLA or DG, we next examined 
whether inhibition of catecholamine synthesis in general using AMPT affects 
PER2 expression in these forebrain regions. As described in the previous 
chapter, three i.p. injections of AMPT or saline were given over the course of one 
day (at 4-h intervals) in this experiment and rats were killed at either ZT13, 5 h 
after the last injection, or ZT1, 17 h after the last injection. This treatment with 
AMPT profoundly decreased DA content in the dorsal striatum to approximately 
10% of saline-injected levels (see Fig. 7 in chapter 1 for striatal DA content in 
saline- and AMPT-treated rats; DA levels in other regions were not assessed). 
The results of this experiment are summarized in row 2 of Table 1. Fig. 2 
shows the mean number of PER2-IR nuclei in the BNSTov, CEA, BLA, and DG 
in AMPT- and saline-treated rats. In the BNSTov (Fig. 2a), the PER2 rhythm was 
not affected by AMPT treatment. In the CEA (Fig. 2b), AMPT reduced PER2 
expression at ZT1 (t (6) = 2.81, p < 0.05), but had no effect on the normal 
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A unilateral 6-OHDA injection into the medial forebrain bundle decreases the 
normal peak of PER2 expression in the BNSTov (a) ipsilateral to the 6-OHDA 
injection, but has no effect on the normal daily fluctuation in PER2 expression in 
the CEA (b), the BLA (c), or the DG (d). For each brain region, data are shown 
as mean PER2-immunoreactive (IR) nuclei ± SEM per ZT in the intact 
hemisphere (open circles) and lesioned hemisphere (black circles); n = 5-6 per 
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Figure 2. 
Inhibition of catecholamine synthesis using the tyrosine hydroxylase inhibitor, 
AMPT, does not affect the normal daily pattern of PER2 in the BNSTov (a) or in 
the CEA (b), but strongly suppresses the daily peak in PER2 expression at ZT1 
in the BLA (c) and DG (d). For each brain region, data are shown as mean 
PER2-immunoreactive (IR) nuclei ± SEM perZT in the vehicle-injected groups 
(open bars) and AMPT-injected groups (black bars); n = 4 per treatment group 
per ZT; * indicates p < 0.05 compared to vehicle. 
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In the BLA and DG, AMPT treatment had a marked effect. As shown in 
Fig. 2c, PER2 expression in the BLA was dramatically decreased at ZT1 in 
AMPT-treated rats (t (6) = 6.56, p < 0.01) and was significantly increased at ZT13 
compared to saline-treated rats (t (6) = -2.57, p < 0.05). In the DG (Fig. 2d), 
PER2 expression was strongly reduced at ZT1 in AMPT-treated rats (t (6) = 8.70, 
p < 0.01) but there was no difference between groups at ZT13. Thus, in contrast 
to the selective effect of a unilateral 6-OHDA lesion on PER2 expression in the 
BNSTov, AMPT treatment did not affect the normal daily fluctuation in PER2 
expression in the BNSTov or in the CEA but strongly suppressed the daily 
increase in PER2 expression at ZT1 in the BLA and DG. 
Effect of chronic infusion of DA receptor antagonists on PER2 
We examined PER2 expression in the forebrain of naive rats given 
chronic, 24-h infusion of the D2 DA receptor antagonist, raclopride (2 mg/kg/day), 
or the D1 DA receptor antagonist, SCH 23390 (0.5 mg/kg/day), via osmotic 
minipump for 5 days. These results are summarized in row 3 of Table 1 and the 
number of PER2-IR nuclei in each region is shown in Fig. 3. In the BNSTov (Fig. 
3a) and CEA (Fig. 3b), neither raclopride nor SCH 23390 infusion significantly 
affected the daily fluctuation of PER2. In the BLA (Fig. 3c), chronic infusion of 
raclopride significantly increased PER2 expression atZT13 in comparison to the 
SCH 23390 and sham groups (F (2, 9) = 13.39, p < 0.01). In the DG (Fig. 3d), no 
effect of either SCH 23390 or raclopride was observed. 
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In the BNSTov (a) and the CEA (b), chronic infusion of the D1 receptor-selective 
antagonist, SCH 23390 (0.5 mg/kg/24 h; black bars), or the D2 receptor-selective 
antagonist, raclopride (2 mg/kg/24 h; hatched bars), via osmotic minipump for 5 
days does not affect the normal daily fluctuation in PER2 expression. In the BLA 
(c), raclopride increases PER2 expression at ZT13 but does not affect the normal 
peak of PER2 at ZT1. In the DG (d), there is no effect of either raclopride or 
SCH 23390 infusion For each brain region, data are shown as mean PER2-
immunoreactive (IR) nuclei ± SEM per ZT in each treatment group; n = 4 per 
treatment group per ZT; * indicates p < 0.05 compared to sham. 
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Effect of daily quinpirole or SKF 81297 injections on PER2 
Unilateral 6-OHDA lesioned rats 
We then examined the effect of daily injections of the D2/3 DA receptor 
agonist, quinpirole (0.5 mg/kg), the D1 agonist, SKF 81297 (1 mg/kg), or saline 
(1 ml/kg), given at ZT1 for 10 days, on PER2 expression in the BNSTov, CEA, 
BLA, and DG of rats with a unilateral 6-OHDA lesion. In the previous chapter, it 
was reported that in 6-OHDA-lesioned rats, daily injections of quinpirole at ZT1 
restored and entrained a daily fluctuation in PER2 expression in the dorsal 
striatum ipsilateral to a 6-OHDA lesion, such that PER2 expression was 
increased at ZT13 on the lesioned side, whereas PER2 expression in the intact 
striatum and in the SCN was unaffected. 
The effects of these daily injections on PER2 expression in the forebrain 
are summarized in row 4 of Table 1 and are depicted in Fig. 4. In the BNSTov 
(Fig. 4a), a unilateral 6-OHDA lesion significantly reduced the daily peak in PER2 
expression at ZT13 in the lesioned hemisphere, consistent with the findings of 
the first 6-OHDA experiment described above, and daily injections of saline at 
ZT1 did not affect this reduction in PER2. Daily injection of quinpirole given at 
ZT1 (Fig. 4b) increased PER2 expression at ZT1 in the BNSTov in both the 
lesioned (F (2, 14) = 3.92, p < 0.05) and intact hemispheres (F (2, 14) = 11.55, p 
< 0.01) and decreased PER2 at ZT13 in both hemispheres (lesioned side, F (2, 
13) = 6.20, p < 0.05; intact side, F (2, 13) = 17.87, p < 0.01) in comparison to the 
SKF 81297- and saline injected-groups. Overall, quinpirole injections inverted the 
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normal daily fluctuation in PER2 expression in the BNSTov, such that PER2 
expression was greater at ZT1, the time of the daily quinpirole injection, than at 
ZT13 (p < 0.05), on both the 6-OHDA-lesioned and intact sides. In contrast, daily 
injection of SKF 81297 (Fig. 4c) had no effect on PER2 in the BNSTov in either 
the 6-OHDA-lesioned or intact hemisphere, indicating that PER2 expression in 
this region is not modulated by D1 receptor stimulation. 
In the CEA (Fig. 4d), a unilateral 6-OHDA lesion did not affect the normal 
daily fluctuation in PER2 expression nor did daily saline injections at ZT1 affect 
this normal pattern. Quinpirole injections at ZT1 (e) did not affect the level of 
PER2 expression at ZT1 in either the 6-OHDA-lesioned or intact hemisphere but 
significantly reduced the normal evening peak of PER2 expression at ZT13 in 
both hemispheres in comparison to the SKF 81297 and saline groups (lesioned 
side, F (2, 13) = 9.16, p < 0.01; intact side, F (2, 13) = 8.30, p < 0.01). Daily 
injection of SKF 81297 at ZT1 (f) had no effect on PER2 expression in the CEA 
of either hemisphere. Taken together, these findings suggest that PER2 
expression in the CEA is modulated by D2 receptor stimulation and not by D1 
receptors. However, because quinpirole injections did not affect PER2 
expression in this region at ZT1, the time of the daily injection, the magnitude of 
this influence of D2 receptor stimulation on PER2 in the CEA would appear to be 
less than the effect in the BNSTov, in which quinpirole actually inverted the daily 
pattern of expression. 
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Figure 4. 
(a) In the BNSTov, a 6-OHDA lesion significantly decreases the normal peak of 
PER2 at ZT13; (b) daily injection of quinpirole (0.5 mg/kg) at ZT1 increases 
PER2 at ZT1 in both the lesioned and intact hemispheres, and decreases PER2 
at ZT13; (c) daily injection of SKF 81297 (1 mg/kg) at ZT1 has no effect, (d) In 
the CEA, PER2 expression is unaffected by a unilateral 6-OHDA lesion; (e) daily 
injection of quinpirole at ZT1 significantly decreases PER2 at ZT13 in both the 
lesioned and intact hemispheres, whereas daily injections of SKF 81297 (f) have 
no effect, (g) In the BLA, PER2 expression is unaffected by a unilateral 6-OHDA 
lesion; (h) daily injection of quinpirole at ZT1 decreases PER2 at ZT1 in the intact 
hemisphere compared to saline control, whereas daily injections of SKF 81297 (i) 
increase PER2 at ZT13 in the 6-OHDA-lesioned hemisphere compared to saline 
control, (j) In the DG, PER2 expression is unaffected by a unilateral 6-OHDA 
lesion, (k) by daily injections of quinpirole, (I) or by daily injections of SKF 81297. 
For each region and treatment group, data are shown as mean PER2-
immunoreactive (IR) nuclei ± SEM per ZT in the intact hemisphere (open bars) 
and lesioned hemisphere (black bars); saline n = 7-8 per ZT; quinpirole n = 6 per 
ZT; SKF n = 3 per ZT; * p < 0.05 compared to intact hemisphere; ** p < 0.05 
compared to 6-OHDA hemisphere in saline condition; § p < 0.05 compared to 
intact hemisphere in saline condition. 
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In the BLA (Fig. 4g), the normal daily fluctuation in PER2 expression was 
unaffected by a unilateral 6-OHDA lesion and by daily saline injection at ZT1. 
Daily injections of quinpirole at ZT1 (h) did not affect PER2 expression in the 6-
OHDA-lesioned hemisphere, but decreased the normal peak of PER2 expression 
at ZT1 in the intact hemisphere compared to the saline group (F (2, 14) = 3.91, p 
< 0.05). Daily injection of SKF 81297 at ZT1 (i) increased PER2 expression at 
ZT13 in the 6-OHDA-lesioned hemisphere in comparison to the saline group (F 
(2, 13) = 5.30, p< 0.05). 
In the DG (Fig. 4j), a unilateral 6-OHDA lesion did not affect the normal 
PER2 fluctuation nor did daily saline injections at ZT1 affect this pattern. Daily 
injection of quinpirole at ZT1 (k) appeared to reduce PER2 expression at ZT1 in 
both the 6-OHDA-lesioned and intact hemispheres in comparison to the saline 
group, but this effect was not significant. Daily injection of SKF 81297 at ZT1 (I) 
had no effect on PER2 in either the 6-OHDA-lesioned or the intact hemispheres. 
Naive rats 
It was shown in chapterl that in naive rats, the normal PER2 rhythms in 
the dorsal striatum and SCN were unaffected by daily injections of quinpirole or 
SKF 81297 at ZT1. We examined in these same rats the effect of daily 
quinpirole and SKF 81297 injections, given at ZT1 for 10 days, on the PER2 
rhythms in the BNSTov, CEA, BLA, and DG. These data are summarized in row 
5 of Table 1 and shown in Figure 5. In the BNSTov (Fig. 5a), daily quinpirole 
injections at ZT1 significantly increased PER2 expression at ZT1 (F (2, 6) = 
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43.95, p < 0.01), the time of the daily injection, but did not affect PER2 levels at 
ZT13, whereas SKF 81297 injections had no effect at either time point. Similarly, 
in the CEA (b), quinpirole injections at ZT1 significantly increased PER2 
expression at ZT1 (F (2, 6) = 8.27, p < 0.05), the time of the daily injection, but 
had no effect at ZT13. Daily injection of SKF 81297 at ZT1 did not affect the 
normal daily fluctuation in PER2 expression in the CEA. In the BLA (c) and the 
DG (d), the normal PER2 pattern was unaffected by daily injections of quinpirole 
or SKF 81297 at ZT1. Thus, quinpirole injections at ZT1 in naive rats increased 
PER2 expression in the BNSTov and CEA at ZT1, when PER2 levels normally 
reach their trough in these regions, and thereby blunted the normal daily 
fluctuation in PER2. In contrast, neither daily quinpirole injection nor SKF 81297 
at ZT1 affected the daily fluctuation in PER2 expression in the BLA or DG. 
Effect of chronic infusion of DA receptor agonists on PER2 
We next examined whether chronic infusion of quinpirole (0.5 mg/kg/day) 
or SKF 81297 (1 mg/kg/day) via osmotic minipump for 10 days would affect the 
rhythms of PER2 expression in the forebrain of rats with unilateral 6-OHDA 
lesions. The effects of these treatments are summarized in row 6 of Table 1 and 
shown in Figure 6. In the BNSTov of rats with a unilateral 6-OHDA lesion (Fig. 
6a), PER2 expression was significantly reduced in the 6-OHDA-lesioned 
hemisphere and this pattern was unaffected by sham minipump surgery. Chronic 
infusion of quinpirole (b) or SKF 81927 (c) for 10 days did not affect the daily 
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Figure 5. 
In naive rats, the normal daily fluctuation in PER2 in the BNSTov (a) and CEA (b) 
is blunted by daily injections at ZT1 of quinpirole (0.5 mg/kg; hatched bars), but 
not by SKF 81297 (1 mg/kg; black bars) or saline (1 mL/kg; open bars): daily 
quinpirole injections significantly increased PER2 expression at ZT1, the normal 
trough of the PER2 fluctuation in the BNSTov and CEA. In the BLA (c) and DG 
(d), daily injections of quinpirole or SKF 81297 have no effect on the normal 
PER2 fluctuations. For each region, data are shown as mean PER2-
immunoreactive (IR) nuclei ± SEM per ZT; n = 3 per treatment group per ZT; * 
indicates p < 0.05 compared to saline. 
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Figure 6. 
(a) In the BNSTov, a unilateral 6-OHDA lesion decreases the daily peak of PER2 
atZT13; (b) chronic infusion via osmotic minipump of quinpirole (0.5 mg/kg/24 h) 
or (c) SKF 81297 (1 mg/kg/24 h) has no effect on the daily fluctuation in PER2 
expression in the BNSTov. In the CEA (d, e, f), the BLA (g, h, i), and the DG (j, 
k, I), the daily fluctuation in PER2 expression is unaffected by a unilateral 6-
OHDA lesion or by chronic infusion of quinpirole or SKF 81297. For each 
treatment group, data are shown as mean PER2-immunoreactive (IR) nuclei ± 
SEM per ZT in the intact hemisphere (open bars) and lesioned hemisphere 
(black bars). Sham n = 3-5 per ZT; quinpirole pump n = 2-3 per ZT; SKF pump n 
= 2-3 per ZT; * indicates p < 0.05 compared to intact hemisphere. 
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hemispheres. In the CEA (d, e, f), BLA (g, h, i), and DG Q, k, I), PER2 expression 
was unaffected by a unilateral 6-OHDA lesion, or by chronic infusion of quinpirole 
or SKF 81297. 
DISCUSSION 
Only a limited number of studies have previously shown an effect of 
changes in catecholamine activity on the expression of clock genes in areas of 
the brain outside of the SCN. In the present experiments, the effect of 
manipulating endogenous DA signaling on rhythmic PER2 expression was 
specifically examined in regions of the limbic forebrain that are innervated by 
fibers from midbrain DA cell groups and that have been previously demonstrated 
to be sensitive to several types of non-photic entraining stimuli. Unlike the 
consistent and marked impact in the dorsal striatum of DA depletion and 
restoration of activity at D2 DA receptors on PER2 expression, these same 
manipulations produced varying effects on PER2 in the BNSTov, CEA, BLA, and 
DG. Unilateral depletion of DA using a 6-OHDA lesion blunted the daily peak of 
PER2 expression in the BNSTov, whereas it had no effect in the CEA, BLA, or 
DG. Furthermore, injections of the D2/3 DA receptor agonist, quinpirole, blunted 
the normal daily fluctuation in PER2 expression in the BNSTov and in the CEA, 
but did not affect the BLA or DG. In contrast, global inhibition of catecholamine 
synthesis using AMPT injections suppressed PER2 in the BLA and DG without 
affecting the normal fluctuation of PER2 in the BNSTov or CEA. Overall, the 
effects in the BNSTov and CEA resemble some of those observed in the dorsal 
striatum and suggest that D2/3 receptor activity modulates the PER2 rhythm in 
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these regions whereas the results in the BLA and DG indicate that DA is not the 
primary neurotransmitter regulating PER2 rhythms in these nuclei. 
Because AMPT blocks the synthesis of not only DA but also noradrenaline 
(NA), the reduction in PER2 in the BLA and DG could be attributable to changes 
in NA levels following AMPT treatment. A potential role for NA signaling in 
modulating PER2 expression in the dorsal striatum was also identified in chapter 
1. As previously noted, there is evidence indicating that NA innervation of the 
forebrain is required for normal circadian rhythms of activity and clock gene 
expression in mice (Warnecke et al., 2005; Gonzalez and Aston-Jones, 2006, 
2008). Both the BLA and DG are innervated by NA fibers arising in part from 
locus coeruleus (Fallon et al., 1978; Loy et al., 1980; Asan, 1998; Buffalari and 
Grace, 2007), whereas the BNSTov and lateral CEA receive only sparse NA 
projections. Thus, a reduction in NA levels and not DA could perhaps account 
for these region-specific decreases in PER2 as a result of AMPT treatment. The 
lack of any clear effect of DA receptor agonist injections or infusion of DA 
receptor antagonists on PER2 expression is also consistent with the idea that DA 
is not a critical signal in the regulation of PER2 in these regions. 
In the BNSTov, only a 6-OHDA lesion and not AMPT injections or infusion 
of DA receptor antagonists reduced PER2 expression, which suggests that this 
reduction in PER2 is not directly attributable to a depletion of DA (which, at least 
in the dorsal striatum, is reported to occur within 2-3 days of an intra-MFB 6-
OHDA injection (Neve et al., 1982; Altar et al., 1987)). Instead, this effect might 
involve changes in a second system that develop as a consequence of DA fiber 
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loss. One candidate system is corticotrophin-releasing hormone (CRH), which is 
expressed in both the BNSTov and CEA. A 6-OHDA injection into the MFB 
decreases CRH mRNA in the BNSTov and central amygdala of the lesioned 
hemisphere (Day et al., 2002); this decrease in CRH mRNA is specific to the 
BNSTov and CEA, as no changes were found in other CRH-containing regions, 
including the ventrolateral BNST. Preliminary studies from our lab have shown 
that PER2 expression in the BNSTov is sensitive to CRH levels, and suppression 
of CRH protein synthesis using injections of double stranded ribonucleic acid 
(dsRNA) into this region blunts the normal peak of PER2 expression in the 
BNSTov at ZT13 (Bhargava et al., 2006). DA afferents to the BNSTov form 
synapses with cell populations known to express CRH (Shimada et al., 1989; 
Bayer et al., 1991; Phelix et al., 1994) and these inputs are thought to positively 
regulate CRH tone in this region (Day et al., 2002). Thus, a reduction in CRH 
expression resulting from the 6-OHDA-induced decrease in DA input could 
underlie the reduction in PER2 expression selectively in the BNSTov. 
One difficulty with this interpretation is that a unilateral 6-OHDA lesion had 
little effect on PER2 in the CEA, even though the lateral CEA also contains CRH-
positive cells and expression of this peptide in the CEA is decreased following a 
6-OHDA lesion of the MFB. This finding, together with the minimal reduction of 
PER2 at ZT1 in the CEA after AMPT treatment, implies that rhythmic PER2 
expression in this region does not depend on catecholamine activity or CRH 
levels to the same extent as does PER2 in the BNSTov. This difference in the 
effect of 6-OHDA lesioning on PER2 between the BNSTov and CEA is unusual, 
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because several studies concerning the impact of non-photic stimuli on PER2 
rhythms in these regions have shown that the BNSTov and CEA typically 
respond in a similar way to a given stimulus, such as manipulations of steroid 
hormones or restricted feeding schedules. 
The finding that quinpirole injections blunted the daily fluctuation in PER2 
expression in both the BNSTov and CEA, however, clearly indicates that 
stimulation of D2 DA receptors can modulate PER2 in these regions. 
Interestingly, PER2 expression in the BNSTov and CEA was increased in both 
lesioned and intact hemispheres of 6-OHDA-lesioned rats and in naTve rats 
around the time of the quinpirole injection (ZT1), which is the normal trough of 
the PER2 rhythm in these regions. The consistency of this effect indicates that 
the action of quinpirole in these regions occurs independently of DA depletion, 
unlike the dorsal striatum in which PER2 was affected only on the lesioned side. 
This finding might indicate that the specific mechanisms by which quinpirole 
modulates PER2 in the BNSTov and CEA are not identical to those in the dorsal 
striatum. D2 receptors are found in both the BNSTov and CEA and, within the 
CEA, these receptors are segregated primarily to the lateral region where PER2-, 
CRH-, and ENK-expressing cells are also found (Day et al., 2002; Eliava et al., 
2003; Lamont et al., 2005a). It is known that DA afferents in both of these 
regions regulate glutamatergic activity (Liu et al., 2004; Kash et al., 2008); thus, 
quinpirole could act at DA receptors to modulate PER2 expression via 
glutamatergic mechanisms. In addition, a role for CRH in mediating the excitatory 
actions of DA on glutamatergic activity in both the BNSTov and CEA has been 
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described, which could further support the relation between DA, CRH, and PER2 
in these regions suggested above (Liu et al., 2004; Kash et al., 2008). 
Taken together, these results indicate that changes in endogenous DA 
levels affect the daily fluctuation in PER2 in the BNSTov, and do so to a lesser 
extent in the CEA, but have minimal impact on PER2 expression in the BLA and 
DG. Although D1 and D2 DA receptors are found within the BLA and DG, 
changes in DA levels did not consistently affect rhythmic PER2 expression in 
these structures. In the BNSTov and CEA, the mechanisms by which DA 
modulates PER2 expression are unlikely to be the same as those operating in 
the dorsal striatum, given that acute DA depletion using AMPT did not affect the 
normal PER2 rhythm in these regions. Furthermore, although stimulation of D2 
receptors and not D1 receptors reversed the normal rhythm of PER2 expression 
in these regions, this effect was not restricted to only the DA-depleted 
hemisphere as it was in the dorsal striatum. More generally, these results also 
suggest that, in addition to the dorsal striatum, the normal rhythms of clock gene 
expression in the BNSTov and CEA are potentially vulnerable to certain 
pathologies affecting catecholamine systems, such as substance abuse and 
Parkinson's disease (PD). Given the involvement of the BNSTov and CEA in the 
regulation of a variety of physiological and behavioral functions, such as activity 
of the hypothalamic-pituitary-adrenal axis, it is possible that, as a result of 
changes in DA tone, a disruption in the circadian activity of these areas could 
contribute to some of the circadian symptoms reported to occur in PD, such as 
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an abnormal rhythm of Cortisol secretion (Bruguerolle and Simon, 2002; Willis, 
2008). 
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SECTION 2: Daily injections of morphine and withdrawal of morphine 
disrupt the daily pattern of wheel running and expression of the clock 
protein, PERIOD2, in regions of the limbic forebrain but not in the 
suprachiasmatic nucleus. 
In Chapter 3, timed, daily injections of morphine were used to examine the 
effect of manipulating DA and other catecholamines on PER2 expression in the 
suprachiasmatic nucleus (SCN) and regions of the limbic forebrain. PER2 
expression in the SCN and the dorsal striatum, BNSTov, CEA, BLA, and DG was 
examined in the morning and the evening at three different intervals following 
three weeks of morphine injections given daily during the mid-light phase: (1) 
within 24 h after the last morphine injection, (2) within 46-58 h after the last 
morphine injection, (3) and 7 days after the last morphine injection. Furthermore, 
to determine if treatments that alleviate some symptoms associated with opiate 
withdrawal also modify the expression of PER2 in the forebrain (Harris and 
Aston-Jones, 1994), an additional group was given a daily injection of the D2/3 
agonist, quinpirole, for two days beginning the evening after the last morphine 
injection. 
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CHAPTER 3 
Daily morphine injections and withdrawal disrupt the circadian rhythm of wheel 
running and expression of the clock protein PERIOD2 in the rat limbic forebrain. 
Suzanne Hood, Pamela Cassidy, Sarah Mathewson, Barry Robinson, Jane 




Symptoms of opiate withdrawal include disturbances in circadian rhythms. 
Other motivationally salient events, such as restricted feeding schedules, have 
been shown to affect rhythms of locomotor activity and the expression of clock 
genes in several forebrain regions without affecting the master clock in the 
suprachiasmatic nucleus (SCN). Here, we examined the effect of daily, mid-
morning morphine injections (5-40mg/kg) and a 1-week withdrawal period on 
rhythms of wheel running and expression of the clock protein PERIOD2 (PER2) 
in the SCN, dorsolateral striatum, and limbic forebrain in rats housed in a 12:12 
light-dark cycle. Morphine injections suppressed wheel running in the dark 
phase, and elicited a modest amount of anticipatory running 3 h before the daily 
injection. Morphine withdrawal blunted the normal nighttime peak of PER2 
expression in the oval nucleus of the bed nucleus of the stria terminalis 
(BNSTov) and central nucleus of the amygdala (CEA), without affecting PER2 
expression in the SCN. In dorsolateral striatum and basolateral nucleus of the 
amygdala (BLA), the normal pattern of PER2 expression was inverted within the 
first 24 h of withdrawal, but recovered after 1 week in withdrawal. Injections of 
the dopamine D2/D3 agonist, quinpirole (0.5 mg/kg), given after the last 
morphine injection, restored the normal pattern of PER2 expression in BNSTov 
and CEA, but not in dorsolateral striatum or BLA. These findings demonstrate 
that daily morphine injections and withdrawal disrupt normal rhythms of wheel 
running and PER2 expression in forebrain regions outside of the SCN, and that 
changes in dopaminergic signaling contribute to these effects. 
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INTRODUCTION 
Opiate withdrawal is characterized by profound physiological and 
motivational deficits that include disturbances in circadian rhythms of activity, 
hormone secretion, and expression of clock genes (Li et al., 2009a; Li et al., 
2009b). Disruptions in sleeping and diurnal activity patterns are common 
symptoms reported in humans undergoing withdrawal and are thought to 
contribute to increased risk of relapse (Howe et al., 1980; Stinus et al., 1998; Shi 
et al., 2007). Recent findings suggest that opiate exposure and withdrawal 
profoundly affect rhythms of adrenocorticotropic hormone (ACTH) and Cortisol 
levels, as well as the transcription of the Periodl (Perl) and Period2 (Per2) clock 
genes for at least one month in recently abstinent opiate users (Li et al., 2009b). 
Circadian timing is generated at the molecular level by a core group of 
genes that interact in a transcriptional feedback loop (for a review, see Reppert 
and Weaver, 2002). Two basic helix-loop-helix-containing transcription factors, 
CLOCK and BMAL, form heterodimers that positively regulate the transcription of 
the Period genes and Cryptochrome genes (Hogenesch et al., 1998; Bunger et 
al., 2000), the protein products of which interact with CLOCK and BMAL to inhibit 
their transcription in a cycle that is completed once every 24 h (Kume et al., 
1999; Vitatema et al., 1999; Shearman et al., 2000). Mutations of the Period 
genes and disruptions of translation of the PERIOD2 protein (PER2) result in 
behavioral arrhythmicity demonstrating a critical role for Period genes in 
maintaining circadian clockwork (Bae et al., 2001; Zheng et al., 2001; Gavrila et 
al., 2008). 
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There are parallels between the effects of drugs of abuse and those of 
other motivationally salient stimuli on circadian locomotor patterns and clock 
gene expression. For example, restricted mid-morning feeding schedules in rats 
elicit intense bouts of wheel running in advance of food delivery and entrain the 
rhythm of PER2 expression in several brain regions that are otherwise 
subordinate to signals from the master clock in the suprachiasmatic nucleus 
(Verwey et al., 2007; Waddington Lamont et al., 2007). Similarly, daily injections 
of methamphetamine, nicotine, and other stimulant drugs in rats housed in 
constant dim light can entrain locomotor activity rhythms and elicit anticipatory 
bouts of wheel running in advance of each daily injection by 1-2 h (Shibata et al., 
1994; Kosobud et al., 1998; lijima et al., 2002; Kosobud et al., 2007). 
Interestingly, this anticipatory activity does not develop when drugs without 
positive motivational effects or abuse potential, such as haloperidol, are 
administered (Kosobud etal., 2007). 
Although anticipatory locomotor activity is reported to develop in response 
to several drugs of abuse, it has not yet been determined whether repeated drug 
injections also entrain rhythms of clock protein expression in brain regions that 
are responsive to other motivationally relevant manipulations such as restricted 
feeding schedules. Studies to date have used a variety of drug administration 
modes and schedules and have limited their interest in clock gene activity 
primarily to the striatum (lijima et al., 2002; Uz et al., 2005; Wang et al., 2006). In 
the present study, we examined the effect of daily, mid-morning injections of 
morphine and subsequent morphine withdrawal in rats housed in 12:12 light-dark 
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(LD) conditions on rhythms of wheel running and PER2 expression in SCN, 
dorsolateral striatum, and regions we have previously shown to be responsive to 
restricted feeding schedules; namely, oval nucleus of the bed nucleus of the stria 
terminalis (BNSTov), central nucleus of the amygdala (CEA), basolateral 
amygdala (BLA), and dentate gyrus of the hippocampus (DG) (Waddington 
Lamont et al., 2007). We report here that although morphine withdrawal does 
not alter the rhythm of PER2 expression in the SCN, it profoundly affects the 
normal rhythm of PER2 expression in all other regions examined. 
The mechanisms whereby drugs of abuse modulate clock gene 
expression are unknown, although evidence suggests that changes in 
dopaminergic signaling contribute to their effects. Opiate and stimulant drugs 
increase extracellular concentrations of dopamine within terminal regions of the 
mesolimbic system, including dorsal and ventral striatum (Di Chiara and 
Imperato, 1988), prefrontal cortex (Moghaddam and Bunney, 1989), BNST 
(Carboni et al., 2000), and amygdala (Harmer et al., 1997), whereas early 
withdrawal from repeated drug use is associated with a reduction in the activity of 
mesolimbic dopamine neurons and in extracellular dopamine levels (Acquas et 
al., 1991; Rossetti etal., 1992; Tran-Nguyen etal., 1998; Diana etal., 1999). In 
support of a role for dopamine in drug-induced modulation of clock gene 
expression, it has been found that methamphetamine-induced shifts in locomotor 
activity rhythms can be antagonized by pre-treatment with dopamine receptor 
antagonists and mimicked with injections of dopamine receptor agonists (Honma 
et al., 1987; Shibata et al., 1994; but see Nikaido et al., 2001) and that induction 
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of Perl mRNA in mouse striatum by an acute injection of methamphetamine is 
blocked by pre-treatment with a D1 antagonist (SCH 23390) (Nikaido et al., 
2001). More recently, dopaminergic modulation of clock gene expression has 
been demonstrated directly both in vitro and in vivo (Yujnovsky et al., 2006; Amir 
et al., 2008; Imbesi et al., 2009). 
We sought to address the role of dopaminergic signaling by administering 
the dopamine D2/3 agonist, quinpirole, to morphine-dependent rats immediately 
following the last morphine injection. Previous studies have demonstrated that 
injections of quinpirole alleviate some somatic symptoms of opiate withdrawal in 
rats (e.g., Harris and Aston-Jones, 1994) and we have found in rats with 
unilateral 60HDA lesions of the medial forebrain bundle that daily intraperitoneal 
injections of quinpirole increase PER2 expression in dorsal striatum 12 h after 
the injection (Amir et al., 2008). 
MATERIALS AND METHODS 
Subjects 
A total of 57 male Wistar rats, weighing 300-350 g at the start of each 
experiment, were used (Charles River, St. Constant, QC). For the running-wheel 
activity experiment (experiment 1), rats were housed singly in shoebox cages 
with running wheels and kept in individual lightproof and sound-attenuated 
cabinets. Within each cabinet, an overhead fluorescent tube provided light on a 
12:12 LD cycle (light intensity within the cage was approximately 300 lux) and 
wheel-running activity was monitored continuously by computer (VitalView, 
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Minimitter, Sunview, OR, USA). For the studies examining the effect of morphine 
on PER2 protein immunoreactivity in brain (experiments 2 and 3), rats were 
housed individually in plastic shoebox cages without running wheels in a light-
and temperature-controlled room (temperature 21 ° C) on a 12:12 LD cycle 
(lights on at 0900 h). Throughout all experiments, rats had ad libitum access to 
laboratory chow (Purina Foods) and tap water. All experimental procedures 
followed the guidelines of the Canadian Council on Animal Care and were 
approved by the Animal Care Committee of Concordia University. 
Drugs 
Morphine hydrochloride (Sigma, Oakville, Ont.) was dissolved in saline at 
a concentration of 40 mg/ml. Quinpirole hydrochloride (Sigma) was dissolved in 
distilled water at a concentration of 1 mg/ml. 
Immunohistochemistry 
At the end of experiments 2 and 3, rats were given an overdose of sodium 
pentobarbital (Somnotol, 100 mg/kg) at their assigned zeitgeber time (ZT) (ZT1, 
1 h after lights on, or ZT13, 1 h after lights off) and perfused intracardially with 
300 ml of cold 0.09% saline, followed by 300 ml of cold 4 % paraformaldehyde in 
0.1 M phosphate buffer. Brains were extracted and kept in 4 % 
paraformaldehyde solution overnight at 4 ° C, then sectioned at 50 urn using a 
vibratome. Sections were stored in Watson's cryoprotectant (Watson et al., 
1986) at-20 ° C until immunohistochemistry was performed. 
Immunohistochemical staining for PER2 protein was carried out according to a 
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protocol described previously (Amir et al., 2004) using an affinity-purified 
polyclonal antibody raised in rabbit against PER2, 1:1000 (ADI, San Antonio, 
TX). 
Microscopy 
Stained brain sections were examined under a light microscope using a 
20x objective and 400 x 400 urn images of unilateral SCN, BNSTov, CEA, BLA, 
DG, and dorsolateral striatum were captured from each hemisphere using a Sony 
XC-77 video camera, a Scion LG-3 frame grabber, and Image SXM software 
(v1.8, S. D. Barrett, http://www.lmageSXM.org.uk). The number of cells 
immunoreactive for PER2 was then counted in each image captured. For each 
brain region of interest, the mean number of PER2-immunoreactive cells was 
calculated for each group by finding for each rat the mean cell count from six 
images having the highest number of labeled nuclei. 
PROCEDURES 
Experiment 1: Running-wheel activity. 
Rats were randomly assigned to morphine or saline conditions and 
allowed to entrain to the LD cycle for 6 days before injections began. Following 
the entrainment period, morphine or saline was injected subcutaneously every 
day, between ZT3-4. Initially, a dose of 5 mg/kg morphine was given for 6 days. 
The dose was increased to 20 mg/kg for the next 6 days, and then increased to 
40 mg/kg for another 6-day period. Following the sixth injection of 40 mg/kg of 
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morphine or saline, injections were discontinued and rats were left unhandled in 
their cages for another 6 days (referred to as the withdrawal period). 
Experiment 2: Effect of morphine withdrawal on PER2 expression. 
Before the start of injections, rats were allowed to entrain to the LD cycle 
for 10 days. Rats were randomly assigned to one of 8 groups in a 4 (treatment: 
saline control, day 1 morphine withdrawal (MWD-1), day 2 morphine withdrawal 
(MWD-2), or day 7 morphine withdrawal (MWD-7)) x 2 (ZT1 or ZT13) design. 
Morphine or saline was injected intraperitoneally (IP) between ZT3-4 every day. 
Rats in MWD-1 were killed either in the evening following their last morphine 
injection (ZT13, 10 h after the last morphine injection) or the next morning (ZT1, 
22 h after the last morphine injection). Rats assigned to MWD-2 were injected 
with saline 24 h after their last morphine injection, then killed during the morning 
(ZT1, 46 h after the last morphine injection) or the evening (ZT13, 58 h after the 
last morphine injection) of the following day. Those in MWD-7 were given saline 
injections every day for 6 days beginning 24 h after the last morphine injection, 
then killed at either ZT1 or ZT13 of the following day. Saline controls were killed 
at times matched with the MWD-1 group. 
The dosing of morphine began at 5 mg/kg and increased by 5 mg/kg every 
second day up to a maximum dose of 40 mg/kg. This 40 mg/kg dose was then 
maintained for 7 days. The rate at which the drug dose was increased in this 
experiment was slower than that of experiment 1 because of a higher incidence 
of mortality due to overdose in rats housed without running wheels. 
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Experiment 3: Effect of quinpirole injection on PER2 expression on day 2 of 
withdrawal of morphine (MWD-2). 
Rats were randomly assigned to one of 4 conditions in a 2 (drug 
treatment: quinpirole or vehicle) x 2 (ZT1 or ZT13) design, and were given 10 
days to entrain to the LD cycle before injections began. All rats were injected 
with morphine between ZT3-4 using a dosing schedule similar to that described 
for experiment 2. On day 1 of injections, morphine was given at a dose of 5 
mg/kg. The dose of morphine was increased by an additional 5 mg/kg every 
second day over 15 days until a maximum dose of 40 mg/kg was reached. On 
day 15, all rats received an injection of 40 mg/kg between ZT3-4 and were then 
given an injection of either quinpirole (0.5 mg/kg) or vehicle (distilled water, 0.5 
ml/kg) that evening at ZT13. The next day, no injection of morphine was given 
between ZT3-4, but as on the previous day, an injection of either quinpirole or 
vehicle was given at ZT13. Rats were killed the following day at either ZT1 (46 h 
after last morphine injection) or ZT13 (58 h after last morphine injection). 
Statistical analyses 
Wheel-running activity during the 12-h light and 12-h dark periods was 
analyzed using separate 2 (treatment: saline and morphine) x 4 (drug dose: 0 
(entrainment period), 5, 20, and 40 mg/kg) x 6 (number of days per dose) mixed 
model analyses of variance (ANOVAs). Significant interactions were examined 
further using ANOVA to compare group activity within a particular drug dose. 
Separate 2 (treatment) x 6 (number of days in withdrawal) ANOVAs were 
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conducted for wheel running activity in light and dark periods during withdrawal. 
The development of anticipatory activity to daily morphine injection was analyzed 
with a 2 (treatment) x 3 (drug dose: 5, 20, and 40 mg/kg) x 6 (number of days per 
dose) ANOVA to compare mean wheel running in each group during the 3-h 
period before each injection (ZTO-3). The presence of anticipatory activity during 
this same 3-h period in withdrawal was also examined with a separate 2 
(treatment) x 6 (number of days in withdrawal) ANOVA. Alpha level for all tests 
was set at 0.05. 
PER2-immunoreactive cell counts were analyzed using two-way ANOVAs 
for treatment group x ZT. Significant interactions were analyzed further using 
one-way ANOVAs and Fisher LSD post-hoc tests, or independent samples t-
tests where appropriate. Alpha level for all tests was set at 0.05. 
RESULTS 
Experiment 1: Wheel-Running Activity. 
Figure 1 shows the mean daily wheel-running activity in morphine- and 
saline-treated groups during the 6-day stages of entrainment (Fig. 1a), of 
morphine treatment; 5, 20, 40 mg/kg (Fig. 1b-d), and withdrawal (Fig. 1e). It can 
been seen that during the 12-h light period morphine and saline groups did not 
differ significantly in the total amount of wheel running in any stage of the 
experiment (main effect of drug treatment: F (1, 10) = 1.24, n.s.; main effect of 
drug dose: F (3, 30) = 1.31, n.s.; drug treatment x drug dose interaction: F (3, 30) 
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Mean daily wheel-running activity in saline-treated (open circles) and morphine-
treated (filled circles) rats during each 6-day stage of Experiment 1. Rats were 
housed in a 12:12 light-dark (LD) cycle; the gray panel indicates the 12-h period 
when lights were off. Daily injections of morphine or saline were given between 
zeitgeber time 3-4. (a) Entrainment period, (b) Morphine injections, 5 mg/kg. (c) 
Morphine injections, 20 mg/kg. (d) Morphine injections, 40 mg/kg. (e) Withdrawal 
period (no injections given). *Significant difference in mean wheel running during 
the 12-h dark period between morphine and saline groups. Morphine group (n = 
6), saline group (n = 6). 
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than did the saline group during withdrawal, this difference was not significant 
(main effect of drug treatment: F (1, 10) = 2.83, n.s.). 
In the 12-h dark period, morphine-treated rats ran less than saline controls 
rats; this difference was significant at the 20 mg/kg and 40 mg/kg doses of 
morphine (drug treatment x drug dose interaction: F (3, 30) = 8.42, p < 0.01; 
ANOVA at 5 mg/kg, main effect of drug treatment: F (1, 10) = 1.43, n.s.; ANOVA 
at 20 mg/kg, main effect of drug treatment: F (1, 10) = 5.03, p = 0.05; ANOVA at 
40 mg/kg, main effect of drug treatment: F (1, 10) = 8.00, p = 0.02). This 
suppression of wheel-running activity in the dark was also observed during the 
withdrawal period (main effect of drug treatment, F (1, 10) = 5.39, p = 0.04). 
Although not shown in this figure, this suppression of wheel-running activity 
gradually abated over days of withdrawal towards levels seen in the saline group; 
the interaction term, however, did not reach statistical significance (drug 
treatment x days in withdrawal interaction: F (5, 50) = 2.21, p = 0.07). 
We also investigated whether the morphine injections affected the pattern 
of wheel-running activity in the dark by comparing the activity of morphine- and 
saline-treated rats in 3-h intervals over the 12-h dark period. Although these data 
are not shown, an analysis of activity in 3-h intervals at each dose of morphine 
revealed that both morphine and saline groups were active during each of the 3-h 
intervals of the dark period but showed the greatest amount of running during the 
second and third 3-h intervals (main effect of interval, 5mg/kg: F (3, 30) = 3.08, p 
= 0.04; 20 mg/kg: F (3, 30) = 3.52, p = 0.03; 40 mg/kg: F (1, 10) = 8.00, p = 0.02). 
As reported above, morphine injections decreased wheel running overall, but did 
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not significantly change this pattern of wheel running over the 3-h intervals as 
compared to saline control (drug treatment x interval, 5mg/kg: F (3, 30) = 0.32, 
n.s.; 20 mg/kg: F (3, 30) = 2.24, n.s.; 40 mg/kg: F (3, 30) = 1.96, n.s.). 
To determine whether rats developed anticipatory activity to the daily 
scheduled morphine injection, we examined wheel-running activity in the 3-h 
period before the injection across the three doses of morphine, as well as in the 
corresponding time window in withdrawal. These data are shown in Figure 2. 
Overall, during the morphine treatment stage, morphine-treated rats ran 
significantly more than did saline controls in the 3-h period before their injections 
(main effect of drug treatment: F (1, 10) = 6.21, p = 0.03). Although there was 
little difference between groups during the initial injection period at the 5 mg/kg 
dose, the group x dose interaction was not significant (F (2, 20) = 2.14, n.s.). In 
the withdrawal stage, wheel-running activity in the morphine group appears from 
Figure 2 to be considerably more than in the saline group, but this was highly 
variable across both rats and days during the 3-h 'pre-injection' window and 
therefore the difference was not statistically significant (F (1, 10) = 2.67, n.s) 
(morphine group mean (± SEM) = 129.5 (±41.1), saline group mean (± SEM) = 
6.8 (± 3.7)). This variability was attributable to a few rats that became very active 
in this 3-h period, but only after several days into withdrawal. 
Though not shown, in both morphine and saline groups there were slight 
increases in wheel-running activity in the 3-h period after the disturbance of the 
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Mean anticipatory wheel-running activity in saline (open bars) and morphine 
groups (filled bars) during the 3-h period before each daily injection, shown for 
each dose of morphine (5 mg/kg, 20 mg/kg, and 40 mg/kg) and for the 
corresponding time period in withdrawal when no injections were given. Each 
bar represents the mean (± SEM) of 6 days' activity. *Significant main effect of 
drug treatment. Morphine group (n = 6), saline group (n = 6). 
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Experiment 2: Effect of morphine withdrawal on PER2 expression 
Figure 3 shows the mean PER2-immunoreactive cell counts in each brain 
region examined as a function of treatment (saline control, MWD-1, MWD-2 and 
MWD-7) and ZT (1 , 13). In the saline control group, PER2 expression in SCN, 
BNSTov, and CEA, as expected, was high at ZT13 and low at ZT1 (Amir et al., 
2004; Lamont et al., 2005a). As shown in Figure 3a, in the SCN this pattern was 
unaffected by morphine withdrawal, although overall PER2 counts in MWD-2 and 
MWD-7 groups were reduced compared to the saline control group (main effect 
of treatment group: F (3, 24) = 3.23, p = 0.04; main effect of ZT: F (1, 24) = 
1619.57, p < 0.01; treatment group xZT interaction: F (3, 24) = 0.62, n.s.). In 
contrast, in BNSTov (Fig. 3 b) and CEA (Fig. 3 c), withdrawal from morphine 
significantly affected the pattern of PER2 expression such that in MWD-1, MWD-
2, and MWD-7 groups the number of cells expressing PER2 was significantly 
reduced at ZT13 compared to that in the saline control group (BNSTov treatment 
group x ZT interaction: F (3, 24) = 9.91, p < 0.01; one-way ANOVA at ZT13: F (3, 
12) = 7.16, p < 0.01; Fisher's LSD post-hoc comparisons of saline control and 
each MWD group at ZT13, p < 0.05; CEA treatment group x ZT interaction: F (3, 
24) = 3.58, p = 0.03; one-way ANOVA at ZT13: F (3, 12) = 4.07, p = 0.03; 
Fisher's LSD post-hoc comparisons of saline control and each MWD group at 
ZT13, p < 0.05). Furthermore, early in withdrawal (MWD-1) PER2 expression at 
ZT1 in the BNSTov was greater than in saline control (BNSTov, one-way ANOVA 
at ZT1: F (3, 12) = 4.27, p = 0.03; Fisher's LSD comparison of saline control and 
MWD-1 atZT1,p<0.05) . 
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Figure 3. 
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Mean number of PER2-immunoreactive (PER2-IR) cells (± SEM) at zeitgeber 
time (ZT) 1 (open bars) and ZT13 (filled bars) in the SCN and regions of the 
limbic forebrain and striatum in saline-treated rats and morphine-treated rats in 1 
(MWD-1), 2 (MWD-2), or 7 (MWD-7) days of withdrawal, (a) SCN. (b) BNSTov. 
(c)CEA. (d) Dorsolateral striatum, (e) BLA. (f) DG. *Significant difference from 
saline ZT13 group; tsignificant difference from saline ZT1 group. Saline group 
ZT1 (n = 4), ZT13 (n = 4); MWD-1 ZT1 (n = 4), ZT13 (n = 4); MWD-2 ZT1 (n = 4), 
ZT13 (n = 4); MWD-7 ZT1 (n = 4), ZT13 (n = 4). 
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It can be seen in Figure 3 that in saline-treated rats PER2 expression in 
dorsolateral striatum, BLA, and DG was high at ZT1 and low at ZT13 in 
antiphase with the rhythm of PER2 expression in SCN (Lamont et al., 2005a). 
This normal pattern was markedly changed in each of these three regions in 
early withdrawal from morphine. In dorsolateral striatum (Fig. 3d), the pattern of 
PER2 expression in group MWD-1 was reversed from that seen in the saline 
control group, such that it was significantly reduced at ZT1 and elevated at ZT13 
compared to that in saline control (drug treatment x ZT interaction: F (3, 24) = 
48.55, p < 0.01; one-way ANOVA at ZT 1: F (3, 12) = 32.57, p < 0.01; Fisher's 
LSD comparison of saline control and MWD-1 at ZT1, p < 0.05; one-way ANOVA 
at ZT13: F (3, 12) = 31.59, p < 0.01; Fisher's LSD post-hoc comparison of saline 
control and MWD-1 ZT13, p < 0.05). In the MWD-2 group, PER2 expression at 
ZT1 was also significantly diminished compared to that in saline control (Fisher's 
LSD comparison, p < 0.05), but did not differ from saline at ZT13. In the MWD-7 
group, the pattern of PER2 expression recovered and did not differ significantly 
from that in the saline control groups at either ZT1 or ZT13. 
Similar results were found for PER2 expression in BLA (Fig. 3e) in both 
MWD-1 and MWD-2 groups (drug treatment x ZT interaction: F (3, 24) = 32.96, p 
< 0.01; one-way ANOVA at ZT1: F (3, 12) = 20.42, p < 0.01; one-way ANOVA at 
ZT13: F(3, 12) = 21.23, p < 0.01). In MWD-1, the normal pattern of PER2 
expression was inverted compared to that in the saline group (Fisher's LSD 
comparison of saline control and MWD-1 at ZT1, p < 0.05; comparison of saline 
control and MWD-1 at ZT13, p < 0.05). In MWD-2, as in dorsolateral striatum, 
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PER2 expression at ZT1 was significantly reduced relative to that in the saline 
group (p < 0.05). No differences were found between the MWD-7 groups and 
saline control groups at either ZT. 
In DG (Fig. 3f), the normally elevated level of PER2 expression at ZT1 
was significantly decreased in both MWD-1 and MWD-2 groups compared to 
saline control (drug treatment x ZT interaction: F (3, 24) = 16.85, p < 0.01; one-
way ANOVA at ZT1: F (3, 12) = 21.07, p < 0.01; Fisher's LSD comparison of 
saline control and MWD-1 at ZT1, p < 0.05; comparison of saline control and 
MWD-2 at ZT1, p < 0.05). At ZT1 no differences were found MWD-7 and the 
saline control group. At ZT13 no differences in PER2 expression were found 
between groups (one-way ANOVA at ZT13: F (3, 12) = 2.34, n.s.). 
Experiment 3: Effect of quinpirole on PER2 expression in early morphine 
withdrawal. 
In experiment 3, following repeated daily injections of morphine, rats were 
given IP injections of either vehicle or 0.5 mg/kg quinpirole during the early 
withdrawal period from morphine in an attempt to prevent or reverse the effects 
of withdrawal on the rhythm of PER2 expression. Figure 4 shows the effects of 
quinpirole treatment on PER2 expression in MWD-2 groups in SCN, BNST, CEA, 
dorsolateral striatum, BLA, and DG at both ZT1 and ZT13. As expected, in the 
SCN the rhythm of PER2 expression was unaffected by morphine withdrawal 
(Fig. 4a), although there was small but significant increase in PER2 expression at 
ZT13 in the quinpirole-treated group (main effect of treatment group: F (1, 9) = 
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7.08, p = 0.03; main effect of ZT: F (1, 9) = 1940.19, p < 0.01; treatment group x 
ZT interaction (F (1, 9) = 10.67, p = 0.01; ZT13 independent samples t-test: t (4) 
= -2.67, p = 0.05). 
In BNSTov (Fig. 4b) and CEA (Fig. 4c), quinpirole treatment reversed the 
effect of morphine withdrawal on the rhythm of PER2 expression in that it 
significantly increased PER2 expression at ZT13 over that in the vehicle-treated 
group (BNSTov treatment group x ZT interaction: F (1, 9) = 12.30, p < 0.01; ZT13 
independent samples t-test: t (4) = -10.94, p < 0.01; CEA treatment group x ZT 
interaction: F (1, 9) = 8.25, p = 0.02; ZT13 independent samples t-test: t (4) = -
4.63, p = 0.01). The quinpirole treatment did not significantly alter PER2 
expression either in dorsolateral striatum (Fig. 4d; main effect of treatment: F (1, 
9) = 1.36, n.s.; treatment group x ZT interaction: F (1, 9) = 3.62, n.s.) or in DG 
(Fig. 4f; main effect of treatment: F (1, 9) = 0.78, n.s.; treatment group x ZT 
interaction: F (1, 9) = 1.19, n.s.) whereas in BLA(Fig. 4e), quinpirole treatment 
significantly increased PER2 counts at both ZT1 and ZT13 compared to vehicle 
controls (main effect of treatment group: F (1, 9) = 5.45, p = 0.04). 
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Figure 4. 
Mean number of PER2-immunoreactive (PER2-IR) cells (± SEM) at zeitgeber 
time (ZT) 1 (open bars) and ZT13 (filled bars) in the SCN and regions of the 
limbic forebrain and striatum in morphine-treated rats given an injection of 
quinpirole (MWD-2+Q; 0.5 mg/kg, IP) or vehicle (MWD-2+V) at ZT13 for 2 days 
beginning the evening after the last morphine injection, (a) SCN. (b) BNSTov. 
(c) CEA. (d) Dorsolateral striatum, (e) BLA. (f) DG. *Significant difference from 
MWD-2+V ZT13 group. MWD-2+Q ZT1 (n = 4), ZT13 (n = 4); MWD-2+V ZT1 (n 
= 3), ZT13(n = 2). 
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DISCUSSION 
The findings of primary interest from the present study are that, in rats 
housed in 12:12 LD, scheduled daily injections of morphine given early in the 
light phase disrupted the normal circadian pattern of wheel-running activity, such 
that running in the dark phase (beginning 8 h after the daily injections) was 
completely suppressed at the higher doses of morphine. In addition there was 
evidence for a modest increase in wheel running in the 3-h period before the 
daily injections of morphine. This same schedule of morphine injections led to 
profound changes in the rhythm of PER2 expression in several regions of the 
limbic forebrain including BNSTov, CEA, dorsolateral striatum, BLA, and DG 
without affecting the PER2 rhythm in the SCN, itself. 
Nighttime wheel-running activity 
To our knowledge, this dramatic and prolonged effect of daily morphine 
injections on wheel-running activity during the dark phase has not been reported 
previously. Studies using different methods of drug delivery and different light 
schedules, however, have shown that opiate agonists can change circadian 
activity rhythms. For example, in mice housed in 12:12 LD, chronic morphine 
given via subcutaneous pellet decreased spontaneous locomotor activity in the 
light phase (Navarro et al., 1992). Using conditions of constant dim light, others 
have shown that an acute injection of an opiate agonist in mice and hamsters 
induces phase shifts in the rhythm of wheel running (Marchant and Mistlberger, 
1995; Vansteensel et al., 2005). This effect was found to be contingent upon a 
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period of drug-induced hyperactivity, as immobilization immediately after the 
injection prevented the phase shift from occurring (Marchant and Mistlberger, 
1995). In these latter studies, however, it was not reported whether the injection 
also affected the amplitude of wheel running in the active phase in addition to 
shifting the onset of daily activity. Interestingly, we have given daily injections of 
morphine (5 - 40 mg/kg) in the middle of the inactive phase to rats housed in 
constant darkness (DD) and have not observed any shift in the phase of the 
wheel-running rhythm (unpublished observations). Consistent with the present 
findings under 12:12 LD conditions, however, in these rats housed in DD the 
amplitude of wheel running during the active phase was reduced. 
One possible explanation for the reduction in nighttime wheel-running 
activity seen the present experiment could be the development of withdrawal 
symptoms over the 24 h following the morning morphine injection. Spontaneous 
withdrawal from chronic morphine treatment, delivered via subcutaneous pellet or 
twice-daily injections, has been reported to diminish nighttime locomotor activity 
in rats (Stinus et al., 1998; Georges et al., 1999). Symptoms of withdrawal from 
morphine have been observed within 14 h after the last morphine injection in rats 
given twice-daily injections over one week (Li et al., 2009a). Given that our 
injections were made eight hours before lights were turned off, the emergence of 
some withdrawal symptoms over the course of the dark period could have 
interfered with the ability or motivation to run. Although, as can been seen in 
Figure 1, nighttime wheel running was reduced even at the lowest dose of 
morphine, it was profoundly and significantly decreased only when the higher 
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doses of morphine were given. Furthermore, the suppression of nighttime wheel 
running persisted for the first few days after morphine injections were 
discontinued, and then began to increase towards saline control levels over the 
remainder of the withdrawal period. 
The disruption of normal nighttime wheel running could also be associated 
with the changes in the expression of PER2 in the dorsolateral striatum that were 
found to occur after repeated morphine treatment. The results of experiment 2 
show that the pattern of PER2 expression in the dorsolateral striatum was 
reversed within the first 24 h after the last morphine injection; that is, PER2 
expression was strongly increased 10 h after the morphine injection, at the onset 
of the dark phase, and decreased 22 h after morphine, at the onset of the light 
phase. Although our observations of wheel-running activity and PER2 
expression were made in different groups of rats, these findings suggest that 
changes in the rhythm of striatal clock gene expression could be functionally 
related to the circadian regulation of locomotor activity. In support of this 
argument, Masubuchi and colleagues (2000) have shown that in rats housed on 
a 12:12 LD cycle and given ad libitum access to methamphetamine (in the 
drinking water), rhythms of wheel-running activity and clock gene expression in 
the striatum gradually desynchronize from the LD schedule and from clock gene 
expression in the SCN, but remain in phase with each other. We have also 
found in rats with unilateral 60HDA lesions of the medial forebrain bundle that 
daily mid-morning quinpirole injections, to which dependence does not develop, 
decrease normal nighttime wheel-running activity and strongly increase PER2 
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expression at ZT13 in the dopamine-depleted dorsal striatum (Amir et al., 2008), 
similar to the pattern of results we report here. A link between the rhythms of 
wheel-running activity and striatal PER2 expression is further supported by our 
observation in the present experiments that both wheel running in the dark phase 
and the rhythm of PER2 expression in the dorsolateral striatum normalized after 
6-7 days in withdrawal. 
Effects of morphine on daytime wheel-running activity 
Although there was no effect of daily morphine injections on overall 
daytime wheel-running activity, we did find modest, but significant increases in 
wheel running in advance of the morphine injections, a finding consistent with 
other reports in the literature that rats show anticipatory locomotor activity when 
given predictable daily injections of drugs of abuse, such as methamphetamine 
and nicotine (Shibata et al., 1994; lijima et al., 2002; Kosobud et al., 2007). 
Interestingly, anticipatory activity also develops when rats are given daily 
restricted access to food, although the level of such anticipatory activity is much 
greater compared to that seen with daily drug injections. Because the 
development and timing of drug-associated anticipatory behavior resembles that 
of food anticipation, similar mechanisms could be mediating and controlling the 
timing of these anticipatory behaviors for both of these motivationally salient 
stimuli. In the present study, unlike what has been reported in previous drug 
studies (Shibata et al., 1994; lijima et al., 2002), this anticipatory activity was not 
evident during the first two days of withdrawal. Some morphine-treated rats did 
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run more than saline-treated rats during the 'pre-injection' 3-h window but only 
after several days into the period of withdrawal. 
It is possible that morphine-treated rats demonstrated signs of anticipation 
of the daily morphine injection other than wheel running. For example, 
Eikelboom and Stewart (1979) reported that in rats given injections of morphine 
at the same time of day over many days, body temperature decreased in a 1 -h 
period in advance of the injection. This hypothermia was found to occur whether 
or not rats were tested in the same environment that predicted drug injections, 
suggesting that the decrease in temperature was mediated via a circadian 
mechanism. 
Effect of morphine withdrawal on PER2 protein expression 
Our findings reveal profound changes in the rhythm of PER2 expression in 
several limbic forebrain regions in rats killed after withdrawal from daily morphine 
injections, although no effects were seen on the rhythm of PER2 expression in 
the SCN. In BNSTov and CEA, PER2 expression at ZT13 was significantly 
decreased in rats killed one, two, and seven days after termination of morphine 
injections. This result is consistent with that of Li and colleagues (Li et al., 
2009a) showing a flattening of the rhythm of Perl and Per2 mRNA transcription 
in CEA, 24-48 h after withdrawal from twice-daily injections of morphine. Our 
finding of a similar effect of morphine withdrawal on the pattern of PER2 
expression in both CEA and BNSTov was expected given the high degree of 
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anatomical and neurochemical similarity between these two structures (Alheid 
and Heimer, 1988; Dong etal., 2001a). 
That the reduction in PER2 immunoreactivity at ZT13 in these regions was 
present after seven days of withdrawal suggests that the disruptive effects of 
opiates on circadian rhythms, including those of clock genes, can be long lasting. 
In humans undergoing withdrawal from heroin, a blunting of the rhythms of Perl 
and Per2 mRNA transcription in blood mononuclear cells, as well as ACTH and 
beta-endorphin secretion, have been observed to persist over 30 days of 
abstinence (Li et al., 2009b). We have previously shown that the rhythm of 
PER2 expression in BNSTov and CEA is dampened under conditions of altered 
glucocorticoid secretion, as well as after a reduction in corticotropin releasing 
factor (CRF) protein levels in BNSTov (Amir et al., 2004; Bhargava et al., 2006; 
Segall et al., 2006). Given that withdrawal from drugs of abuse is associated with 
changes in extracellular levels of CRF (Merlo Pich et al., 1995; Richter and 
Weiss, 1999; Olive et al., 2002) and CRF mRNA transcription in BNSTov and 
CEA (Maj et al., 2003; Houshyar et al., 2004), it is possible that changes in these 
systems over the course of withdrawal contribute to the prolonged blunting of 
PER2 expression in these regions. 
Perhaps the most dramatic finding from the present experiments was the 
reversal of the normal rhythm of PER2 expression in dorsolateral striatum, BLA, 
and DG observed within 10 h after the last morphine injection (MWD-1). Under 
normal conditions, the rhythm of expression of PER2 protein in dorsolateral 
striatum, BLA, and DG is 180 degrees out of phase with that in BNSTov and CEA 
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(Amir et al., 2004; Lamont et al., 2005a). Here we see that daily morphine 
injections actually reversed the pattern of PER2 expression in dorsolateral 
striatum, BLA, and DG, an effect that was evident early in withdrawal after which 
the rhythm gradually re-entrained to the LD cycle. Reversal of the rhythm of 
PER2 expression in BLA and DG has also been found to occur under daytime 
restricted feeding schedules. Peak PER2 expression in these regions 
synchronizes with those in BNSTov and CEA and occurs 12 h after food 
presentation (Waddington Lamont et al., 2007). 
In a preliminary attempt to investigate the mechanisms underlying these 
changes in PER2 expression, we examined the role of dopamine signaling. 
Because mesolimbic dopaminergic activity is reduced during the acute period of 
opiate withdrawal (Diana et al., 1999), and because injections of D2 dopamine 
receptor agonists reduce some symptoms of withdrawal (Harris and Aston-
Jones, 1994), we gave injections of the D2/D3 receptor agonist, quinpirole, to 
morphine-treated rats beginning the evening of the last morphine injection. 
Quinpirole significantly reversed the loss of PER2 immunoreactivity at ZT13 in 
BNSTov and CEA (58 h following the last morphine injection), and tended to 
increase PER2 expression in dorsolateral striatum, BLA, and DG at this time 
without restoring the normal peak of PER2 expression in these regions at ZT1. 
These results indicate that stimulation of dopamine D2/D3 receptors in opiate 
withdrawal at the beginning of the dark phase, when dopamine levels would 
normally increase in terminal regions of the mesolimbic dopamine system (e.g., 
Castaneda et al., 2004), can increase the expression of PER2, but that the 
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strength of this effect varies between forebrain regions. This variation in the 
effect of quinpirole could be attributable to regional differences in requirements 
for dopaminergic stimulation and possibly to differences in the rhythm of 
dopamine receptor sensitivity. A circadian rhythm in the locomotor activating 
effects of quinpirole in drosophila and in mice (Andretic and Hirsh, 2000; 
Akhisaroglu et al., 2005) and in the induction of PER1 in mouse striatum by 
quinpirole (Imbesi et al., 2009) has been reported. 
The effect of morphine treatment and withdrawal on wheel running 
rhythms and PER2 expression in the limbic forebrain could be also mediated 
through other mechanisms, such as the activation of opiate receptors. There is 
some evidence for a role of mu receptors in the development of anticipatory 
activity to food presentation under conditions of restricted feeding (Kas et al., 
2004) and previous studies have demonstrated that the mu receptor agonist, 
fentanyl, can modulate the effects of light on circadian rhythms of locomotor 
activity and on the induction of Perl mRNA in SCN (Vansteensel et al., 2005). 
Mu opiate receptors are expressed in all of the regions examined for PER2 
immunoreactivity in the present experiments (Ding et al., 1996). 
Changes in glutamatergic signaling as a result of morphine treatment and 
withdrawal might also be involved in the disruption of normal PER2 rhythms 
observed in the present experiments. An increasing number of studies have 
demonstrated that repeated drug exposure leads to alterations in the 
responsiveness of cells to glutamatergic excitation in regions including striatum, 
BNSTov, and amygdala (Boudreau and Wolf, 2005; Kauer and Malenka, 2007; 
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Kourrich et al., 2007; Dumont et al., 2008). Notably, the Pert gene has been 
implicated in the normal functioning of glutamate systems and in glutamatergic-
mediated responses to drugs of abuse, such as cocaine and alcohol (Abarca et 
al., 2002; Spanagel et al., 2005). Given that glutamate is one of the primary 
neurotransmitters regulating the effects of light on the entrainment of clock gene 
activity in the SCN (for review, see Reppert and Weaver, 2001), it seems likely 
that opiate modulation of glutamatergic activity could have important effects on 
the rhythmic expression of clock genes in the forebrain regions examined in the 
present study. Other manipulations that alter normal glutamatergic signaling in 
dorsal striatum, such as depletion of dopamine via 60HDA lesions (Day et al., 
2006), have been found to strongly reduce the normal rhythm of PER2 
expression (Amir et al., 2008). 
CONCLUSION 
Taken together, our results show dramatic effects of daily morphine 
injections, given in the light phase, on circadian rhythms of wheel running and 
expression of PER2 in the limbic forebrain. Morphine-treated rats exhibited 
profound suppression of the normal nighttime wheel-running activity and modest 
levels of anticipatory wheel running in the 3-h period before the daily morphine 
injection. In addition, we found major changes in the rhythms of PER2 
expression in BNSTov, CEA, BLA, DG and dorsolateral striatum in rats killed 
after withdrawal from daily morphine injections, although no effects were seen on 
the rhythm of PER2 expression in the SCN. The finding that repeated morphine 
injections suppress wheel-running activity during the dark phase and reverse the 
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normal pattern of PER2 expression in the dorsolateral striatum suggests that 
striatal clock gene activity is closely associated with the circadian regulation of 
this behavior (see also Masubuchi et al., 2000). Future studies will investigate 
further the role of dopamine and other neurotransmitters in the modulation of 
PER2 expression resulting from morphine treatment. 
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General Discussion 
Rhythmic clock gene expression in tissues outside of the SCN can be 
influenced independently of entraining signals from the master clock by timed, 
daily non-photic events. Previous evidence has suggested that catecholamine 
signaling serves as a non-photic zeitgeber in specific tissues, such as the retina. 
These findings are supported by an increasing body of research indicating an 
effect of drugs of abuse and withdrawal states in shifting clock gene expression 
in several brain regions and a number of physiological and behavioral rhythms. 
However, a role for daily, endogenous activity of midbrain DA systems in the 
normal rhythms of clock gene expression in the brain has not been previously 
demonstrated in vivo. 
The experiments described in this thesis were designed to directly 
examine whether endogenous DA signaling contributes to the daily pattern of 
expression of the clock protein, PER2, in the SCN and several forebrain regions 
in which PER2 rhythms have been found to entrain to a variety of non-photic 
stimuli. Several methods were used to address this question. In one approach, 
activity at DA receptors was directly manipulated using 6-OHDA lesions of DA 
fibers, D1 or D2 receptor-selective antagonists, and D1 or D2/3 receptor-
selective agonists. A second approach involved manipulating DA activity, but 
non-selectively, using acute injections of the tyrosine hydroxylase inhibitor, 
AMPT, and by using daily injections of morphine and subsequently withdrawing 
the drug. The results of these combined approaches to this question 
demonstrate an important and region-specific role for DA in the daily fluctuation 
145 
of PER2 expression in the rat forebrain. These findings offer new insight into the 
mechanisms that regulate circadian clockwork at the cellular level as well as the 
ways in which disturbances of DA and catecholamine systems can disrupt 
normal circadian functions. The findings of these experiments are summarized in 
Table 21 and are reviewed in the sections below. 
Dorsal Striatum 
The most salient finding of these experiments is that endogenous 
dopaminergic activity at D2 receptors is necessary for the normal daily fluctuation 
in PER2 in the dorsal striatum, but not in any other region examined. Targeted 
disruption of normal DA activity using a unilateral 6-OHDA lesion or blockade of 
D2 receptors with raclopride decreased the normal peak of PER2 in the dorsal 
striatum, whereas daily stimulation of D2/3 receptors using quinpirole injections 
restored an increase in PER2 expression in this region. Importantly, the timing of 
this increase in PER2 appeared to be entrained by the timing of the quinpirole 
injection, given that this increase occurred when the PER2 rhythm in the striatum 
normally reaches its trough. This result indicates that the phase and amplitude of 
the PER2 rhythm in the dorsal striatum are influenced by a daily fluctuation in D2 
receptor stimulation, which is presumably associated with the 24-h rhythm of 
extracellular DA levels in this region. 
1
 Table 2 (next page). Summary of the effects of each experimental manipulation 
described in Chapters 1, 2, and 3 on the daily fluctuation of PER2 expression in the 



















SCN dorsal striatum BNSTov CEA BLA DG 














46-58 h after 
last morphine 
injection 










no effect of 
6-OHDA 
lesion 





no effect of 
6-OHDA 
lesion 








§ lesion blunts 
PER2 peak; 
§ PER2 blunted 
at ZT1 and 
increased at 
ZT13 
§ PER2 blunted 
atZT1 




atZT13 on the 
lesioned side 
no effect 
§ lesion blunts 
PER2; 
no effect of 





increases it at 
ZT13 












at ZT1 and 
decreases it at 






§ lesion blunts 
PER2; 


































PER2 at ZT1 
no effect of 
6-OHDA 
lesion 















































no effect of 
6-OHDA 
lesion 




















no effect of 6-
OHDA lesion 





no effect of 6-
OHDA lesion 















The effects of the experiments in which not only DA but also NA and 
adrenaline levels were manipulated further demonstrate the necessity of normal 
dopaminergic activity for PER2 expression in the striatum. The normal peak of 
PER2 was strongly suppressed following one day of AMPT treatment and 
approximately 48 h after withdrawing daily morphine injections, two separate 
manipulations that are associated with a profound reduction in DA levels in the 
striatum. Importantly, a daily mid-morning morphine injection also changed the 
normal daily pattern of PER2 expression in this region, such that the normal peak 
at ZT1 was suppressed and an increase was observed at ZT13, 8-9 h after the 
last morphine injection. The similarity of this pattern of PER2 expression to that 
produced by daily quinpirole injections in 6-OHDA lesioned rats implies that the 
effect of the daily morphine injection was mediated at least in part through a 
stimulation of D2/3 receptors. It seems reasonable to speculate that the schedule 
of daily morphine injections used in this experiment affected the normal circadian 
rhythm of extracellular DA release in the dorsal striatum, and additional 
experiments using in vivo microdialysis would be useful to test whether this is 
indeed the case. 
BNSTov and CEA 
The results of both DA-specific and catecholamine-general manipulations 
indicate that PER2 expression in the BNSTov and CEA is responsive to changes 
in DA tone, but that dopaminergic activity is not directly, or solely, responsible for 
the normal daily fluctuation in PER2 in these regions. This conclusion is 
supported by the observations that, although a 6-OHDA lesion decreased peak 
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PER2 expression in the BNSTov, neither chronic infusion of DA antagonists nor 
an acute suppression of catecholamine synthesis following AMPT treatment 
affected the normal daily PER2 fluctuation in these regions. As discussed in 
chapter 2, this pattern of results would suggest that the reduction in PER2 in the 
BNSTov ipsilateral to the 6-OHDA lesion is attributable to changes in another 
system that arise in response to a prolonged reduction in DA content, such as 
the CRH system. 
Interestingly, daily stimulation of D2/3 receptors using quinpirole injections 
was found to disrupt the normal PER2 fluctuation. Specifically, in 6-OHDA-
lesioned rats daily quinpirole injections given at ZT1 increased PER2 expression 
at its normal trough at ZT1, whereas the normal peak of PER2 at ZT13 was 
reduced. Notably, these effects occurred in both the intact and 6-OHDA-lesioned 
hemispheres. This pattern of results stands in contrast to the effect of quinpirole 
in the dorsal striatum, in which daily quinpirole injections at ZT1 increased PER2 
at ZT13, and this increase occurred only in the 6-OHDA-lesioned hemisphere 
and not in the intact hemisphere. On the basis of the results observed in the 
BNSTov and CEA, it would appear that the effect of quinpirole injections on 
PER2 is not mediated by DA afferents to these regions because the effect was 
the same irrespective of whether dopaminergic fibers had been destroyed with 6-
OHDA toxin. Although the specific mechanisms underlying this effect remain to 
be determined, these findings suggest that the influence of quinpirole on PER2 
expression in these regions occurs through D2 receptor-mediated effects on 
other systems, perhaps CRH and glutamate as discussed in chapter 2. 
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In the morphine experiments, the finding that the normal PER2 fluctuation 
in the BNSTov and CEA was disrupted both immediately after the last morphine 
injection and for several days following withdrawal of daily morphine injections 
suggests that changes in catecholamine systems, in addition to DA alone, 
influence the expression of PER2 in these regions. Furthermore, the persistence 
of this disruption in PER2 for up to 7 days after morphine withdrawal suggests 
that the effect of daily morphine injections and withdrawal on PER2 expression 
involves a prolonged change in DA tone and/or subsequent changes in other 
neurotransmitter or peptide systems. As noted above, the necessity of a 
prolonged change in DA and other catecholamine levels to produce an effect on 
the daily fluctuation of PER2 in the BNSTov and CEA is reinforced by the finding 
that an acute suppression of catecholamine synthesis using one day of AMPT 
injections had no effect on PER2. 
BLA and DG 
The daily fluctuations of PER2 expression in the BLA and DG were 
affected by manipulations of catecholamine levels in general, although the lack of 
effect of DA-selective manipulations on PER2 expression in these regions 
indicates that the changes in PER2 were not attributable to DA per se. In 
particular, a unilateral 6-OHDA lesion did not affect the normal pattern of PER2 
expression and chronic infusion of DA receptor antagonists did not clearly 
change the daily PER2 fluctuation in either region. Furthermore, treatment with 
DA receptor agonists had minimal effect on the normal PER2 pattern in the BLA 
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and DG. Together, these findings suggest that dopaminergic activity does not 
regulate PER2 expression in either of these regions. 
Manipulation of catecholamine levels using AMPT treatment and daily 
morphine injection and withdrawal, however, had a profound effect on the daily 
pattern of PER2 in the BLA and DG. These findings highlight an important role 
for NA in the regulation of PER2 expression in these regions. Following the last 
morphine injection, PER2 expression in both the BLA and DG was reduced at the 
normal peak time of ZT1, but was strongly elevated at ZT13, 8-9 h after the final 
injection. The normal peak of PER2 expression in these regions was also 
strongly suppressed within 48 h after the last morphine injection and following 
AMPT treatment. Taken together, this pattern of results suggests that NA 
signaling specifically contributes to the daily fluctuation in PER2 expression in 
these regions, and opens an interesting new avenue for research into this 
relation. 
SCN 
None of the experimental manipulations disrupted the normal daily 
fluctuation in PER2 expression in the SCN. This finding was not unexpected, 
given that the LD schedule is the primary zeitgeber to entrain clock gene rhythms 
in this region and a normal 12:12 LD cycle was maintained in all of these 
experiments. Furthermore, other studies examining the effects of non-photic 
cues in the entrainment of clock gene expression, such as restricted feeding 
schedules, have shown that the rhythm of PER2 expression in this region 
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remains entrained to normal LD conditions (Waddington Lamont et al., 2007). As 
previously noted, DA plays a critical role during early development of the rat in 
the entrainment of the rhythm of fos expression in the foetal SCN, as well as the 
subsequent locomotor activity rhythm in the neonate. However, studies of the 
adult rat indicate that changes in catecholamine signaling have no effect on clock 
gene expression in the master clock and the results of this thesis support this 
conclusion. 
Mechanisms of DA modulation of PER2 expression 
In the following sections, the possible mechanisms by which DA signaling 
via D2 receptors modulates PER2 are considered. The potential contributions of 
other, non-dopaminergic signaling mechanisms are also reviewed, given that the 
effects of a 6-OHDA lesion, AMPT treatment, and daily morphine injections and 
withdrawal are not limited to DA but also extend to NA, CRH, opiate, and 
glutamate signaling. Previous evidence suggests that changes in these systems, 
as well as another, melatonin, could play a role in modulating PER2 expression. 
DA stimulation of D2 receptors 
As discussed in chapter 1, several different mechanisms could underlie 
the effect of DA signaling on PER2 expression, including changes at the level of 
Per2 mRNA transcription, changes at the level of the PER2 protein itself through 
post-translational modifications, and changes in the transcription and/or 
translation of other components of the molecular clockwork that in turn affect the 
expression of Per2. Preliminary findings from Weigl and colleagues (2010) using 
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real time PCR suggest that at least part of the effect of DA on PER2 expression 
in the dorsal striatum that we observed with 6-OHDA lesioning is mediated at the 
level of Per2 transcription. This finding is consistent with other reports of a role 
for D2 receptors in regulating rhythmic Per2 expression in the striatum (Sahar et 
al., 2010). These results do not exclude the possibility that stimulation of D2 
receptors could also directly modify the expression of the PER2 protein, 
however. For example, converging evidence suggests a possible mechanism 
whereby D2 receptor stimulation increases phosphorylation of PER2 by 
activation of the Akt-GSK3U pathway. In the dorsal striatum, binding of D2 
receptors increases the phosphorylation activity of GSK3IS (Beaulieu et al., 2004; 
Beaulieu et al., 2007), a kinase thought to play a critical role in regulating the 
'speed' of the circadian clock through phosphorylation of clock proteins, including 
PER2 (litaka et al., 2005). Specifically, phosphorylation of PER2 by GSK3R is 
reported to affect the rate of nuclear translocation of PER2 from the cytoplasm by 
modulating its interaction with other clock proteins (Martinek et al., 2001). 
Importantly, GSK3R phosphorylates other components of the clock, such as 
BMAL1 (Sahar et al., 2010), suggesting that D2 receptor-mediated changes in 
GSK3U activity could affect PER2 protein expression indirectly as well as directly. 
An additional route of action of DA receptor signaling on PER expression 
has been proposed in studies of the retina. As noted in the general introduction 
and chapter 1, in vitro studies of the African clawed frog (xenopus laevi) and 
mouse retina have demonstrated that stimulation of D2 receptors using 
quinpirole upregulates expression of Perl and Per2 through a CREB-dependent 
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mechanism (Besharse et al., 2004; Yujnovsky et al., 2006). Activation of the D2 
receptor regulates the cAMP-CREB pathway (Montmayeur and Borrelli, 1991) 
and a CRE-responsive element has been identified on the Per2 promoter 
(Travnickova-Bendova et al., 2002). Interestingly, Yujnovsky and colleagues 
(2006) proposed a model in which D2 receptor signaling increases levels of 
phosphorylated CREB, which interacts with the CLOCK:BMAL1 dimer to 
enhance its transcriptional activity at E box sites on the Perl promoter. Thus, in 
this model, the enhancement of PER expression by DA in the retina is mediated 
through actions on other components of the clock. It is important to note, 
however, that findings from a study of explants of retina from PER2::Luc mice 
suggest that the phase of the PER2 rhythm in this tissue is regulated by an 
action of DA at D1 receptors and not D2 (Ruan et al., 2008). This finding 
suggests that the mechanisms by which DA signaling affects PER2 expression in 
this tissue remain unclear and caution against extrapolating results from one 
tissue to another. 
Noradrenaline (NA) 
Given that AMPT treatment and daily morphine injection and withdrawal 
are not DA-selective manipulations, but influence noradrenergic activity as well, 
changes in NA signaling are a likely contributor to the effects on PER2 
expression observed in these experiments. A possible role for NA in regulating 
PER2 expression is best illustrated by the results of the AMPT experiment, in 
which a profound decrease in PER2 was observed not only in the dorsal striatum 
but also in the BLA and DG (and primary motor cortex, reported in chapter 1). 
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Although the amount of noradrenergic innervation to the dorsal striatum is 
modest relative to DA innervation, the greater reduction in PER2 expression 
following inhibition of catecholamine synthesis with AMPT compared to the effect 
of a 6-OHDA lesion suggests that NA can influence PER2 in the striatum. An 
effect of NA signaling in clock gene expression is also evidenced by the dramatic 
reduction in the daily peak of PER2 expression in the BLA and DG following 
AMPT treatment but not after a 6-OHDA lesion. This outcome is particularly 
interesting, because it suggests that the effect of different catecholamines on the 
regulation of PER2 expression is specific to different regions of the forebrain. 
The effects of daily morphine injections and withdrawal of morphine also 
support a tissue-specific involvement of NA in regulation of PER2 expression. 
What is interesting to note in the context of the morphine experiment, however, is 
that previous evidence shows that the activity of noradrenergic cell groups 
increases following cessation of chronic treatment with opiates (Maldonado, 
1997), an event that is associated with the somatic symptoms of opiate 
withdrawal (Delfs et al., 2000). However, PER2 expression in the dorsal 
striatum, BLA, and DG was significantly decreased at 46-58 h after morphine 
withdrawal as well as following the NA-depleting effects of AMPT treatment. To 
better characterize the contribution of NA to the changes in PER2 observed in 
this early period after the last morphine injection, we are conducting additional 
experiments in which clonidine, an inhibitor of NA release, is administered for two 
days beginning immediately after the final morphine injection. 
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As reviewed in chapters 1 and 2, there is already some evidence in the 
literature suggesting a role for NA signaling in the regulation of circadian 
rhythms. In particular, efferents from the SCN project indirectly to noradrenergic 
neurons in the locus coeruleus (Aston-Jones et al., 2001) and levels of NA in the 
forebrain are modulated by light exposure (Gonzalez and Aston-Jones, 2006). 
SCN-mediated activation of NA inputs to the pineal gland in rats and hamsters 
regulates the circadian rhythm of melatonin synthesis and the expression of Perl 
and Cry1 in this region (Simonneaux et al., 2004). Furthermore, depletion of NA 
levels in the forebrain of the mouse, as a result of a mutation in the development 
of noradrenergic projections, is associated with a loss of normal clock gene 
expression in cortex and impaired phase-shifting of locomotor activity following a 
light pulse (Warnecke et al., 2005). Other findings, however, indicate no effect of 
NA on clock gene expression in peripheral tissues (Reilly et al., 2008). Taken 
together, the evidence to date suggests that the role of NA in regulating clock 
gene expression might be region-specific, similar to the action of DA. 
The specific intracellular mechanisms by which NA might regulate clock 
gene expression have not, to my knowledge, been investigated. It would be of 
interest to determine whether the actions of NA and DA are similar; for example, 
involving changes in the cAMP-CREB pathway. Future studies using 6-OHDA 
lesions to target NA fibers specifically, such as through direct injection of the 
toxin into the LC or using pre-treatment with a DAT-selective blocker, like GBR 
12909, to protect DA fibers could address these questions. 
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CRH 
As previously noted, research from the Amir laboratory has demonstrated 
that CRH levels affect PER2 expression in the BNSTov (Bhargava et al., 2006). 
CRH levels, specifically in the BNSTov and CEA, were very likely affected by 
some of the experimental manipulations performed, such as 6-OHDA lesioning 
and daily morphine injections. These effects have been discussed in the 
previous chapters and future experiments in which CRH levels are directly 
measured or manipulated, using central infusions of CRH receptor-selective 
drugs or double-stranded RNA (ds-RNA) against CRH for example, might prove 
useful in determining the contribution of this system to the effect of DA on PER2 
in the BNSTov and CEA. Furthermore, in view of evidence that CRH levels can 
modulate the effect of other signals, such as glutamate, in regulating the activity 
of cells in regions such as the BNSTov (e.g., Kash et al., 2008), CRH signaling 
might act as an intermediary between DA and other systems in the modulation of 
clock gene expression. In support of this idea, Bhargava et al. (2006) showed in 
the BNSTov that PER2 and CRH are expressed in separate cell populations. 
Related to the effects of CRH on clock gene expression in these regions is 
the influence of corticosterone levels on PER2. As previously noted, rhythmic 
corticosterone secretion is regulated by signals from the SCN and exogenous 
delivery of corticosterone to adrenalectomized rats can entrain the PER2 rhythm 
in the BNSTov and CEA (Segall et al., 2006; Segall and Amir, 2010). Previous 
evidence has shown that basal corticosterone levels significantly increase in 
rodents following the cessation of chronic opiate exposure (Pechnick, 1993). We 
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have also observed an increase in basal corticosterone levels in rats following 
the last daily morphine injection (unpublished observations). Similarly, in 
humans withdrawing from long-term heroin use, the normal circadian rhythm of 
adrenocorticotropin releasing hormone secretion, a critical signal in the regulation 
of the HPA axis, is blunted for up to one month after the last drug use (Li et al., 
2009b). As such, it is possible that changes in corticosterone secretion as a 
result of the daily morphine injections and withdrawal of morphine are implicated 
in the changes in clock gene expression in the BNSTov and CEA. 
Opiates 
As reviewed in chapter 3, opiates have been shown previously to affect 
aspects of circadian functioning, including locomotor activity rhythms (Marchant 
and Mistlberger, 1995), the firing rate of SCN neurons, and modulating the 
effects of light in inducing Perl expression in the hamster SCN (Vansteensel et 
al., 2005). Other reports indicate that repeated injections of morphine upregulate 
expression of Pert in frontal cortex (Ammon et al., 2003), and that the rhythms of 
Perl and Per2 transcription in multiple brain regions, including CEA, 
hippocampus, nucleus accumbens, and ventral tegmental area, are disrupted 
following cessation of repeated morphine injections (Li et al., 2009a). As 
previously noted, acute injection of opiates including morphine results in 
increased extracellular levels of DA in terminal regions of the mesolimbic DA 
system through a disinhibition of DA cell bodies in the ventral tegmental area. 
However, opiate receptors are also present in each forebrain region examined in 
these experiments (Ding et al., 1996), which allows for the possibility of a local 
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action of morphine on clock gene expression. The specific mechanisms by which 
opiates influence clock gene expression have not been investigated. Within the 
dorsal striatum, however, the observation that u opiate receptors are primarily 
expressed by D1 receptor-bearing neurons (Delfs et al., 1994), as well as by 
cholinergic interneurons (Jabourian et al., 2005), implies that the actions of 
morphine in modulating PER2 expression, at least within this region, would 
presumably be indirect. 
Glutamate 
Glutamate release from fibers in the retinohypothalamic tract regulates 
expression of clock genes in the SCN. Given the abundance of evidence 
indicating a role for DA in modulating the effects of glutamate on cellular activity 
in several different brain regions, including those examined in the present 
studies, glutamatergic signaling is likely implicated in the changes in PER2 
observed following both selective manipulations of DA levels and manipulations 
of catecholamine levels in general. For example, depletion of DA content in the 
striatum using 6-OHDA lesions or AMPT is associated with a rapid loss of 
dendritic spines on D2 receptor-expressing medium spiny neurons, on which 
glutamatergic corticostriatal fibers form synapses (Day et al., 2006). Similarly, 
repeated exposure to drugs of abuse also induces changes in glutamatergic 
signaling in terminal regions of the mesolimbic DA system (e.g., Sepulveda et al., 
2004; Fu et al., 2007; Kourrich et al., 2007; Dumont et al., 2008). In the SCN, 
calcium-dependent modulation of the cAMP-CREB pathway following stimulation 
of NMDA receptors has been shown to regulate fos expression in response to 
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light (Schurov et al., 1999), and perhaps a similar mechanism might operate in 
regions such as the dorsal striatum in the regulation of PER2 expression. 
Interestingly, blockade of voltage-gated calcium channels containing the cav1.3 
subunit has been shown to prevent the loss of dendritic spines on striatopallidal 
medium spiny neurons following a 6-OHDA lesion or AMPT treatment, 
suggesting that the effect of DA depletion on glutamatergic regulation of these 
cells involves changes in calcium signaling (Day et al., 2006). 
Melatonin 
Although the involvement of melatonin signaling in the effects of DA on 
PER2 expression was not discussed previously, evidence suggests that these 
two systems are closely interrelated. Melatonin synthesis and release from the 
pineal gland are prominent circadian signals that are downstream of SCN control, 
and which in turn influence the organization of the locomotor activity rhythm, the 
activity of the SCN (for a review, see Cassone, 1990), and the expression of 
clock genes. For example, removal of circulating melatonin in mice through 
pinealectomy abolishes Perl mRNA and PER1 protein rhythms in the dorsal and 
ventral striatum (Uz et al., 2003). However, this regulation of the clock by 
melatonin appears to be both tissue- and gene-specific, as pinealectomy was not 
found to affect Perl or Per2 mRNA in the SCN (Oishi et al., 2000), or the 
rhythms of PER2 expression in SCN, dorsal striatum, BNSTov, CEA, or DG in 
rats (Amir et al., 2006), even though each of these regions expresses melatonin 
receptors (Laudon et al., 1988; Musshoff et al., 2002; Uz et al., 2003). 
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Importantly, there is evidence for a mutually inhibitory relationship 
between melatonin and DA in tissues such as the retina. The rhythms of DA and 
melatonin release in the retina are 180 degrees out of phase with each other, 
and stimulation of melatonin receptors during the dark phase prevents DA 
release, whereas stimulation of D2 receptors during the light phase inhibits 
melatonin release (for a review, see Tosini et al., 2008). Behavioral evidence 
also suggests that this mutual antagonism operates in the striatum. For 
example, the reduction of melatonin by pinealectomy in mice enhances the 
expression of locomotor sensitization to cocaine during the dark phase (Uz et al., 
2003), whereas injections of high doses of melatonin inhibit locomotor activity 
(Chuang and Lin, 1994). It has also been proposed that an imbalance between 
melatonin and DA levels contributes to the circadian disruptions and motor 
deficits observed in Parkinson's disease (PD) (Willis, 2008). Thus, it is possible 
that the reduction in PER2 expression in the dorsal striatum following depletion of 
DA or catecholamines in general could be attributable in part to a dysregulation 
of melatonin signaling. To examine this possibility, it would be of interest to 
investigate whether blockade of melatonin receptors in the dorsal striatum, for 
example, would influence the loss of PER2 expression in this region following a 
unilateral 6-OHDA lesion. 
Functional significance of DA modulation of PER2 expression 
The findings of the present thesis suggest a number of implications for the 
role of circadian clockwork in brain regions outside of the SCN, specifically the 
dorsal striatum, and provide further insight into the mechanisms involved in the 
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regulation of circadian rhythms in general. These implications are discussed in 
the following sections. In particular, the finding that a shift in the normal rhythm 
of PER2 expression in the dorsal striatum was associated with a loss of the 
normal increase in wheel running at night suggests that one role of a striatal 
clock is to regulate the circadian locomotor activity rhythm. More generally, the 
responsiveness of PER2 to DA signaling suggests that events that activate 
midbrain DA neurons, such as rewards, can influence the rhythmic activity of the 
dorsal striatum. Importantly, however, this responsiveness also renders the 
circadian clock in this region vulnerable to potentially maladaptive signals that 
distort normal dopaminergic activity, such as drugs of abuse. 
PER2 in the dorsal striatum regulates daily wheel-running activity 
Several findings from the present experiments indicate that the daily 
fluctuation in PER2 expression in the dorsal striatum is associated with the daily 
wheel-running activity rhythm. First, both daily injections of quinpirole in 6-OHDA 
lesioned rats and morphine injections in intact rats dramatically suppressed 
nighttime wheel running in addition to shifting the daily rise in PER2 in the dorsal 
striatum away from its normal peak in the early morning. Notably, quinpirole 
injections in naive rats did not affect the normal PER2 rhythm in the dorsal 
striatum, nor did they markedly suppress nighttime activity. Second, the 
observation from the double immunolabeling study that PER2 expression in the 
dorsal striatum is primarily found in D2 receptor- and enkephalin-positive cells 
suggests that rhythmic PER2 expression in this region is confined to 
striatopallidal neurons. Importantly, this projection pathway from the dorsal 
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striatum is implicated in the regulation of locomotor activity (Albin et al., 1989; 
Durieuxetal.,2009). 
Interestingly, other studies have illustrated the importance of D2 receptor 
stimulation and rhythmic clock gene expression in the dorsal striatum for normal 
activity rhythms. For example, D2 receptor knock-out mice show less of a day-
night difference in their locomotor activity and exhibit reduced masking of activity 
by light (Doi et al., 2006). Although the disruption of rhythmic activity in these 
mice has been attributed to the loss of D2 receptors in the retina, the rhythms of 
Per2 and dbp transcription, as well as BMAL1 phosphorylation in the striatum of 
these mice are also significantly blunted (Sahar et al., 2010). A number of other 
findings in the literature have demonstrated an association between changes in 
clock gene rhythms in the striatum and changes in the rhythm of locomotor 
activity (e.g., Masubuchi et al., 2000). An interesting illustration of this 
association is found in studies of the diurnal grass rat (Arvicanthis niloticus). 
Normally, this rodent is active during the light phase; however, if given access to 
a running wheel, some grass rats develop a nocturnal activity pattern. Notably, it 
has been reported that the phase of PER1 expression in the striatum varies 
according to the activity rhythm of the individual animal, such that expression of 
PER1 peaks during the inactive phase irrespective of whether this inactivity 
occurs during the light or dark (Ramanathan et al., 2008). 
Related to the involvement of a striatal clock in the regulation of activity 
rhythms is the expression of a so-called 'anticipatory' activity rhythm in advance 
of a predictable, salient event, such as food delivery to food-restricted rats. 
163 
Bouts of anticipatory activity have been reported to develop in advance of daily, 
timed injections of drugs of abuse, and we report a similar, albeit modest effect in 
our morphine experiments. Some have emphasized the importance of 
anticipatory activity as a marker of entrainment by non-photic cues, such as 
restricted feeding schedules. However, the notion that the development of 
anticipatory running to a daily morphine injection contributed to the shift in PER2 
expression observed in the dorsal striatum of these rats is undermined by other 
results, such as those from the quinpirole injection study in 6-OHDA-lesioned 
rats, in which daily quinpirole injections re-entrained the expression of PER2 in 
the lesioned striatum but did not elicit any anticipatory wheel running. 
Furthermore, 6-OHDA-lesioned rats that were injected with the D1 receptor 
agonist, SKF 81297, exhibited an increase in wheel-running activity at the time of 
the daily injection, but showed no changes in PER2 expression in the dorsal 
striatum of either hemisphere. Several studies of anticipatory running in food-
restricted rodents suggest that this activity is regulated by the dorsomedial 
hypothalamus (Gooley et al., 2006; Fuller et al., 2008), although others have 
disputed this conclusion (Verwey et al., 2009). Taken together, these findings 
suggest that although the striatal clock is associated with the wheel-running 
activity rhythm, it is not clearly involved in the development of anticipatory 
activity. 
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Extracellular DA levels in the dorsal striatum: a clock-controlled output and 
entrainment signal 
Finally, the finding that DA can affect the expression of clock genes in 
extra-SCN tissues is particularly intriguing in light of previous evidence showing 
that clock genes regulate the activity of midbrain DA systems themselves. 
Specifically, clock gene expression in the ventral tegmental area has been shown 
to regulate the firing rate of DA neurons (McClung et al., 2005; Roybal et al., 
2007; Mukherjee et al., 2010), and the Pert gene is implicated in the expression 
of monoamine oxidase A in the striatum (Hampp et al., 2008). Behavioral studies 
indicate that responding for particular rewards follows a circadian rhythm (for a 
review, see Webb et al., 2009b); for example, rats given 24-h access to cocaine 
self-administer more drug during the dark phase than the light (Roberts et al., 
2002; Bass et al., 2010), and male rats show a greater conditioned place 
preference during the mid-dark phase than during the light for an environment 
previously paired with access to a sexually receptive female (Webb et al., 
2009c). The daily variation in responding to these rewards might be mediated in 
part by rhythmic clock gene expression in the midbrain (Roybal et al., 2007). 
Taken together with the present results that DA signaling can itself entrain the 
expression of PER2 in the striatum, these findings suggest that daily fluctuation 
in extracellular DA levels is both a clock-controlled output signal and an 
entrainment signal for rhythmic clock gene expression in the dorsal striatum. 
That PER2 expression in the dorsal striatum can be modified 
independently of the LD schedule by stimulation of DA receptors suggests a 
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mechanism by which events that activate DA release, such as rewards, can 
influence the circadian functioning of an organism. This mechanism could allow 
an organism to adjust its daily pattern of activities to take advantage of 
predictable events that are rewarding or have adaptive value. Such a 
mechanism could also prove disadvantageous, however, in that it renders 
circadian systems vulnerable to potentially harmful stimuli that distort the normal 
pattern of DA signaling, such as late-night activity schedules associated with shift 
work, drugs of abuse, or diseases of catecholamine systems, as in the case of 
PD. Given the interaction between clock gene expression and activity of 
midbrain DA systems, a dysregulation of either DA tone or clock gene expression 
in regions such as the ventral tegmental area or the dorsal striatum could 
perhaps contribute to the circadian symptoms observed in mood disorders, 
substance abuse, and PD. 
It also follows from the above suggestion, however, that treatments 
targeting the circadian clock might prove effective in alleviating certain 
pathologies. There is already some support for this proposal. For example, 
lithium treatment for bipolar disorder has been demonstrated to lengthen the 
period of the circadian clock as a result of the effect of lithium on the 
phosphorylation activity of GSK3IS (Martinek et al., 2001; Doble and Woodgett, 
2003; Beaulieu et al., 2007). Also supporting circadian-oriented treatments are 
new clinical findings of an effect of melatonin agonists in the treatment of 
depression (Mendlewicz, 2009), as well as previous evidence showing roles for 
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light therapy and sleep deprivation in alleviating depression (Wirz-Justice and 
Van den Hoofdakker, 1999). 
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